id	sid	tid	token	lemma	pos
dti-2613	1	1	dti	dti	PROPN
dti-2613	1	2	drug	drug	PROPN
dti-2613	1	3	target	target	NOUN
dti-2613	1	4	insights	insight	NOUN
dti-2613	1	5	2023	2023	NUM
dti-2613	1	6	;	;	PUNCT
dti-2613	1	7	17	17	NUM
dti-2613	1	8	:	:	SYM
dti-2613	1	9	92	92	NUM
dti-2613	1	10	-	-	SYM
dti-2613	1	11	100	100	NUM
dti-2613	1	12	issn	issn	PROPN
dti-2613	1	13	1177	1177	NUM
dti-2613	1	14	-	-	SYM
dti-2613	1	15	3928	3928	NUM
dti-2613	1	16	|	|	ADV
dti-2613	1	17	doi	doi	NOUN
dti-2613	1	18	:	:	PUNCT
dti-2613	1	19	10.33393	10.33393	NUM
dti-2613	1	20	/	/	SYM
dti-2613	1	21	dti.2023.2613	dti.2023.2613	ADJ
dti-2613	1	22	original	original	ADJ
dti-2613	1	23	research	research	NOUN
dti-2613	1	24	article	article	NOUN
dti-2613	1	25	drug	drug	NOUN
dti-2613	1	26	target	target	NOUN
dti-2613	1	27	insights	insight	NOUN
dti-2613	1	28	issn	issn	VERB
dti-2613	1	29	1177	1177	NUM
dti-2613	1	30	-	-	SYM
dti-2613	1	31	3928	3928	NUM
dti-2613	1	32	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2613	1	33	©	©	PROPN
dti-2613	1	34	2023	2023	NUM
dti-2613	1	35	the	the	DET
dti-2613	1	36	authors	author	NOUN
dti-2613	1	37	.	.	PUNCT
dti-2613	2	1	this	this	DET
dti-2613	2	2	article	article	NOUN
dti-2613	2	3	is	be	AUX
dti-2613	2	4	published	publish	VERB
dti-2613	2	5	by	by	ADP
dti-2613	2	6	aboutscience	aboutscience	NOUN
dti-2613	2	7	and	and	CCONJ
dti-2613	2	8	licensed	license	VERB
dti-2613	2	9	under	under	ADP
dti-2613	2	10	creative	creative	ADJ
dti-2613	2	11	commons	common	NOUN
dti-2613	2	12	attribution	attribution	NOUN
dti-2613	2	13	-	-	PUNCT
dti-2613	2	14	noncommercial	noncommercial	ADJ
dti-2613	2	15	4.0	4.0	NUM
dti-2613	2	16	international	international	NOUN
dti-2613	2	17	(	(	PUNCT
dti-2613	2	18	cc	cc	NOUN
dti-2613	2	19	by	by	ADP
dti-2613	2	20	-	-	PUNCT
dti-2613	2	21	nc	nc	PROPN
dti-2613	2	22	4.0	4.0	NUM
dti-2613	2	23	)	)	PUNCT
dti-2613	2	24	.	.	PUNCT
dti-2613	3	1	commercial	commercial	ADJ
dti-2613	3	2	use	use	NOUN
dti-2613	3	3	is	be	AUX
dti-2613	3	4	not	not	PART
dti-2613	3	5	permitted	permit	VERB
dti-2613	3	6	and	and	CCONJ
dti-2613	3	7	is	be	AUX
dti-2613	3	8	subject	subject	ADJ
dti-2613	3	9	to	to	ADP
dti-2613	3	10	publisher	publisher	NOUN
dti-2613	3	11	’s	’s	PART
dti-2613	3	12	permissions	permission	NOUN
dti-2613	3	13	.	.	PUNCT
dti-2613	4	1	full	full	ADJ
dti-2613	4	2	information	information	NOUN
dti-2613	4	3	is	be	AUX
dti-2613	4	4	available	available	ADJ
dti-2613	4	5	at	at	ADP
dti-2613	4	6	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2613	4	7	esbl	esbl	NOUN
dti-2613	4	8	and	and	CCONJ
dti-2613	4	9	carbapenemase	carbapenemase	NOUN
dti-2613	4	10	-	-	PUNCT
dti-2613	4	11	producing	produce	VERB
dti-2613	4	12	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	4	13	in	in	ADP
dti-2613	4	14	infectious	infectious	ADJ
dti-2613	4	15	pleural	pleural	ADJ
dti-2613	4	16	effusions	effusion	NOUN
dti-2613	4	17	:	:	PUNCT
dti-2613	4	18	current	current	ADJ
dti-2613	4	19	epidemiology	epidemiology	NOUN
dti-2613	4	20	at	at	ADP
dti-2613	4	21	hôpital	hôpital	PROPN
dti-2613	4	22	du	du	PROPN
dti-2613	4	23	mali	mali	PROPN
dti-2613	4	24	aimé	aimé	PROPN
dti-2613	4	25	césaire	césaire	PROPN
dti-2613	4	26	kalambry1	kalambry1	PROPN
dti-2613	4	27	,	,	PUNCT
dti-2613	4	28	tchamou	tchamou	NOUN
dti-2613	4	29	malraux	malraux	PROPN
dti-2613	4	30	fleury	fleury	PROPN
dti-2613	4	31	potindji2	potindji2	PROPN
dti-2613	4	32	,	,	PUNCT
dti-2613	4	33	ibrehima	ibrehima	PROPN
dti-2613	4	34	guindo3	guindo3	NOUN
dti-2613	4	35	,	,	PUNCT
dti-2613	4	36	ambara	ambara	PROPN
dti-2613	4	37	kassogue1	kassogue1	PROPN
dti-2613	4	38	,	,	PUNCT
dti-2613	4	39	boubacar	boubacar	NOUN
dti-2613	4	40	sidiki	sidiki	PROPN
dti-2613	4	41	ibrahim	ibrahim	PROPN
dti-2613	4	42	drame1	drame1	PROPN
dti-2613	4	43	,	,	PUNCT
dti-2613	4	44	seydou	seydou	ADJ
dti-2613	4	45	togo4	togo4	NOUN
dti-2613	4	46	,	,	PUNCT
dti-2613	4	47	sadio	sadio	NOUN
dti-2613	4	48	yena4	yena4	NOUN
dti-2613	4	49	,	,	PUNCT
dti-2613	4	50	seydou	seydou	PROPN
dti-2613	4	51	doumbia5,6	doumbia5,6	PROPN
dti-2613	4	52	,	,	PUNCT
dti-2613	4	53	mahamadou	mahamadou	VERB
dti-2613	4	54	diakite6,7	diakite6,7	PROPN
dti-2613	4	55	1medical	1medical	PROPN
dti-2613	4	56	biology	biology	NOUN
dti-2613	4	57	laboratory	laboratory	NOUN
dti-2613	4	58	,	,	PUNCT
dti-2613	4	59	“	"	PUNCT
dti-2613	4	60	hôpital	hôpital	PROPN
dti-2613	4	61	du	du	PROPN
dti-2613	4	62	mali	mali	PROPN
dti-2613	4	63	”	"	PUNCT
dti-2613	4	64	teaching	teaching	NOUN
dti-2613	4	65	hospital	hospital	NOUN
dti-2613	4	66	,	,	PUNCT
dti-2613	4	67	bamako	bamako	PROPN
dti-2613	4	68	mali	mali	VERB
dti-2613	4	69	2graduate	2graduate	NUM
dti-2613	4	70	school	school	NOUN
dti-2613	4	71	of	of	ADP
dti-2613	4	72	biological	biological	ADJ
dti-2613	4	73	and	and	CCONJ
dti-2613	4	74	food	food	NOUN
dti-2613	4	75	techniques	technique	NOUN
dti-2613	4	76	,	,	PUNCT
dti-2613	4	77	university	university	NOUN
dti-2613	4	78	of	of	ADP
dti-2613	4	79	lomé	lomé	NOUN
dti-2613	4	80	,	,	PUNCT
dti-2613	4	81	lomé	lomé	ADJ
dti-2613	4	82	togo	togo	PROPN
dti-2613	4	83	3national	3national	PROPN
dti-2613	4	84	institute	institute	NOUN
dti-2613	4	85	of	of	ADP
dti-2613	4	86	public	public	ADJ
dti-2613	4	87	health	health	NOUN
dti-2613	4	88	,	,	PUNCT
dti-2613	4	89	bamako	bamako	PROPN
dti-2613	4	90	mali	mali	VERB
dti-2613	4	91	4department	4department	NUM
dti-2613	4	92	of	of	ADP
dti-2613	4	93	thoracic	thoracic	NOUN
dti-2613	4	94	surgery	surgery	NOUN
dti-2613	4	95	,	,	PUNCT
dti-2613	4	96	“	"	PUNCT
dti-2613	4	97	hôpital	hôpital	PROPN
dti-2613	4	98	du	du	PROPN
dti-2613	4	99	mali	mali	PROPN
dti-2613	4	100	”	"	PUNCT
dti-2613	4	101	teaching	teaching	NOUN
dti-2613	4	102	hospital	hospital	NOUN
dti-2613	4	103	,	,	PUNCT
dti-2613	4	104	bamako	bamako	PROPN
dti-2613	4	105	mali	mali	VERB
dti-2613	4	106	5faculty	5faculty	NUM
dti-2613	4	107	of	of	ADP
dti-2613	4	108	medicine	medicine	NOUN
dti-2613	4	109	and	and	CCONJ
dti-2613	4	110	odontostomatology	odontostomatology	NOUN
dti-2613	4	111	of	of	ADP
dti-2613	4	112	bamako	bamako	PROPN
dti-2613	4	113	,	,	PUNCT
dti-2613	4	114	bamako	bamako	PROPN
dti-2613	4	115	mali	mali	VERB
dti-2613	4	116	6university	6university	NUM
dti-2613	4	117	clinical	clinical	ADJ
dti-2613	4	118	research	research	NOUN
dti-2613	4	119	center	center	NOUN
dti-2613	4	120	(	(	PUNCT
dti-2613	4	121	ucrc	ucrc	PROPN
dti-2613	4	122	)	)	PUNCT
dti-2613	4	123	,	,	PUNCT
dti-2613	4	124	university	university	NOUN
dti-2613	4	125	of	of	ADP
dti-2613	4	126	science	science	NOUN
dti-2613	4	127	,	,	PUNCT
dti-2613	4	128	technique	technique	NOUN
dti-2613	4	129	and	and	CCONJ
dti-2613	4	130	technologies	technology	NOUN
dti-2613	4	131	of	of	ADP
dti-2613	4	132	bamako	bamako	PROPN
dti-2613	4	133	,	,	PUNCT
dti-2613	4	134	bamako	bamako	PROPN
dti-2613	4	135	mali	mali	VERB
dti-2613	4	136	7malaria	7malaria	PROPN
dti-2613	4	137	research	research	NOUN
dti-2613	4	138	and	and	CCONJ
dti-2613	4	139	training	training	NOUN
dti-2613	4	140	center	center	NOUN
dti-2613	4	141	(	(	PUNCT
dti-2613	4	142	mrtc	mrtc	PROPN
dti-2613	4	143	)	)	PUNCT
dti-2613	4	144	,	,	PUNCT
dti-2613	4	145	bamako	bamako	PROPN
dti-2613	4	146	mali	mali	VERB
dti-2613	4	147	abstract	abstract	ADJ
dti-2613	4	148	background	background	NOUN
dti-2613	4	149	:	:	PUNCT
dti-2613	4	150	antimicrobial	antimicrobial	ADJ
dti-2613	4	151	resistance	resistance	NOUN
dti-2613	4	152	(	(	PUNCT
dti-2613	4	153	amr	amr	NOUN
dti-2613	4	154	)	)	PUNCT
dti-2613	4	155	is	be	AUX
dti-2613	4	156	a	a	DET
dti-2613	4	157	global	global	ADJ
dti-2613	4	158	health	health	NOUN
dti-2613	4	159	concern	concern	NOUN
dti-2613	4	160	,	,	PUNCT
dti-2613	4	161	with	with	ADP
dti-2613	4	162	extended	extend	VERB
dti-2613	4	163	-	-	PUNCT
dti-2613	4	164	spectrum	spectrum	NOUN
dti-2613	4	165	β	β	NOUN
dti-2613	4	166	-	-	NOUN
dti-2613	4	167	lactamases	lactamase	NOUN
dti-2613	4	168	(	(	PUNCT
dti-2613	4	169	esbls	esbls	PROPN
dti-2613	4	170	)	)	PUNCT
dti-2613	4	171	and	and	CCONJ
dti-2613	4	172	carbapenemases	carbapenemase	NOUN
dti-2613	4	173	being	be	AUX
dti-2613	4	174	major	major	ADJ
dti-2613	4	175	contributors	contributor	NOUN
dti-2613	4	176	.	.	PUNCT
dti-2613	5	1	pleural	pleural	ADJ
dti-2613	5	2	infection	infection	NOUN
dti-2613	5	3	(	(	PUNCT
dti-2613	5	4	pi	pi	NOUN
dti-2613	5	5	)	)	PUNCT
dti-2613	5	6	is	be	AUX
dti-2613	5	7	a	a	DET
dti-2613	5	8	severe	severe	ADJ
dti-2613	5	9	condition	condition	NOUN
dti-2613	5	10	in	in	ADP
dti-2613	5	11	west	west	PROPN
dti-2613	5	12	africa	africa	PROPN
dti-2613	5	13	,	,	PUNCT
dti-2613	5	14	complicated	complicate	VERB
dti-2613	5	15	by	by	ADP
dti-2613	5	16	amr	amr	PROPN
dti-2613	5	17	.	.	PROPN
dti-2613	6	1	this	this	DET
dti-2613	6	2	study	study	NOUN
dti-2613	6	3	aimed	aim	VERB
dti-2613	6	4	to	to	PART
dti-2613	6	5	investigate	investigate	VERB
dti-2613	6	6	the	the	DET
dti-2613	6	7	prevalence	prevalence	NOUN
dti-2613	6	8	and	and	CCONJ
dti-2613	6	9	molecular	molecular	ADJ
dti-2613	6	10	characteristics	characteristic	NOUN
dti-2613	6	11	of	of	ADP
dti-2613	6	12	esbl	esbl	NOUN
dti-2613	6	13	and	and	CCONJ
dti-2613	6	14	carbapenemase	carbapenemase	NOUN
dti-2613	6	15	-	-	PUNCT
dti-2613	6	16	producing	produce	VERB
dti-2613	6	17	enterobacteria	enterobacteria	NOUN
dti-2613	6	18	in	in	ADP
dti-2613	6	19	pleural	pleural	ADJ
dti-2613	6	20	effusions	effusion	NOUN
dti-2613	6	21	in	in	ADP
dti-2613	6	22	mali	mali	PROPN
dti-2613	6	23	.	.	PUNCT
dti-2613	7	1	materials	material	NOUN
dti-2613	7	2	and	and	CCONJ
dti-2613	7	3	methods	method	NOUN
dti-2613	7	4	:	:	PUNCT
dti-2613	7	5	pleural	pleural	ADJ
dti-2613	7	6	fluid	fluid	ADJ
dti-2613	7	7	samples	sample	NOUN
dti-2613	7	8	from	from	ADP
dti-2613	7	9	526	526	NUM
dti-2613	7	10	patients	patient	NOUN
dti-2613	7	11	with	with	ADP
dti-2613	7	12	pleuritis	pleuritis	PROPN
dti-2613	7	13	were	be	AUX
dti-2613	7	14	analyzed	analyze	VERB
dti-2613	7	15	.	.	PUNCT
dti-2613	8	1	enterobacterial	enterobacterial	ADJ
dti-2613	8	2	species	specie	NOUN
dti-2613	8	3	were	be	AUX
dti-2613	8	4	isolated	isolate	VERB
dti-2613	8	5	and	and	CCONJ
dti-2613	8	6	identified	identify	VERB
dti-2613	8	7	,	,	PUNCT
dti-2613	8	8	and	and	CCONJ
dti-2613	8	9	the	the	DET
dti-2613	8	10	prevalence	prevalence	NOUN
dti-2613	8	11	of	of	ADP
dti-2613	8	12	resistance	resistance	NOUN
dti-2613	8	13	genes	gene	NOUN
dti-2613	8	14	(	(	PUNCT
dti-2613	8	15	blaoxa-48	blaoxa-48	NOUN
dti-2613	8	16	,	,	PUNCT
dti-2613	8	17	blandm-1	blandm-1	PROPN
dti-2613	8	18	,	,	PUNCT
dti-2613	8	19	blakpc	blakpc	NOUN
dti-2613	8	20	,	,	PUNCT
dti-2613	8	21	blatem	blatem	NOUN
dti-2613	8	22	,	,	PUNCT
dti-2613	8	23	blashv	blashv	NOUN
dti-2613	8	24	)	)	PUNCT
dti-2613	8	25	and	and	CCONJ
dti-2613	8	26	virulence	virulence	NOUN
dti-2613	8	27	factors	factor	NOUN
dti-2613	8	28	was	be	AUX
dti-2613	8	29	determined	determine	VERB
dti-2613	8	30	.	.	PUNCT
dti-2613	9	1	results	result	NOUN
dti-2613	9	2	:	:	PUNCT
dti-2613	9	3	among	among	ADP
dti-2613	9	4	the	the	DET
dti-2613	9	5	patients	patient	NOUN
dti-2613	9	6	,	,	PUNCT
dti-2613	9	7	110	110	NUM
dti-2613	9	8	were	be	AUX
dti-2613	9	9	diagnosed	diagnose	VERB
dti-2613	9	10	with	with	ADP
dti-2613	9	11	enterobacterial	enterobacterial	PROPN
dti-2613	9	12	pleuritis	pleuritis	PROPN
dti-2613	9	13	.	.	PUNCT
dti-2613	9	14	escherichia	escherichia	NOUN
dti-2613	9	15	coli	coli	NOUN
dti-2613	9	16	,	,	PUNCT
dti-2613	9	17	klebsiella	klebsiella	NOUN
dti-2613	9	18	pneumoniae	pneumoniae	ADJ
dti-2613	9	19	,	,	PUNCT
dti-2613	9	20	and	and	CCONJ
dti-2613	9	21	proteus	proteus	PROPN
dti-2613	9	22	mirabilis	mirabilis	PROPN
dti-2613	9	23	were	be	AUX
dti-2613	9	24	the	the	DET
dti-2613	9	25	main	main	ADJ
dti-2613	9	26	pathogens	pathogen	NOUN
dti-2613	9	27	identified	identify	VERB
dti-2613	9	28	.	.	PUNCT
dti-2613	10	1	resistance	resistance	NOUN
dti-2613	10	2	to	to	ADP
dti-2613	10	3	β	β	NOUN
dti-2613	10	4	-	-	NOUN
dti-2613	10	5	lactams	lactam	NOUN
dti-2613	10	6	and	and	CCONJ
dti-2613	10	7	cephalosporins	cephalosporin	NOUN
dti-2613	10	8	was	be	AUX
dti-2613	10	9	high	high	ADJ
dti-2613	10	10	,	,	PUNCT
dti-2613	10	11	while	while	SCONJ
dti-2613	10	12	carbapenems	carbapenem	NOUN
dti-2613	10	13	showed	show	VERB
dti-2613	10	14	good	good	ADJ
dti-2613	10	15	activity	activity	NOUN
dti-2613	10	16	.	.	PUNCT
dti-2613	11	1	esbl	esbl	PROPN
dti-2613	11	2	production	production	NOUN
dti-2613	11	3	was	be	AUX
dti-2613	11	4	detected	detect	VERB
dti-2613	11	5	in	in	ADP
dti-2613	11	6	33.6	33.6	NUM
dti-2613	11	7	%	%	NOUN
dti-2613	11	8	of	of	ADP
dti-2613	11	9	isolates	isolate	NOUN
dti-2613	11	10	,	,	PUNCT
dti-2613	11	11	with	with	ADP
dti-2613	11	12	blatem	blatem	NOUN
dti-2613	11	13	being	be	AUX
dti-2613	11	14	the	the	DET
dti-2613	11	15	most	most	ADV
dti-2613	11	16	common	common	ADJ
dti-2613	11	17	gene	gene	NOUN
dti-2613	11	18	.	.	PUNCT
dti-2613	12	1	carbapenemase	carbapenemase	NOUN
dti-2613	12	2	gene	gene	NOUN
dti-2613	12	3	(	(	PUNCT
dti-2613	12	4	blandm-1	blandm-1	NOUN
dti-2613	12	5	)	)	PUNCT
dti-2613	12	6	was	be	AUX
dti-2613	12	7	found	find	VERB
dti-2613	12	8	in	in	ADP
dti-2613	12	9	three	three	NUM
dti-2613	12	10	isolates	isolate	NOUN
dti-2613	12	11	.	.	PUNCT
dti-2613	13	1	conclusion	conclusion	NOUN
dti-2613	13	2	:	:	PUNCT
dti-2613	13	3	the	the	DET
dti-2613	13	4	study	study	NOUN
dti-2613	13	5	highlights	highlight	VERB
dti-2613	13	6	the	the	DET
dti-2613	13	7	high	high	ADJ
dti-2613	13	8	prevalence	prevalence	NOUN
dti-2613	13	9	of	of	ADP
dti-2613	13	10	multidrug	multidrug	NOUN
dti-2613	13	11	-	-	PUNCT
dti-2613	13	12	resistant	resistant	ADJ
dti-2613	13	13	bacteria	bacteria	NOUN
dti-2613	13	14	and	and	CCONJ
dti-2613	13	15	the	the	DET
dti-2613	13	16	need	need	NOUN
dti-2613	13	17	for	for	ADP
dti-2613	13	18	appropriate	appropriate	ADJ
dti-2613	13	19	antibiotic	antibiotic	ADJ
dti-2613	13	20	selection	selection	NOUN
dti-2613	13	21	based	base	VERB
dti-2613	13	22	on	on	ADP
dti-2613	13	23	local	local	ADJ
dti-2613	13	24	resistance	resistance	NOUN
dti-2613	13	25	patterns	pattern	NOUN
dti-2613	13	26	.	.	PUNCT
dti-2613	14	1	understanding	understand	VERB
dti-2613	14	2	the	the	DET
dti-2613	14	3	molecular	molecular	ADJ
dti-2613	14	4	characteristics	characteristic	NOUN
dti-2613	14	5	of	of	ADP
dti-2613	14	6	resistance	resistance	NOUN
dti-2613	14	7	is	be	AUX
dti-2613	14	8	crucial	crucial	ADJ
dti-2613	14	9	for	for	ADP
dti-2613	14	10	optimizing	optimize	VERB
dti-2613	14	11	patient	patient	NOUN
dti-2613	14	12	care	care	NOUN
dti-2613	14	13	and	and	CCONJ
dti-2613	14	14	developing	develop	VERB
dti-2613	14	15	effective	effective	ADJ
dti-2613	14	16	therapeutic	therapeutic	ADJ
dti-2613	14	17	strategies	strategy	NOUN
dti-2613	14	18	.	.	PUNCT
dti-2613	15	1	further	further	ADJ
dti-2613	15	2	research	research	NOUN
dti-2613	15	3	is	be	AUX
dti-2613	15	4	needed	need	VERB
dti-2613	15	5	to	to	PART
dti-2613	15	6	monitor	monitor	VERB
dti-2613	15	7	and	and	CCONJ
dti-2613	15	8	control	control	VERB
dti-2613	15	9	amr	amr	NOUN
dti-2613	15	10	in	in	ADP
dti-2613	15	11	pis	pis	NOUN
dti-2613	15	12	in	in	ADP
dti-2613	15	13	mali	mali	PROPN
dti-2613	15	14	.	.	PUNCT
dti-2613	16	1	keywords	keyword	NOUN
dti-2613	16	2	:	:	PUNCT
dti-2613	16	3	carbapenem	carbapenem	NOUN
dti-2613	16	4	-	-	PUNCT
dti-2613	16	5	resistant	resistant	ADJ
dti-2613	16	6	enterobacteriaceae	enterobacteriaceae	PROPN
dti-2613	16	7	,	,	PUNCT
dti-2613	16	8	esbl	esbl	PROPN
dti-2613	16	9	,	,	PUNCT
dti-2613	16	10	mali	mali	ADJ
dti-2613	16	11	,	,	PUNCT
dti-2613	16	12	pleural	pleural	ADJ
dti-2613	16	13	effusions	effusion	NOUN
dti-2613	16	14	received	receive	VERB
dti-2613	16	15	:	:	PUNCT
dti-2613	16	16	may	may	AUX
dti-2613	16	17	29	29	NUM
dti-2613	16	18	,	,	PUNCT
dti-2613	16	19	2023	2023	NUM
dti-2613	16	20	accepted	accept	VERB
dti-2613	16	21	:	:	PUNCT
dti-2613	16	22	august	august	PROPN
dti-2613	16	23	2	2	NUM
dti-2613	16	24	,	,	PUNCT
dti-2613	16	25	2023	2023	NUM
dti-2613	16	26	published	publish	VERB
dti-2613	16	27	online	online	ADV
dti-2613	16	28	:	:	PUNCT
dti-2613	16	29	august	august	PROPN
dti-2613	16	30	29	29	NUM
dti-2613	16	31	,	,	PUNCT
dti-2613	16	32	2023	2023	NUM
dti-2613	16	33	corresponding	correspond	VERB
dti-2613	16	34	author	author	NOUN
dti-2613	16	35	:	:	PUNCT
dti-2613	16	36	aimé	aimé	X
dti-2613	16	37	césaire	césaire	PROPN
dti-2613	16	38	kalambry	kalambry	PROPN
dti-2613	16	39	medical	medical	ADJ
dti-2613	16	40	biology	biology	NOUN
dti-2613	16	41	laboratory	laboratory	NOUN
dti-2613	16	42	,	,	PUNCT
dti-2613	16	43	hopital	hopital	PROPN
dti-2613	16	44	du	du	PROPN
dti-2613	16	45	mali	mali	PROPN
dti-2613	16	46	bamako	bamako	PROPN
dti-2613	16	47	mali	mali	VERB
dti-2613	17	1	kaimecesaire@gmail.com	kaimecesaire@gmail.com	PROPN
dti-2613	17	2	introduction	introduction	NOUN
dti-2613	17	3	infectious	infectious	ADJ
dti-2613	17	4	pleural	pleural	ADJ
dti-2613	17	5	effusion	effusion	NOUN
dti-2613	17	6	(	(	PUNCT
dti-2613	17	7	ipe	ipe	NOUN
dti-2613	17	8	)	)	PUNCT
dti-2613	17	9	is	be	AUX
dti-2613	17	10	a	a	DET
dti-2613	17	11	severe	severe	ADJ
dti-2613	17	12	clinical	clinical	ADJ
dti-2613	17	13	issue	issue	NOUN
dti-2613	17	14	.	.	PUNCT
dti-2613	18	1	often	often	ADV
dti-2613	18	2	secondary	secondary	ADJ
dti-2613	18	3	to	to	ADP
dti-2613	18	4	a	a	DET
dti-2613	18	5	pre	pre	ADJ
dti-2613	18	6	-	-	ADJ
dti-2613	18	7	evolving	evolve	VERB
dti-2613	18	8	pulmonary	pulmonary	ADJ
dti-2613	18	9	infection	infection	NOUN
dti-2613	18	10	,	,	PUNCT
dti-2613	18	11	the	the	DET
dti-2613	18	12	condition	condition	NOUN
dti-2613	18	13	presents	present	VERB
dti-2613	18	14	with	with	ADP
dti-2613	18	15	an	an	DET
dti-2613	18	16	increasing	increase	VERB
dti-2613	18	17	incidence	incidence	NOUN
dti-2613	18	18	worldwide	worldwide	ADV
dti-2613	18	19	(	(	PUNCT
dti-2613	18	20	1,2	1,2	NUM
dti-2613	18	21	)	)	PUNCT
dti-2613	18	22	.	.	PUNCT
dti-2613	19	1	care	care	NOUN
dti-2613	19	2	of	of	ADP
dti-2613	19	3	ipe	ipe	NOUN
dti-2613	19	4	involves	involve	VERB
dti-2613	19	5	pleural	pleural	ADJ
dti-2613	19	6	drainage	drainage	NOUN
dti-2613	19	7	in	in	ADP
dti-2613	19	8	most	most	ADJ
dti-2613	19	9	of	of	ADP
dti-2613	19	10	the	the	DET
dti-2613	19	11	cases	case	NOUN
dti-2613	19	12	and	and	CCONJ
dti-2613	19	13	antibiotic	antibiotic	ADJ
dti-2613	19	14	therapy	therapy	NOUN
dti-2613	19	15	;	;	PUNCT
dti-2613	19	16	however	however	ADV
dti-2613	19	17	,	,	PUNCT
dti-2613	19	18	treatment	treatment	NOUN
dti-2613	19	19	proves	prove	VERB
dti-2613	19	20	inadequate	inadequate	ADJ
dti-2613	19	21	in	in	ADP
dti-2613	19	22	substantial	substantial	ADJ
dti-2613	19	23	cases	case	NOUN
dti-2613	19	24	,	,	PUNCT
dti-2613	19	25	resulting	result	VERB
dti-2613	19	26	in	in	ADP
dti-2613	19	27	mortality	mortality	NOUN
dti-2613	19	28	rate	rate	NOUN
dti-2613	19	29	ranging	range	VERB
dti-2613	19	30	from	from	ADP
dti-2613	19	31	10.7	10.7	NUM
dti-2613	19	32	%	%	NOUN
dti-2613	19	33	to	to	PART
dti-2613	19	34	22	22	NUM
dti-2613	19	35	%	%	NOUN
dti-2613	19	36	(	(	PUNCT
dti-2613	19	37	3	3	NUM
dti-2613	19	38	-	-	SYM
dti-2613	19	39	5	5	NUM
dti-2613	19	40	)	)	PUNCT
dti-2613	19	41	.	.	PUNCT
dti-2613	20	1	few	few	ADJ
dti-2613	20	2	studies	study	NOUN
dti-2613	20	3	have	have	AUX
dti-2613	20	4	evaluated	evaluate	VERB
dti-2613	20	5	ipe	ipe	NOUN
dti-2613	20	6	management	management	NOUN
dti-2613	20	7	,	,	PUNCT
dti-2613	20	8	status	status	NOUN
dti-2613	20	9	,	,	PUNCT
dti-2613	20	10	and	and	CCONJ
dti-2613	20	11	microbiology	microbiology	NOUN
dti-2613	20	12	in	in	ADP
dti-2613	20	13	mali	mali	PROPN
dti-2613	20	14	.	.	PUNCT
dti-2613	21	1	a	a	DET
dti-2613	21	2	recent	recent	ADJ
dti-2613	21	3	study	study	NOUN
dti-2613	21	4	by	by	ADP
dti-2613	21	5	tapia	tapia	PROPN
dti-2613	21	6	et	et	PROPN
dti-2613	21	7	al	al	PROPN
dti-2613	21	8	in	in	ADP
dti-2613	21	9	2021	2021	NUM
dti-2613	21	10	reported	report	VERB
dti-2613	21	11	13.3	13.3	NUM
dti-2613	21	12	%	%	NOUN
dti-2613	21	13	mortality	mortality	NOUN
dti-2613	21	14	rate	rate	NOUN
dti-2613	21	15	(	(	PUNCT
dti-2613	21	16	6	6	NUM
dti-2613	21	17	)	)	PUNCT
dti-2613	21	18	.	.	PUNCT
dti-2613	22	1	among	among	ADP
dti-2613	22	2	causal	causal	ADJ
dti-2613	22	3	factors	factor	NOUN
dti-2613	22	4	predictive	predictive	ADJ
dti-2613	22	5	of	of	ADP
dti-2613	22	6	treatment	treatment	NOUN
dti-2613	22	7	failure	failure	NOUN
dti-2613	22	8	is	be	AUX
dti-2613	22	9	the	the	DET
dti-2613	22	10	alarming	alarming	ADJ
dti-2613	22	11	emergence	emergence	NOUN
dti-2613	22	12	of	of	ADP
dti-2613	22	13	antimicrobial	antimicrobial	ADJ
dti-2613	22	14	resistance	resistance	NOUN
dti-2613	22	15	(	(	PUNCT
dti-2613	22	16	amr	amr	NOUN
dti-2613	22	17	)	)	PUNCT
dti-2613	22	18	.	.	PUNCT
dti-2613	23	1	amr	amr	PROPN
dti-2613	23	2	has	have	AUX
dti-2613	23	3	emerged	emerge	VERB
dti-2613	23	4	as	as	ADP
dti-2613	23	5	a	a	DET
dti-2613	23	6	significant	significant	ADJ
dti-2613	23	7	global	global	ADJ
dti-2613	23	8	health	health	NOUN
dti-2613	23	9	concern	concern	NOUN
dti-2613	23	10	,	,	PUNCT
dti-2613	23	11	undermining	undermine	VERB
dti-2613	23	12	the	the	DET
dti-2613	23	13	effectiveness	effectiveness	NOUN
dti-2613	23	14	of	of	ADP
dti-2613	23	15	antibiotics	antibiotic	NOUN
dti-2613	23	16	and	and	CCONJ
dti-2613	23	17	exacerbating	exacerbate	VERB
dti-2613	23	18	the	the	DET
dti-2613	23	19	burden	burden	NOUN
dti-2613	23	20	of	of	ADP
dti-2613	23	21	infectious	infectious	ADJ
dti-2613	23	22	diseases	disease	NOUN
dti-2613	23	23	.	.	PUNCT
dti-2613	24	1	major	major	ADJ
dti-2613	24	2	contributors	contributor	NOUN
dti-2613	24	3	to	to	ADP
dti-2613	24	4	amr	amr	PROPN
dti-2613	24	5	include	include	VERB
dti-2613	24	6	extended	extend	VERB
dti-2613	24	7	-	-	PUNCT
dti-2613	24	8	spectrum	spectrum	NOUN
dti-2613	24	9	β	β	NOUN
dti-2613	24	10	-	-	NOUN
dti-2613	24	11	lactamases	lactamase	NOUN
dti-2613	24	12	(	(	PUNCT
dti-2613	24	13	esbls	esbls	PROPN
dti-2613	24	14	)	)	PUNCT
dti-2613	24	15	and	and	CCONJ
dti-2613	24	16	carbapenemases	carbapenemase	NOUN
dti-2613	24	17	produced	produce	VERB
dti-2613	24	18	by	by	ADP
dti-2613	24	19	enterobacteriaceae	enterobacteriaceae	PROPN
dti-2613	24	20	(	(	PUNCT
dti-2613	24	21	7,8	7,8	NUM
dti-2613	24	22	)	)	PUNCT
dti-2613	24	23	.	.	PUNCT
dti-2613	25	1	both	both	DET
dti-2613	25	2	enzymes	enzyme	NOUN
dti-2613	25	3	are	be	AUX
dti-2613	25	4	β	β	NOUN
dti-2613	25	5	-	-	NOUN
dti-2613	25	6	lactamases	lactamase	NOUN
dti-2613	25	7	with	with	ADP
dti-2613	25	8	proven	prove	VERB
dti-2613	25	9	ability	ability	NOUN
dti-2613	25	10	to	to	PART
dti-2613	25	11	degrade	degrade	VERB
dti-2613	25	12	β	β	NOUN
dti-2613	25	13	-	-	NOUN
dti-2613	25	14	lactam	lactam	NOUN
dti-2613	25	15	antibiotics	antibiotic	NOUN
dti-2613	25	16	.	.	PUNCT
dti-2613	26	1	the	the	DET
dti-2613	26	2	esbls	esbls	PROPN
dti-2613	26	3	exhibit	exhibit	VERB
dti-2613	26	4	hydrolytic	hydrolytic	ADJ
dti-2613	26	5	activity	activity	NOUN
dti-2613	26	6	against	against	ADP
dti-2613	26	7	penicillins	penicillin	NOUN
dti-2613	26	8	and	and	CCONJ
dti-2613	26	9	all	all	DET
dti-2613	26	10	cephalosporins	cephalosporin	NOUN
dti-2613	26	11	,	,	PUNCT
dti-2613	26	12	yet	yet	CCONJ
dti-2613	26	13	are	be	AUX
dti-2613	26	14	suppressed	suppress	VERB
dti-2613	26	15	by	by	ADP
dti-2613	26	16	β	β	NOUN
dti-2613	26	17	-	-	NOUN
dti-2613	26	18	lactam	lactam	ADJ
dti-2613	26	19	inhibitors	inhibitor	NOUN
dti-2613	26	20	(	(	PUNCT
dti-2613	26	21	9	9	NUM
dti-2613	26	22	)	)	PUNCT
dti-2613	26	23	.	.	PUNCT
dti-2613	27	1	mutation	mutation	NOUN
dti-2613	27	2	-	-	PUNCT
dti-2613	27	3	wise	wise	ADJ
dti-2613	27	4	,	,	PUNCT
dti-2613	27	5	esbls	esbls	PROPN
dti-2613	27	6	encoding	encoding	NOUN
dti-2613	27	7	genes	gene	NOUN
dti-2613	27	8	can	can	AUX
dti-2613	27	9	be	be	AUX
dti-2613	27	10	grouped	group	VERB
dti-2613	27	11	into	into	ADP
dti-2613	27	12	several	several	ADJ
dti-2613	27	13	variants	variant	NOUN
dti-2613	27	14	:	:	PUNCT
dti-2613	28	1	blatem	blatem	ADJ
dti-2613	28	2	,	,	PUNCT
dti-2613	28	3	blashv	blashv	NOUN
dti-2613	28	4	,	,	PUNCT
dti-2613	28	5	blairt	blairt	NOUN
dti-2613	28	6	,	,	PUNCT
dti-2613	28	7	etc	etc	X
dti-2613	28	8	(	(	PUNCT
dti-2613	28	9	10	10	NUM
dti-2613	28	10	)	)	PUNCT
dti-2613	28	11	.	.	PUNCT
dti-2613	29	1	on	on	ADP
dti-2613	29	2	the	the	DET
dti-2613	29	3	other	other	ADJ
dti-2613	29	4	hand	hand	NOUN
dti-2613	29	5	,	,	PUNCT
dti-2613	29	6	another	another	DET
dti-2613	29	7	important	important	ADJ
dti-2613	29	8	https://doi.org/10.33393/dti.2023.2613	https://doi.org/10.33393/dti.2023.2613	PROPN
dti-2613	29	9	https://creativecommons.org/licenses/by-nc/4.0/legalcode	https://creativecommons.org/licenses/by-nc/4.0/legalcode	PROPN
dti-2613	29	10	mailto:kaimecesaire@gmail.com	mailto:kaimecesaire@gmail.com	PROPN
dti-2613	29	11	kalambry	kalambry	PROPN
dti-2613	29	12	et	et	PROPN
dti-2613	29	13	al	al	PROPN
dti-2613	29	14	drug	drug	PROPN
dti-2613	29	15	target	target	NOUN
dti-2613	29	16	insights	insight	NOUN
dti-2613	29	17	2023	2023	NUM
dti-2613	29	18	;	;	PUNCT
dti-2613	29	19	17	17	NUM
dti-2613	29	20	:	:	SYM
dti-2613	29	21	93	93	NUM
dti-2613	29	22	©	©	ADP
dti-2613	29	23	2023	2023	NUM
dti-2613	29	24	the	the	DET
dti-2613	29	25	authors	author	NOUN
dti-2613	29	26	.	.	PUNCT
dti-2613	30	1	published	publish	VERB
dti-2613	30	2	by	by	ADP
dti-2613	30	3	aboutscience	aboutscience	NOUN
dti-2613	30	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2613	30	5	enzyme	enzyme	NOUN
dti-2613	30	6	is	be	AUX
dti-2613	30	7	carbapenemase	carbapenemase	NOUN
dti-2613	30	8	,	,	PUNCT
dti-2613	30	9	which	which	PRON
dti-2613	30	10	degrade	degrade	VERB
dti-2613	30	11	carbapenem	carbapenem	PROPN
dti-2613	30	12	antibiotics	antibiotic	NOUN
dti-2613	30	13	and	and	CCONJ
dti-2613	30	14	include	include	VERB
dti-2613	30	15	gene	gene	NOUN
dti-2613	30	16	variants	variant	NOUN
dti-2613	30	17	like	like	ADP
dti-2613	30	18	blakpc	blakpc	NOUN
dti-2613	30	19	,	,	PUNCT
dti-2613	30	20	blaimp	blaimp	NOUN
dti-2613	30	21	,	,	PUNCT
dti-2613	30	22	blaoxa-1	blaoxa-1	NUM
dti-2613	30	23	,	,	PUNCT
dti-2613	30	24	etc	etc	X
dti-2613	30	25	(	(	PUNCT
dti-2613	30	26	9	9	NUM
dti-2613	30	27	)	)	PUNCT
dti-2613	30	28	.	.	PUNCT
dti-2613	31	1	thus	thus	ADV
dti-2613	31	2	,	,	PUNCT
dti-2613	31	3	their	their	PRON
dti-2613	31	4	inclusion	inclusion	NOUN
dti-2613	31	5	in	in	ADP
dti-2613	31	6	world	world	NOUN
dti-2613	31	7	health	health	NOUN
dti-2613	31	8	organization	organization	NOUN
dti-2613	31	9	list	list	NOUN
dti-2613	31	10	as	as	ADP
dti-2613	31	11	top	top	ADJ
dti-2613	31	12	priority	priority	NOUN
dti-2613	31	13	pathogens	pathogen	NOUN
dti-2613	31	14	underscores	underscore	VERB
dti-2613	31	15	their	their	PRON
dti-2613	31	16	potential	potential	NOUN
dti-2613	31	17	to	to	PART
dti-2613	31	18	pose	pose	VERB
dti-2613	31	19	significant	significant	ADJ
dti-2613	31	20	challenge	challenge	NOUN
dti-2613	31	21	in	in	ADP
dti-2613	31	22	clinical	clinical	ADJ
dti-2613	31	23	settings	setting	NOUN
dti-2613	31	24	(	(	PUNCT
dti-2613	31	25	11	11	NUM
dti-2613	31	26	)	)	PUNCT
dti-2613	31	27	.	.	PUNCT
dti-2613	32	1	data	datum	NOUN
dti-2613	32	2	from	from	ADP
dti-2613	32	3	recent	recent	ADJ
dti-2613	32	4	studies	study	NOUN
dti-2613	32	5	found	find	VERB
dti-2613	32	6	an	an	DET
dti-2613	32	7	association	association	NOUN
dti-2613	32	8	between	between	ADP
dti-2613	32	9	extendedspectrum	extendedspectrum	PROPN
dti-2613	32	10	β	β	NOUN
dti-2613	32	11	-	-	NOUN
dti-2613	32	12	lactamases	lactamase	NOUN
dti-2613	32	13	and	and	CCONJ
dti-2613	32	14	carbapenemases	carbapenemase	NOUN
dti-2613	32	15	producing	produce	VERB
dti-2613	32	16	enterobacteriaceae	enterobacteriaceae	PROPN
dti-2613	32	17	(	(	PUNCT
dti-2613	32	18	esbl	esbl	NOUN
dti-2613	32	19	-	-	PUNCT
dti-2613	32	20	e	e	NOUN
dti-2613	32	21	/	/	SYM
dti-2613	32	22	cpe	cpe	PROPN
dti-2613	32	23	)	)	PUNCT
dti-2613	32	24	infections	infection	NOUN
dti-2613	32	25	and	and	CCONJ
dti-2613	32	26	risk	risk	NOUN
dti-2613	32	27	of	of	ADP
dti-2613	32	28	mortality	mortality	NOUN
dti-2613	32	29	(	(	PUNCT
dti-2613	32	30	12,13	12,13	NUM
dti-2613	32	31	)	)	PUNCT
dti-2613	32	32	.	.	PUNCT
dti-2613	33	1	moreover	moreover	ADV
dti-2613	33	2	,	,	PUNCT
dti-2613	33	3	prior	prior	ADV
dti-2613	33	4	to	to	ADP
dti-2613	33	5	antibiotherapy	antibiotherapy	PROPN
dti-2613	33	6	,	,	PUNCT
dti-2613	33	7	comorbidities	comorbiditie	NOUN
dti-2613	33	8	as	as	ADV
dti-2613	33	9	well	well	ADV
dti-2613	33	10	as	as	ADP
dti-2613	33	11	persistent	persistent	ADJ
dti-2613	33	12	colonization	colonization	NOUN
dti-2613	33	13	were	be	AUX
dti-2613	33	14	found	find	VERB
dti-2613	33	15	to	to	PART
dti-2613	33	16	be	be	AUX
dti-2613	33	17	strong	strong	ADJ
dti-2613	33	18	predictors	predictor	NOUN
dti-2613	33	19	of	of	ADP
dti-2613	33	20	infection	infection	NOUN
dti-2613	33	21	and	and	CCONJ
dti-2613	33	22	subsequent	subsequent	ADJ
dti-2613	33	23	treatment	treatment	NOUN
dti-2613	33	24	failure	failure	NOUN
dti-2613	33	25	(	(	PUNCT
dti-2613	33	26	14,15	14,15	NUM
dti-2613	33	27	)	)	PUNCT
dti-2613	33	28	.	.	PUNCT
dti-2613	34	1	yet	yet	ADV
dti-2613	34	2	to	to	ADP
dti-2613	34	3	date	date	NOUN
dti-2613	34	4	,	,	PUNCT
dti-2613	34	5	detailed	detailed	ADJ
dti-2613	34	6	reports	report	NOUN
dti-2613	34	7	on	on	ADP
dti-2613	34	8	the	the	DET
dti-2613	34	9	magnitude	magnitude	NOUN
dti-2613	34	10	of	of	ADP
dti-2613	34	11	esbl	esbl	NOUN
dti-2613	34	12	-	-	PUNCT
dti-2613	34	13	e	e	NOUN
dti-2613	34	14	/	/	SYM
dti-2613	34	15	cpe	cpe	PROPN
dti-2613	34	16	in	in	ADP
dti-2613	34	17	west	west	PROPN
dti-2613	34	18	africa	africa	PROPN
dti-2613	34	19	are	be	AUX
dti-2613	34	20	scarce	scarce	ADJ
dti-2613	34	21	(	(	PUNCT
dti-2613	34	22	16	16	NUM
dti-2613	34	23	)	)	PUNCT
dti-2613	34	24	.	.	PUNCT
dti-2613	35	1	although	although	SCONJ
dti-2613	35	2	there	there	PRON
dti-2613	35	3	are	be	VERB
dti-2613	35	4	data	datum	NOUN
dti-2613	35	5	on	on	ADP
dti-2613	35	6	phenotypic	phenotypic	ADJ
dti-2613	35	7	and	and	CCONJ
dti-2613	35	8	genotypic	genotypic	ADJ
dti-2613	35	9	distribution	distribution	NOUN
dti-2613	35	10	of	of	ADP
dti-2613	35	11	amr	amr	NOUN
dti-2613	35	12	in	in	ADP
dti-2613	35	13	pathogens	pathogen	NOUN
dti-2613	35	14	responsible	responsible	ADJ
dti-2613	35	15	for	for	ADP
dti-2613	35	16	various	various	ADJ
dti-2613	35	17	clinical	clinical	ADJ
dti-2613	35	18	infections	infection	NOUN
dti-2613	35	19	in	in	ADP
dti-2613	35	20	mali	mali	PROPN
dti-2613	35	21	,	,	PUNCT
dti-2613	35	22	there	there	PRON
dti-2613	35	23	are	be	VERB
dti-2613	35	24	still	still	ADV
dti-2613	35	25	unanswered	unanswered	ADJ
dti-2613	35	26	questions	question	NOUN
dti-2613	35	27	related	relate	VERB
dti-2613	35	28	to	to	ADP
dti-2613	35	29	the	the	DET
dti-2613	35	30	genotypic	genotypic	ADJ
dti-2613	35	31	distribution	distribution	NOUN
dti-2613	35	32	of	of	ADP
dti-2613	35	33	these	these	DET
dti-2613	35	34	amr	amr	ADJ
dti-2613	35	35	genes	gene	NOUN
dti-2613	35	36	in	in	ADP
dti-2613	35	37	ipes	ipe	NOUN
dti-2613	35	38	(	(	PUNCT
dti-2613	35	39	17	17	NUM
dti-2613	35	40	-	-	SYM
dti-2613	35	41	19	19	NUM
dti-2613	35	42	)	)	PUNCT
dti-2613	35	43	.	.	PUNCT
dti-2613	36	1	understanding	understand	VERB
dti-2613	36	2	the	the	DET
dti-2613	36	3	extent	extent	NOUN
dti-2613	36	4	of	of	ADP
dti-2613	36	5	resistance	resistance	NOUN
dti-2613	36	6	and	and	CCONJ
dti-2613	36	7	identifying	identify	VERB
dti-2613	36	8	the	the	DET
dti-2613	36	9	underlying	underlying	ADJ
dti-2613	36	10	resistance	resistance	NOUN
dti-2613	36	11	mechanisms	mechanism	NOUN
dti-2613	36	12	is	be	AUX
dti-2613	36	13	crucial	crucial	ADJ
dti-2613	36	14	for	for	ADP
dti-2613	36	15	designing	design	VERB
dti-2613	36	16	effective	effective	ADJ
dti-2613	36	17	therapeutic	therapeutic	ADJ
dti-2613	36	18	strategies	strategy	NOUN
dti-2613	36	19	and	and	CCONJ
dti-2613	36	20	optimizing	optimize	VERB
dti-2613	36	21	patient	patient	ADJ
dti-2613	36	22	care	care	NOUN
dti-2613	36	23	in	in	ADP
dti-2613	36	24	this	this	DET
dti-2613	36	25	region	region	NOUN
dti-2613	36	26	.	.	PUNCT
dti-2613	37	1	this	this	DET
dti-2613	37	2	study	study	NOUN
dti-2613	37	3	has	have	AUX
dti-2613	37	4	mainly	mainly	ADV
dti-2613	37	5	focused	focus	VERB
dti-2613	37	6	on	on	ADP
dti-2613	37	7	the	the	DET
dti-2613	37	8	epidemiology	epidemiology	NOUN
dti-2613	37	9	of	of	ADP
dti-2613	37	10	blaoxa-48	blaoxa-48	PROPN
dti-2613	37	11	,	,	PUNCT
dti-2613	37	12	blandm-1	blandm-1	PROPN
dti-2613	37	13	,	,	PUNCT
dti-2613	37	14	blakpc	blakpc	VERB
dti-2613	37	15	genes	gene	NOUN
dti-2613	37	16	responsible	responsible	ADJ
dti-2613	37	17	for	for	ADP
dti-2613	37	18	the	the	DET
dti-2613	37	19	induction	induction	NOUN
dti-2613	37	20	of	of	ADP
dti-2613	37	21	carbapenem	carbapenem	PROPN
dti-2613	37	22	resistance	resistance	NOUN
dti-2613	37	23	;	;	PUNCT
dti-2613	37	24	blatem	blatem	NOUN
dti-2613	37	25	,	,	PUNCT
dti-2613	37	26	blashv	blashv	VERB
dti-2613	37	27	genes	gene	NOUN
dti-2613	37	28	that	that	PRON
dti-2613	37	29	are	be	AUX
dti-2613	37	30	responsible	responsible	ADJ
dti-2613	37	31	for	for	ADP
dti-2613	37	32	esbl	esbl	NOUN
dti-2613	37	33	production	production	NOUN
dti-2613	37	34	,	,	PUNCT
dti-2613	37	35	as	as	ADV
dti-2613	37	36	well	well	ADV
dti-2613	37	37	as	as	ADP
dti-2613	37	38	genes	gene	NOUN
dti-2613	37	39	associated	associate	VERB
dti-2613	37	40	with	with	ADP
dti-2613	37	41	bacterial	bacterial	ADJ
dti-2613	37	42	adhesins	adhesin	NOUN
dti-2613	37	43	(	(	PUNCT
dti-2613	37	44	bfp	bfp	NOUN
dti-2613	37	45	,	,	PUNCT
dti-2613	37	46	eae	eae	PROPN
dti-2613	37	47	,	,	PUNCT
dti-2613	37	48	ipah	ipah	PROPN
dti-2613	37	49	,	,	PUNCT
dti-2613	37	50	eagg	eagg	NOUN
dti-2613	37	51	)	)	PUNCT
dti-2613	37	52	and	and	CCONJ
dti-2613	37	53	toxin	toxin	NOUN
dti-2613	37	54	genes	gene	NOUN
dti-2613	37	55	(	(	PUNCT
dti-2613	37	56	slt1	slt1	NOUN
dti-2613	37	57	,	,	PUNCT
dti-2613	37	58	slt2	slt2	NOUN
dti-2613	37	59	,	,	PUNCT
dti-2613	37	60	lt	lt	PROPN
dti-2613	37	61	,	,	PUNCT
dti-2613	37	62	sta	sta	NOUN
dti-2613	37	63	)	)	PUNCT
dti-2613	37	64	.	.	PUNCT
dti-2613	38	1	the	the	DET
dti-2613	38	2	primary	primary	ADJ
dti-2613	38	3	objective	objective	NOUN
dti-2613	38	4	of	of	ADP
dti-2613	38	5	this	this	DET
dti-2613	38	6	study	study	NOUN
dti-2613	38	7	was	be	AUX
dti-2613	38	8	to	to	PART
dti-2613	38	9	isolate	isolate	VERB
dti-2613	38	10	,	,	PUNCT
dti-2613	38	11	identify	identify	VERB
dti-2613	38	12	,	,	PUNCT
dti-2613	38	13	and	and	CCONJ
dti-2613	38	14	analyze	analyze	VERB
dti-2613	38	15	the	the	DET
dti-2613	38	16	diversity	diversity	NOUN
dti-2613	38	17	of	of	ADP
dti-2613	38	18	enterobacterial	enterobacterial	ADJ
dti-2613	38	19	species	specie	NOUN
dti-2613	38	20	found	find	VERB
dti-2613	38	21	in	in	ADP
dti-2613	38	22	pleural	pleural	ADJ
dti-2613	38	23	fluid	fluid	ADJ
dti-2613	38	24	samples	sample	NOUN
dti-2613	38	25	from	from	ADP
dti-2613	38	26	patients	patient	NOUN
dti-2613	38	27	with	with	ADP
dti-2613	38	28	ipe	ipe	PROPN
dti-2613	38	29	.	.	PUNCT
dti-2613	39	1	a	a	DET
dti-2613	39	2	better	well	ADJ
dti-2613	39	3	knowledge	knowledge	NOUN
dti-2613	39	4	of	of	ADP
dti-2613	39	5	ipe	ipe	NOUN
dti-2613	39	6	in	in	ADP
dti-2613	39	7	mali	mali	PROPN
dti-2613	39	8	could	could	AUX
dti-2613	39	9	facilitate	facilitate	VERB
dti-2613	39	10	the	the	DET
dti-2613	39	11	management	management	NOUN
dti-2613	39	12	of	of	ADP
dti-2613	39	13	the	the	DET
dti-2613	39	14	condition	condition	NOUN
dti-2613	39	15	and	and	CCONJ
dti-2613	39	16	thus	thus	ADV
dti-2613	39	17	reduce	reduce	VERB
dti-2613	39	18	the	the	DET
dti-2613	39	19	level	level	NOUN
dti-2613	39	20	of	of	ADP
dti-2613	39	21	mortality	mortality	NOUN
dti-2613	39	22	.	.	PUNCT
dti-2613	40	1	material	material	NOUN
dti-2613	40	2	and	and	CCONJ
dti-2613	40	3	methods	method	NOUN
dti-2613	40	4	study	study	NOUN
dti-2613	40	5	design	design	NOUN
dti-2613	40	6	and	and	CCONJ
dti-2613	40	7	population	population	NOUN
dti-2613	40	8	the	the	DET
dti-2613	40	9	present	present	ADJ
dti-2613	40	10	research	research	NOUN
dti-2613	40	11	is	be	AUX
dti-2613	40	12	a	a	DET
dti-2613	40	13	prospective	prospective	ADJ
dti-2613	40	14	cross	cross	ADJ
dti-2613	40	15	-	-	ADJ
dti-2613	40	16	sectional	sectional	ADJ
dti-2613	40	17	study	study	NOUN
dti-2613	40	18	conducted	conduct	VERB
dti-2613	40	19	between	between	ADP
dti-2613	40	20	october	october	PROPN
dti-2613	40	21	2021	2021	NUM
dti-2613	40	22	and	and	CCONJ
dti-2613	40	23	december	december	PROPN
dti-2613	40	24	2022	2022	NUM
dti-2613	40	25	,	,	PUNCT
dti-2613	40	26	in	in	ADP
dti-2613	40	27	the	the	DET
dti-2613	40	28	thoracic	thoracic	NOUN
dti-2613	40	29	surgery	surgery	NOUN
dti-2613	40	30	and	and	CCONJ
dti-2613	40	31	pediatrics	pediatric	NOUN
dti-2613	40	32	departments	department	NOUN
dti-2613	40	33	of	of	ADP
dti-2613	40	34	chu	chu	PROPN
dti-2613	40	35	“	"	PUNCT
dti-2613	40	36	hôpital	hôpital	PROPN
dti-2613	40	37	du	du	PROPN
dti-2613	40	38	mali	mali	PROPN
dti-2613	40	39	”	"	PUNCT
dti-2613	40	40	in	in	ADP
dti-2613	40	41	bamako	bamako	PROPN
dti-2613	40	42	.	.	PUNCT
dti-2613	41	1	the	the	DET
dti-2613	41	2	study	study	NOUN
dti-2613	41	3	included	include	VERB
dti-2613	41	4	all	all	DET
dti-2613	41	5	6,096	6,096	NUM
dti-2613	41	6	hospitalized	hospitalize	VERB
dti-2613	41	7	patients	patient	NOUN
dti-2613	41	8	with	with	ADP
dti-2613	41	9	pleurisy	pleurisy	PROPN
dti-2613	41	10	in	in	ADP
dti-2613	41	11	these	these	DET
dti-2613	41	12	two	two	NUM
dti-2613	41	13	departments	department	NOUN
dti-2613	41	14	.	.	PUNCT
dti-2613	42	1	the	the	DET
dti-2613	42	2	inclusion	inclusion	NOUN
dti-2613	42	3	criteria	criterion	NOUN
dti-2613	42	4	were	be	AUX
dti-2613	42	5	:	:	PUNCT
dti-2613	42	6	(	(	PUNCT
dti-2613	42	7	1	1	X
dti-2613	42	8	)	)	PUNCT
dti-2613	42	9	clinical	clinical	ADJ
dti-2613	42	10	diagnosis	diagnosis	NOUN
dti-2613	42	11	of	of	ADP
dti-2613	42	12	pleural	pleural	ADJ
dti-2613	42	13	infection	infection	NOUN
dti-2613	42	14	(	(	PUNCT
dti-2613	42	15	pi	pi	NOUN
dti-2613	42	16	)	)	PUNCT
dti-2613	42	17	with	with	ADP
dti-2613	42	18	subsequent	subsequent	ADJ
dti-2613	42	19	diagnostic	diagnostic	ADJ
dti-2613	42	20	thoracentesis	thoracentesis	NOUN
dti-2613	42	21	and	and	CCONJ
dti-2613	42	22	microbiological	microbiological	ADJ
dti-2613	42	23	confirmation	confirmation	NOUN
dti-2613	42	24	(	(	PUNCT
dti-2613	42	25	pleural	pleural	ADJ
dti-2613	42	26	fluid	fluid	ADJ
dti-2613	42	27	culture	culture	NOUN
dti-2613	42	28	positive	positive	ADJ
dti-2613	42	29	to	to	ADP
dti-2613	42	30	at	at	ADV
dti-2613	42	31	least	least	ADV
dti-2613	42	32	one	one	NUM
dti-2613	42	33	microorganism	microorganism	NOUN
dti-2613	42	34	)	)	PUNCT
dti-2613	42	35	.	.	PUNCT
dti-2613	43	1	pi	pi	PROPN
dti-2613	43	2	was	be	AUX
dti-2613	43	3	defined	define	VERB
dti-2613	43	4	as	as	ADP
dti-2613	43	5	the	the	DET
dti-2613	43	6	presence	presence	NOUN
dti-2613	43	7	of	of	ADP
dti-2613	43	8	positive	positive	ADJ
dti-2613	43	9	pleural	pleural	ADJ
dti-2613	43	10	fluid	fluid	ADJ
dti-2613	43	11	culture	culture	NOUN
dti-2613	43	12	and/or	and/or	CCONJ
dti-2613	43	13	purulent	purulent	ADJ
dti-2613	43	14	pleural	pleural	ADJ
dti-2613	43	15	fluid	fluid	NOUN
dti-2613	43	16	and	and	CCONJ
dti-2613	43	17	clinically	clinically	ADV
dti-2613	43	18	manifesting	manifest	VERB
dti-2613	43	19	as	as	ADP
dti-2613	43	20	complex	complex	ADJ
dti-2613	43	21	parapneumonic	parapneumonic	ADJ
dti-2613	43	22	effusion	effusion	NOUN
dti-2613	43	23	(	(	PUNCT
dti-2613	43	24	cppe	cppe	PROPN
dti-2613	43	25	)	)	PUNCT
dti-2613	43	26	or	or	CCONJ
dti-2613	43	27	empyema	empyema	NOUN
dti-2613	43	28	(	(	PUNCT
dti-2613	43	29	20	20	NUM
dti-2613	43	30	)	)	PUNCT
dti-2613	43	31	;	;	PUNCT
dti-2613	43	32	(	(	PUNCT
dti-2613	43	33	2	2	X
dti-2613	43	34	)	)	PUNCT
dti-2613	43	35	patients	patient	NOUN
dti-2613	43	36	who	who	PRON
dti-2613	43	37	provided	provide	VERB
dti-2613	43	38	written	write	VERB
dti-2613	43	39	informed	inform	VERB
dti-2613	43	40	consent	consent	NOUN
dti-2613	43	41	to	to	PART
dti-2613	43	42	participate	participate	VERB
dti-2613	43	43	in	in	ADP
dti-2613	43	44	the	the	DET
dti-2613	43	45	study	study	NOUN
dti-2613	43	46	.	.	PUNCT
dti-2613	44	1	the	the	DET
dti-2613	44	2	exclusion	exclusion	NOUN
dti-2613	44	3	criteria	criterion	NOUN
dti-2613	44	4	were	be	AUX
dti-2613	44	5	:	:	PUNCT
dti-2613	44	6	(	(	PUNCT
dti-2613	44	7	1	1	X
dti-2613	44	8	)	)	PUNCT
dti-2613	44	9	patients	patient	NOUN
dti-2613	44	10	who	who	PRON
dti-2613	44	11	had	have	VERB
dti-2613	44	12	nonpurulent	nonpurulent	NOUN
dti-2613	44	13	or	or	CCONJ
dti-2613	44	14	no	no	DET
dti-2613	44	15	growth	growth	NOUN
dti-2613	44	16	from	from	ADP
dti-2613	44	17	pleural	pleural	ADJ
dti-2613	44	18	fluid	fluid	NOUN
dti-2613	44	19	;	;	PUNCT
dti-2613	44	20	(	(	PUNCT
dti-2613	44	21	2	2	X
dti-2613	44	22	)	)	PUNCT
dti-2613	44	23	patients	patient	NOUN
dti-2613	44	24	with	with	ADP
dti-2613	44	25	pleural	pleural	ADJ
dti-2613	44	26	effusion	effusion	NOUN
dti-2613	44	27	caused	cause	VERB
dti-2613	44	28	by	by	ADP
dti-2613	44	29	noninfectious	noninfectious	ADJ
dti-2613	44	30	etiologies	etiology	NOUN
dti-2613	44	31	such	such	ADJ
dti-2613	44	32	as	as	ADP
dti-2613	44	33	malignancy	malignancy	NOUN
dti-2613	44	34	and	and	CCONJ
dti-2613	44	35	congestive	congestive	ADJ
dti-2613	44	36	heart	heart	NOUN
dti-2613	44	37	failure	failure	NOUN
dti-2613	44	38	.	.	PUNCT
dti-2613	45	1	the	the	DET
dti-2613	45	2	data	datum	NOUN
dti-2613	45	3	were	be	AUX
dti-2613	45	4	collected	collect	VERB
dti-2613	45	5	using	use	VERB
dti-2613	45	6	microsoft	microsoft	PROPN
dti-2613	45	7	excel	excel	VERB
dti-2613	45	8	through	through	ADP
dti-2613	45	9	questionnaires	questionnaire	NOUN
dti-2613	45	10	administered	administer	VERB
dti-2613	45	11	to	to	ADP
dti-2613	45	12	consenting	consent	VERB
dti-2613	45	13	patients	patient	NOUN
dti-2613	45	14	by	by	ADP
dti-2613	45	15	physicians	physician	NOUN
dti-2613	45	16	prior	prior	ADV
dti-2613	45	17	to	to	ADP
dti-2613	45	18	sample	sample	NOUN
dti-2613	45	19	collection	collection	NOUN
dti-2613	45	20	.	.	PUNCT
dti-2613	46	1	subsequently	subsequently	ADV
dti-2613	46	2	,	,	PUNCT
dti-2613	46	3	laboratory	laboratory	NOUN
dti-2613	46	4	data	datum	NOUN
dti-2613	46	5	were	be	AUX
dti-2613	46	6	obtained	obtain	VERB
dti-2613	46	7	and	and	CCONJ
dti-2613	46	8	combined	combine	VERB
dti-2613	46	9	with	with	ADP
dti-2613	46	10	the	the	DET
dti-2613	46	11	questionnaire	questionnaire	NOUN
dti-2613	46	12	responses	response	NOUN
dti-2613	46	13	.	.	PUNCT
dti-2613	47	1	microbiological	microbiological	ADJ
dti-2613	47	2	processing	processing	NOUN
dti-2613	47	3	and	and	CCONJ
dti-2613	47	4	identification	identification	NOUN
dti-2613	47	5	all	all	DET
dti-2613	47	6	pleural	pleural	ADJ
dti-2613	47	7	fluid	fluid	ADJ
dti-2613	47	8	samples	sample	NOUN
dti-2613	47	9	were	be	AUX
dti-2613	47	10	processed	process	VERB
dti-2613	47	11	within	within	ADP
dti-2613	47	12	an	an	DET
dti-2613	47	13	hour	hour	NOUN
dti-2613	47	14	after	after	ADP
dti-2613	47	15	collection	collection	NOUN
dti-2613	47	16	at	at	ADP
dti-2613	47	17	the	the	DET
dti-2613	47	18	microbiology	microbiology	NOUN
dti-2613	47	19	laboratory	laboratory	NOUN
dti-2613	47	20	of	of	ADP
dti-2613	47	21	chu	chu	PROPN
dti-2613	47	22	hôpital	hôpital	PROPN
dti-2613	47	23	du	du	PROPN
dti-2613	47	24	mali	mali	PROPN
dti-2613	47	25	.	.	PUNCT
dti-2613	48	1	samples	sample	NOUN
dti-2613	48	2	were	be	AUX
dti-2613	48	3	inoculated	inoculate	VERB
dti-2613	48	4	on	on	ADP
dti-2613	48	5	brain	brain	NOUN
dti-2613	48	6	-	-	PUNCT
dti-2613	48	7	heart	heart	NOUN
dti-2613	48	8	infusion	infusion	NOUN
dti-2613	48	9	(	(	PUNCT
dti-2613	48	10	bhi	bhi	PROPN
dti-2613	48	11	)	)	PUNCT
dti-2613	48	12	and	and	CCONJ
dti-2613	48	13	an	an	DET
dti-2613	48	14	anaerobic	anaerobic	NOUN
dti-2613	48	15	blood	blood	NOUN
dti-2613	48	16	culture	culture	NOUN
dti-2613	48	17	flask	flask	NOUN
dti-2613	48	18	and	and	CCONJ
dti-2613	48	19	incubated	incubate	VERB
dti-2613	48	20	for	for	ADP
dti-2613	48	21	18	18	NUM
dti-2613	48	22	to	to	PART
dti-2613	48	23	24	24	NUM
dti-2613	48	24	hours	hour	NOUN
dti-2613	48	25	at	at	ADP
dti-2613	48	26	35±2	35±2	NUM
dti-2613	48	27	°	°	NOUN
dti-2613	48	28	c	c	NOUN
dti-2613	48	29	.	.	PUNCT
dti-2613	49	1	from	from	ADP
dti-2613	49	2	these	these	DET
dti-2613	49	3	broth	broth	ADJ
dti-2613	49	4	cultures	culture	NOUN
dti-2613	49	5	,	,	PUNCT
dti-2613	49	6	fresh	fresh	ADJ
dti-2613	49	7	blood	blood	NOUN
dti-2613	49	8	agar	agar	NOUN
dti-2613	49	9	,	,	PUNCT
dti-2613	49	10	enriched	enrich	VERB
dti-2613	49	11	chocolate	chocolate	NOUN
dti-2613	49	12	agar	agar	NOUN
dti-2613	49	13	,	,	PUNCT
dti-2613	49	14	and	and	CCONJ
dti-2613	49	15	sabouraud	sabouraud	NOUN
dti-2613	49	16	agar	agar	NOUN
dti-2613	49	17	were	be	AUX
dti-2613	49	18	plated	plate	VERB
dti-2613	49	19	.	.	PUNCT
dti-2613	50	1	the	the	DET
dti-2613	50	2	colonies	colony	NOUN
dti-2613	50	3	were	be	AUX
dti-2613	50	4	characterized	characterize	VERB
dti-2613	50	5	and	and	CCONJ
dti-2613	50	6	identified	identify	VERB
dti-2613	50	7	using	use	VERB
dti-2613	50	8	gram	gram	NOUN
dti-2613	50	9	stain	stain	NOUN
dti-2613	50	10	,	,	PUNCT
dti-2613	50	11	biochemical	biochemical	ADJ
dti-2613	50	12	tests	test	NOUN
dti-2613	50	13	,	,	PUNCT
dti-2613	50	14	and	and	CCONJ
dti-2613	50	15	the	the	DET
dti-2613	50	16	phoenix	phoenix	PROPN
dti-2613	50	17	m50	m50	PROPN
dti-2613	50	18	automated	automate	VERB
dti-2613	50	19	system	system	NOUN
dti-2613	50	20	(	(	PUNCT
dti-2613	50	21	panel	panel	NOUN
dti-2613	50	22	449044	449044	NUM
dti-2613	50	23	-	-	PUNCT
dti-2613	50	24	nmic	nmic	ADJ
dti-2613	50	25	/	/	SYM
dti-2613	50	26	id-435	id-435	ADJ
dti-2613	50	27	)	)	PUNCT
dti-2613	50	28	.	.	PUNCT
dti-2613	51	1	susceptibility	susceptibility	NOUN
dti-2613	51	2	to	to	ADP
dti-2613	51	3	antibiotics	antibiotic	NOUN
dti-2613	51	4	all	all	DET
dti-2613	51	5	isolates	isolate	NOUN
dti-2613	51	6	were	be	AUX
dti-2613	51	7	subjected	subject	VERB
dti-2613	51	8	to	to	ADP
dti-2613	51	9	susceptibility	susceptibility	NOUN
dti-2613	51	10	testing	testing	NOUN
dti-2613	51	11	against	against	ADP
dti-2613	51	12	19	19	NUM
dti-2613	51	13	antibiotics	antibiotic	NOUN
dti-2613	51	14	(	(	PUNCT
dti-2613	51	15	tab	tab	NOUN
dti-2613	51	16	.	.	PUNCT
dti-2613	52	1	i	i	PRON
dti-2613	52	2	)	)	PUNCT
dti-2613	52	3	.	.	PUNCT
dti-2613	53	1	table	table	NOUN
dti-2613	53	2	i	i	PRON
dti-2613	53	3	provides	provide	VERB
dti-2613	53	4	an	an	DET
dti-2613	53	5	overview	overview	NOUN
dti-2613	53	6	of	of	ADP
dti-2613	53	7	the	the	DET
dti-2613	53	8	different	different	ADJ
dti-2613	53	9	antibiotic	antibiotic	ADJ
dti-2613	53	10	classes	class	NOUN
dti-2613	53	11	and	and	CCONJ
dti-2613	53	12	specific	specific	ADJ
dti-2613	53	13	antibiotic	antibiotic	NOUN
dti-2613	53	14	used	use	VERB
dti-2613	53	15	for	for	ADP
dti-2613	53	16	susceptibility	susceptibility	NOUN
dti-2613	53	17	tests	test	NOUN
dti-2613	53	18	.	.	PUNCT
dti-2613	54	1	the	the	DET
dti-2613	54	2	antibiogram	antibiogram	PROPN
dti-2613	54	3	was	be	AUX
dti-2613	54	4	conducted	conduct	VERB
dti-2613	54	5	using	use	VERB
dti-2613	54	6	the	the	DET
dti-2613	54	7	phoenix	phoenix	PROPN
dti-2613	54	8	m50	m50	PROPN
dti-2613	54	9	automated	automate	VERB
dti-2613	54	10	system	system	NOUN
dti-2613	54	11	(	(	PUNCT
dti-2613	54	12	panel	panel	NOUN
dti-2613	54	13	449044	449044	NUM
dti-2613	54	14	-	-	SYM
dti-2613	54	15	nmic/	nmic/	NUM
dti-2613	54	16	id-435	id-435	NOUN
dti-2613	54	17	)	)	PUNCT
dti-2613	54	18	and	and	CCONJ
dti-2613	54	19	was	be	AUX
dti-2613	54	20	complemented	complement	VERB
dti-2613	54	21	by	by	ADP
dti-2613	54	22	disk	disk	NOUN
dti-2613	54	23	diffusion	diffusion	NOUN
dti-2613	54	24	technique	technique	NOUN
dti-2613	54	25	for	for	ADP
dti-2613	54	26	antibiotics	antibiotic	NOUN
dti-2613	54	27	not	not	PART
dti-2613	54	28	covered	cover	VERB
dti-2613	54	29	by	by	ADP
dti-2613	54	30	the	the	DET
dti-2613	54	31	automated	automate	VERB
dti-2613	54	32	panel	panel	NOUN
dti-2613	54	33	.	.	PUNCT
dti-2613	55	1	the	the	DET
dti-2613	55	2	results	result	NOUN
dti-2613	55	3	were	be	AUX
dti-2613	55	4	expressed	express	VERB
dti-2613	55	5	as	as	ADP
dti-2613	55	6	susceptible	susceptible	ADJ
dti-2613	55	7	or	or	CCONJ
dti-2613	55	8	resistant	resistant	ADJ
dti-2613	55	9	in	in	ADP
dti-2613	55	10	accordance	accordance	NOUN
dti-2613	55	11	with	with	ADP
dti-2613	55	12	the	the	DET
dti-2613	55	13	guidelines	guideline	NOUN
dti-2613	55	14	previously	previously	ADV
dti-2613	55	15	described	describe	VERB
dti-2613	55	16	(	(	PUNCT
dti-2613	55	17	21	21	NUM
dti-2613	55	18	)	)	PUNCT
dti-2613	55	19	.	.	PUNCT
dti-2613	56	1	esbl	esbl	PROPN
dti-2613	56	2	production	production	NOUN
dti-2613	56	3	was	be	AUX
dti-2613	56	4	detected	detect	VERB
dti-2613	56	5	using	use	VERB
dti-2613	56	6	the	the	DET
dti-2613	56	7	combination	combination	NOUN
dti-2613	56	8	disk	disk	NOUN
dti-2613	56	9	test	test	NOUN
dti-2613	56	10	method	method	NOUN
dti-2613	56	11	with	with	ADP
dti-2613	56	12	the	the	DET
dti-2613	56	13	following	follow	VERB
dti-2613	56	14	combinations	combination	NOUN
dti-2613	56	15	:	:	PUNCT
dti-2613	56	16	ceftazidime	ceftazidime	NOUN
dti-2613	56	17	clavulanate	clavulanate	NOUN
dti-2613	56	18	,	,	PUNCT
dti-2613	56	19	cefepime	cefepime	NOUN
dti-2613	56	20	-	-	PUNCT
dti-2613	56	21	clavulanate	clavulanate	NOUN
dti-2613	56	22	,	,	PUNCT
dti-2613	56	23	and	and	CCONJ
dti-2613	56	24	cefotaxime	cefotaxime	NOUN
dti-2613	56	25	-	-	PUNCT
dti-2613	56	26	clavulanate	clavulanate	NOUN
dti-2613	56	27	(	(	PUNCT
dti-2613	56	28	21	21	NUM
dti-2613	56	29	)	)	PUNCT
dti-2613	56	30	.	.	PUNCT
dti-2613	57	1	klebsiella	klebsiella	PROPN
dti-2613	57	2	pneumoniae	pneumoniae	ADJ
dti-2613	57	3	atcc	atcc	ADJ
dti-2613	57	4	700603	700603	NUM
dti-2613	57	5	was	be	AUX
dti-2613	57	6	used	use	VERB
dti-2613	57	7	as	as	ADP
dti-2613	57	8	quality	quality	NOUN
dti-2613	57	9	control	control	NOUN
dti-2613	57	10	strain	strain	NOUN
dti-2613	57	11	.	.	PUNCT
dti-2613	58	1	table	table	NOUN
dti-2613	58	2	i	i	PRON
dti-2613	58	3	antibiotic	antibiotic	ADJ
dti-2613	58	4	classes	class	NOUN
dti-2613	58	5	and	and	CCONJ
dti-2613	58	6	specific	specific	ADJ
dti-2613	58	7	antibiotics	antibiotic	NOUN
dti-2613	58	8	used	use	VERB
dti-2613	58	9	in	in	ADP
dti-2613	58	10	this	this	DET
dti-2613	58	11	study	study	NOUN
dti-2613	58	12	family	family	NOUN
dti-2613	58	13	antibiotics	antibiotic	NOUN
dti-2613	58	14	beta	beta	NOUN
dti-2613	58	15	-	-	PUNCT
dti-2613	58	16	lactam	lactam	NOUN
dti-2613	58	17	antibiotics	antibiotic	NOUN
dti-2613	58	18	amoxicillin	amoxicillin	NOUN
dti-2613	58	19	(	(	PUNCT
dti-2613	58	20	20	20	NUM
dti-2613	58	21	µg	µg	NOUN
dti-2613	58	22	)	)	PUNCT
dti-2613	58	23	amoxicillin	amoxicillin	NOUN
dti-2613	58	24	(	(	PUNCT
dti-2613	58	25	20	20	NUM
dti-2613	58	26	µg	µg	NOUN
dti-2613	58	27	)	)	PUNCT
dti-2613	59	1	+	+	CCONJ
dti-2613	59	2	clavulanic	clavulanic	ADJ
dti-2613	59	3	acid	acid	NOUN
dti-2613	59	4	(	(	PUNCT
dti-2613	59	5	10	10	NUM
dti-2613	59	6	µg	µg	NOUN
dti-2613	59	7	)	)	PUNCT
dti-2613	59	8	piperacillin	piperacillin	NOUN
dti-2613	59	9	(	(	PUNCT
dti-2613	59	10	30	30	NUM
dti-2613	59	11	µg	µg	NOUN
dti-2613	59	12	)	)	PUNCT
dti-2613	59	13	piperacillin	piperacillin	NOUN
dti-2613	59	14	(	(	PUNCT
dti-2613	59	15	30	30	NUM
dti-2613	59	16	µg	µg	NOUN
dti-2613	59	17	)	)	PUNCT
dti-2613	60	1	+	+	CCONJ
dti-2613	60	2	tazobactam	tazobactam	NOUN
dti-2613	60	3	(	(	PUNCT
dti-2613	60	4	6	6	NUM
dti-2613	60	5	µg	µg	NOUN
dti-2613	60	6	)	)	PUNCT
dti-2613	60	7	ticarcillin	ticarcillin	NOUN
dti-2613	60	8	(	(	PUNCT
dti-2613	60	9	75	75	NUM
dti-2613	60	10	µg	µg	NOUN
dti-2613	60	11	)	)	PUNCT
dti-2613	60	12	cefuroxime	cefuroxime	NOUN
dti-2613	60	13	(	(	PUNCT
dti-2613	60	14	30	30	NUM
dti-2613	60	15	µg	µg	NOUN
dti-2613	60	16	)	)	PUNCT
dti-2613	60	17	cefoxitin	cefoxitin	NOUN
dti-2613	60	18	(	(	PUNCT
dti-2613	60	19	30	30	NUM
dti-2613	60	20	µg	µg	NOUN
dti-2613	60	21	)	)	PUNCT
dti-2613	60	22	ceftazidime	ceftazidime	NOUN
dti-2613	60	23	(	(	PUNCT
dti-2613	60	24	10	10	NUM
dti-2613	60	25	µg	µg	NOUN
dti-2613	60	26	)	)	PUNCT
dti-2613	60	27	ceftriaxone	ceftriaxone	NOUN
dti-2613	60	28	(	(	PUNCT
dti-2613	60	29	30	30	NUM
dti-2613	60	30	µg	µg	NOUN
dti-2613	60	31	)	)	PUNCT
dti-2613	60	32	cefepime	cefepime	NOUN
dti-2613	60	33	(	(	PUNCT
dti-2613	60	34	30	30	NUM
dti-2613	60	35	µg	µg	NOUN
dti-2613	60	36	)	)	PUNCT
dti-2613	60	37	aztreonam	aztreonam	NOUN
dti-2613	60	38	(	(	PUNCT
dti-2613	60	39	30	30	NUM
dti-2613	60	40	µg	µg	NOUN
dti-2613	60	41	)	)	PUNCT
dti-2613	60	42	imipenem	imipenem	PROPN
dti-2613	60	43	(	(	PUNCT
dti-2613	60	44	10	10	NUM
dti-2613	60	45	µg	µg	NOUN
dti-2613	60	46	)	)	PUNCT
dti-2613	60	47	meropenem	meropenem	PROPN
dti-2613	60	48	(	(	PUNCT
dti-2613	60	49	10	10	NUM
dti-2613	60	50	µg	µg	NOUN
dti-2613	60	51	)	)	PUNCT
dti-2613	60	52	ertapenem	ertapenem	PROPN
dti-2613	60	53	(	(	PUNCT
dti-2613	60	54	10	10	NUM
dti-2613	60	55	µg	µg	NOUN
dti-2613	60	56	)	)	PUNCT
dti-2613	60	57	aminosides	aminoside	NOUN
dti-2613	60	58	amikacin	amikacin	PROPN
dti-2613	60	59	(	(	PUNCT
dti-2613	60	60	30	30	NUM
dti-2613	60	61	µg	µg	NOUN
dti-2613	60	62	)	)	PUNCT
dti-2613	60	63	gentamicin	gentamicin	NOUN
dti-2613	60	64	(	(	PUNCT
dti-2613	60	65	10	10	NUM
dti-2613	60	66	µg	µg	NOUN
dti-2613	60	67	)	)	PUNCT
dti-2613	60	68	tobramycin	tobramycin	NOUN
dti-2613	60	69	(	(	PUNCT
dti-2613	60	70	10	10	NUM
dti-2613	60	71	µg	µg	NOUN
dti-2613	60	72	)	)	PUNCT
dti-2613	60	73	quinolones	quinolone	NOUN
dti-2613	60	74	ciprofloxacin	ciprofloxacin	NOUN
dti-2613	60	75	(	(	PUNCT
dti-2613	60	76	05	05	NUM
dti-2613	60	77	µg	µg	NOUN
dti-2613	60	78	)	)	PUNCT
dti-2613	60	79	other	other	ADJ
dti-2613	60	80	trimethoprim	trimethoprim	NOUN
dti-2613	60	81	(	(	PUNCT
dti-2613	60	82	1.25	1.25	NUM
dti-2613	60	83	µg	µg	NOUN
dti-2613	60	84	)	)	PUNCT
dti-2613	60	85	+	+	NUM
dti-2613	60	86	sulfamethoxazole	sulfamethoxazole	NOUN
dti-2613	60	87	(	(	PUNCT
dti-2613	60	88	23.75	23.75	NUM
dti-2613	60	89	µg	µg	NOUN
dti-2613	60	90	)	)	PUNCT
dti-2613	60	91	hôpital	hôpital	PROPN
dti-2613	60	92	du	du	PROPN
dti-2613	60	93	mali	mali	PROPN
dti-2613	60	94	:	:	PUNCT
dti-2613	60	95	antibiotic	antibiotic	ADJ
dti-2613	60	96	resistance	resistance	NOUN
dti-2613	60	97	in	in	ADP
dti-2613	60	98	ipes94	ipes94	NOUN
dti-2613	60	99	©	©	PROPN
dti-2613	60	100	2023	2023	NUM
dti-2613	60	101	the	the	DET
dti-2613	60	102	authors	author	NOUN
dti-2613	60	103	.	.	PUNCT
dti-2613	61	1	drug	drug	NOUN
dti-2613	61	2	target	target	NOUN
dti-2613	61	3	insights	insight	NOUN
dti-2613	61	4	issn	issn	VERB
dti-2613	61	5	1177	1177	NUM
dti-2613	61	6	-	-	SYM
dti-2613	61	7	3928	3928	NUM
dti-2613	61	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2613	61	9	molecular	molecular	ADJ
dti-2613	61	10	analysis	analysis	NOUN
dti-2613	61	11	dna	dna	NOUN
dti-2613	61	12	was	be	AUX
dti-2613	61	13	extracted	extract	VERB
dti-2613	61	14	according	accord	VERB
dti-2613	61	15	to	to	ADP
dti-2613	61	16	the	the	DET
dti-2613	61	17	method	method	NOUN
dti-2613	61	18	described	describe	VERB
dti-2613	61	19	previously	previously	ADV
dti-2613	61	20	(	(	PUNCT
dti-2613	61	21	22	22	NUM
dti-2613	61	22	)	)	PUNCT
dti-2613	61	23	.	.	PUNCT
dti-2613	62	1	briefly	briefly	NOUN
dti-2613	62	2	,	,	PUNCT
dti-2613	62	3	pure	pure	ADJ
dti-2613	62	4	colonies	colony	NOUN
dti-2613	62	5	were	be	AUX
dti-2613	62	6	suspended	suspend	VERB
dti-2613	62	7	in	in	ADP
dti-2613	62	8	200	200	NUM
dti-2613	62	9	μl	μl	ADP
dti-2613	62	10	of	of	ADP
dti-2613	62	11	tris	tris	ADJ
dti-2613	62	12	-	-	PUNCT
dti-2613	62	13	ethylenediamine	ethylenediamine	NOUN
dti-2613	62	14	tetraacetic	tetraacetic	ADJ
dti-2613	62	15	acid	acid	NOUN
dti-2613	62	16	(	(	PUNCT
dti-2613	62	17	edta	edta	NOUN
dti-2613	62	18	)	)	PUNCT
dti-2613	62	19	solution	solution	NOUN
dti-2613	62	20	,	,	PUNCT
dti-2613	62	21	heated	heat	VERB
dti-2613	62	22	at	at	ADP
dti-2613	62	23	100	100	NUM
dti-2613	62	24	°	°	ADP
dti-2613	62	25	c	c	NOUN
dti-2613	62	26	for	for	ADP
dti-2613	62	27	10	10	NUM
dti-2613	62	28	minutes	minute	NOUN
dti-2613	62	29	,	,	PUNCT
dti-2613	62	30	and	and	CCONJ
dti-2613	62	31	then	then	ADV
dti-2613	62	32	immediately	immediately	ADV
dti-2613	62	33	placed	place	VERB
dti-2613	62	34	at	at	ADP
dti-2613	62	35	−20	−20	NOUN
dti-2613	62	36	°	°	ADP
dti-2613	62	37	c	c	NOUN
dti-2613	62	38	for	for	ADP
dti-2613	62	39	5	5	NUM
dti-2613	62	40	to	to	PART
dti-2613	62	41	10	10	NUM
dti-2613	62	42	minutes	minute	NOUN
dti-2613	62	43	.	.	PUNCT
dti-2613	63	1	after	after	ADP
dti-2613	63	2	centrifugation	centrifugation	NOUN
dti-2613	63	3	at	at	ADP
dti-2613	63	4	12,000	12,000	NUM
dti-2613	63	5	rpm	rpm	NOUN
dti-2613	63	6	for	for	ADP
dti-2613	63	7	10	10	NUM
dti-2613	63	8	minutes	minute	NOUN
dti-2613	63	9	,	,	PUNCT
dti-2613	63	10	the	the	DET
dti-2613	63	11	obtained	obtain	VERB
dti-2613	63	12	supernatant	supernatant	NOUN
dti-2613	63	13	was	be	AUX
dti-2613	63	14	used	use	VERB
dti-2613	63	15	as	as	ADP
dti-2613	63	16	dna	dna	PROPN
dti-2613	63	17	template	template	NOUN
dti-2613	63	18	.	.	PUNCT
dti-2613	64	1	quality	quality	NOUN
dti-2613	64	2	control	control	NOUN
dti-2613	64	3	of	of	ADP
dti-2613	64	4	the	the	DET
dti-2613	64	5	extraction	extraction	NOUN
dti-2613	64	6	was	be	AUX
dti-2613	64	7	carried	carry	VERB
dti-2613	64	8	out	out	ADP
dti-2613	64	9	using	use	VERB
dti-2613	64	10	thermo	thermo	NOUN
dti-2613	64	11	scientific	scientific	ADJ
dti-2613	64	12	nanodrop	nanodrop	NOUN
dti-2613	64	13	one	one	NUM
dti-2613	64	14	/	/	SYM
dti-2613	64	15	onec	onec	PROPN
dti-2613	64	16	instrument	instrument	NOUN
dti-2613	64	17	at	at	ADP
dti-2613	64	18	the	the	DET
dti-2613	64	19	molecular	molecular	ADJ
dti-2613	64	20	biology	biology	NOUN
dti-2613	64	21	unit	unit	NOUN
dti-2613	64	22	of	of	ADP
dti-2613	64	23	the	the	DET
dti-2613	64	24	university	university	NOUN
dti-2613	64	25	centre	centre	NOUN
dti-2613	64	26	for	for	ADP
dti-2613	64	27	clinical	clinical	ADJ
dti-2613	64	28	research	research	NOUN
dti-2613	64	29	(	(	PUNCT
dti-2613	64	30	ucrc	ucrc	NOUN
dti-2613	64	31	)	)	PUNCT
dti-2613	64	32	in	in	ADP
dti-2613	64	33	bamako	bamako	PROPN
dti-2613	64	34	.	.	PUNCT
dti-2613	65	1	using	use	VERB
dti-2613	65	2	conventional	conventional	ADJ
dti-2613	65	3	polymerase	polymerase	NOUN
dti-2613	65	4	chain	chain	NOUN
dti-2613	65	5	reaction	reaction	NOUN
dti-2613	65	6	(	(	PUNCT
dti-2613	65	7	pcr	pcr	PROPN
dti-2613	65	8	)	)	PUNCT
dti-2613	65	9	,	,	PUNCT
dti-2613	65	10	eight	eight	NUM
dti-2613	65	11	virulence	virulence	NOUN
dti-2613	65	12	factor	factor	NOUN
dti-2613	65	13	genes	gene	NOUN
dti-2613	65	14	from	from	ADP
dti-2613	65	15	escherichia	escherichia	NOUN
dti-2613	65	16	coli	coli	NOUN
dti-2613	65	17	,	,	PUNCT
dti-2613	65	18	namely	namely	ADV
dti-2613	65	19	bfp	bfp	NOUN
dti-2613	65	20	,	,	PUNCT
dti-2613	65	21	eae	eae	PROPN
dti-2613	65	22	,	,	PUNCT
dti-2613	65	23	eagg	eagg	NOUN
dti-2613	65	24	,	,	PUNCT
dti-2613	65	25	ipah	ipah	NOUN
dti-2613	65	26	,	,	PUNCT
dti-2613	65	27	slt1	slt1	PROPN
dti-2613	65	28	,	,	PUNCT
dti-2613	65	29	slt2	slt2	NOUN
dti-2613	65	30	,	,	PUNCT
dti-2613	65	31	lt	lt	NOUN
dti-2613	65	32	and	and	CCONJ
dti-2613	65	33	sta	sta	NOUN
dti-2613	65	34	,	,	PUNCT
dti-2613	65	35	as	as	ADV
dti-2613	65	36	well	well	ADV
dti-2613	65	37	as	as	ADP
dti-2613	65	38	esbl	esbl	NOUN
dti-2613	65	39	coding	code	VERB
dti-2613	65	40	genes	gene	NOUN
dti-2613	65	41	,	,	PUNCT
dti-2613	65	42	namely	namely	ADV
dti-2613	65	43	blatem	blatem	NOUN
dti-2613	65	44	and	and	CCONJ
dti-2613	65	45	blashv	blashv	NOUN
dti-2613	65	46	,	,	PUNCT
dti-2613	65	47	were	be	AUX
dti-2613	65	48	characterized	characterize	VERB
dti-2613	65	49	.	.	PUNCT
dti-2613	66	1	in	in	ADP
dti-2613	66	2	addition	addition	NOUN
dti-2613	66	3	,	,	PUNCT
dti-2613	66	4	the	the	DET
dti-2613	66	5	following	follow	VERB
dti-2613	66	6	genes	gene	NOUN
dti-2613	66	7	were	be	AUX
dti-2613	66	8	screened	screen	VERB
dti-2613	66	9	for	for	ADP
dti-2613	66	10	their	their	PRON
dti-2613	66	11	role	role	NOUN
dti-2613	66	12	in	in	ADP
dti-2613	66	13	conferring	confer	VERB
dti-2613	66	14	antibiotic	antibiotic	ADJ
dti-2613	66	15	resistance	resistance	NOUN
dti-2613	66	16	:	:	PUNCT
dti-2613	66	17	the	the	DET
dti-2613	66	18	cata1	cata1	NOUN
dti-2613	66	19	gene	gene	NOUN
dti-2613	66	20	responsible	responsible	ADJ
dti-2613	66	21	for	for	ADP
dti-2613	66	22	encoding	encode	VERB
dti-2613	66	23	chloramphenicol	chloramphenicol	NOUN
dti-2613	66	24	acetyltransferase	acetyltransferase	NOUN
dti-2613	66	25	,	,	PUNCT
dti-2613	66	26	mutations	mutation	NOUN
dti-2613	66	27	on	on	ADP
dti-2613	66	28	genes	gene	NOUN
dti-2613	66	29	encoding	encode	VERB
dti-2613	66	30	for	for	ADP
dti-2613	66	31	topoisomerase	topoisomerase	NOUN
dti-2613	66	32	iv	iv	NUM
dti-2613	66	33	,	,	PUNCT
dti-2613	66	34	and	and	CCONJ
dti-2613	66	35	dna	dna	PROPN
dti-2613	66	36	gyrase	gyrase	NOUN
dti-2613	66	37	protective	protective	ADJ
dti-2613	66	38	proteins	protein	NOUN
dti-2613	66	39	targeted	target	VERB
dti-2613	66	40	by	by	ADP
dti-2613	66	41	quinolones	quinolone	NOUN
dti-2613	66	42	(	(	PUNCT
dti-2613	66	43	qnra	qnra	NOUN
dti-2613	66	44	,	,	PUNCT
dti-2613	66	45	qnrb	qnrb	NOUN
dti-2613	66	46	,	,	PUNCT
dti-2613	66	47	qnrs	qnrs	NOUN
dti-2613	66	48	)	)	PUNCT
dti-2613	66	49	,	,	PUNCT
dti-2613	66	50	as	as	ADV
dti-2613	66	51	well	well	ADV
dti-2613	66	52	as	as	ADP
dti-2613	66	53	class	class	NOUN
dti-2613	66	54	1	1	NUM
dti-2613	66	55	(	(	PUNCT
dti-2613	66	56	int1	int1	PROPN
dti-2613	66	57	)	)	PUNCT
dti-2613	66	58	,	,	PUNCT
dti-2613	66	59	class	class	NOUN
dti-2613	66	60	2	2	NUM
dti-2613	66	61	(	(	PUNCT
dti-2613	66	62	int2	int2	PROPN
dti-2613	66	63	)	)	PUNCT
dti-2613	66	64	,	,	PUNCT
dti-2613	66	65	and	and	CCONJ
dti-2613	66	66	class	class	NOUN
dti-2613	66	67	3	3	NUM
dti-2613	66	68	(	(	PUNCT
dti-2613	66	69	int3	int3	PROPN
dti-2613	66	70	)	)	PUNCT
dti-2613	66	71	integrons	integron	NOUN
dti-2613	66	72	,	,	PUNCT
dti-2613	66	73	which	which	PRON
dti-2613	66	74	carry	carry	VERB
dti-2613	66	75	resistance	resistance	NOUN
dti-2613	66	76	genes	gene	NOUN
dti-2613	66	77	for	for	ADP
dti-2613	66	78	multiple	multiple	ADJ
dti-2613	66	79	antibiotics	antibiotic	NOUN
dti-2613	66	80	.	.	PUNCT
dti-2613	67	1	we	we	PRON
dti-2613	67	2	screened	screen	VERB
dti-2613	67	3	bacterial	bacterial	ADJ
dti-2613	67	4	isolates	isolate	NOUN
dti-2613	67	5	for	for	ADP
dti-2613	67	6	the	the	DET
dti-2613	67	7	presence	presence	NOUN
dti-2613	67	8	of	of	ADP
dti-2613	67	9	carbapenemase	carbapenemase	NOUN
dti-2613	67	10	genes	gene	NOUN
dti-2613	67	11	,	,	PUNCT
dti-2613	67	12	namely	namely	ADV
dti-2613	67	13	:	:	PUNCT
dti-2613	67	14	blakpc	blakpc	NOUN
dti-2613	67	15	,	,	PUNCT
dti-2613	67	16	blandm-1	blandm-1	PROPN
dti-2613	67	17	,	,	PUNCT
dti-2613	67	18	and	and	CCONJ
dti-2613	67	19	blaoxa-48	blaoxa-48	NOUN
dti-2613	67	20	.	.	PROPN
dti-2613	67	21	pcr	pcr	PROPN
dti-2613	67	22	was	be	AUX
dti-2613	67	23	performed	perform	VERB
dti-2613	67	24	using	use	VERB
dti-2613	67	25	abi	abi	PROPN
dti-2613	67	26	9700	9700	NUM
dti-2613	67	27	thermocycler	thermocycler	NOUN
dti-2613	67	28	(	(	PUNCT
dti-2613	67	29	applied	apply	VERB
dti-2613	67	30	biosystems	biosystem	NOUN
dti-2613	67	31	,	,	PUNCT
dti-2613	67	32	usa	usa	PROPN
dti-2613	67	33	)	)	PUNCT
dti-2613	67	34	with	with	ADP
dti-2613	67	35	the	the	DET
dti-2613	67	36	following	follow	VERB
dti-2613	67	37	cycling	cycling	NOUN
dti-2613	67	38	parameters	parameter	NOUN
dti-2613	67	39	:	:	PUNCT
dti-2613	67	40	initial	initial	ADJ
dti-2613	67	41	denaturation	denaturation	NOUN
dti-2613	67	42	at	at	ADP
dti-2613	67	43	95	95	NUM
dti-2613	67	44	°	°	ADP
dti-2613	67	45	c	c	NOUN
dti-2613	67	46	for	for	ADP
dti-2613	67	47	5	5	NUM
dti-2613	67	48	minutes	minute	NOUN
dti-2613	67	49	,	,	PUNCT
dti-2613	67	50	followed	follow	VERB
dti-2613	67	51	by	by	ADP
dti-2613	67	52	35	35	NUM
dti-2613	67	53	cycles	cycle	NOUN
dti-2613	67	54	of	of	ADP
dti-2613	67	55	denaturation	denaturation	NOUN
dti-2613	67	56	at	at	ADP
dti-2613	67	57	95	95	NUM
dti-2613	67	58	°	°	ADP
dti-2613	67	59	c	c	NOUN
dti-2613	67	60	for	for	ADP
dti-2613	67	61	30	30	NUM
dti-2613	67	62	seconds	second	NOUN
dti-2613	67	63	,	,	PUNCT
dti-2613	67	64	annealing	anneal	VERB
dti-2613	67	65	at	at	ADP
dti-2613	67	66	variable	variable	ADJ
dti-2613	67	67	temperature	temperature	NOUN
dti-2613	67	68	for	for	ADP
dti-2613	67	69	each	each	DET
dti-2613	67	70	primer	primer	NOUN
dti-2613	67	71	set	set	VERB
dti-2613	67	72	for	for	ADP
dti-2613	67	73	39	39	NUM
dti-2613	67	74	seconds	second	NOUN
dti-2613	67	75	,	,	PUNCT
dti-2613	67	76	and	and	CCONJ
dti-2613	67	77	extension	extension	NOUN
dti-2613	67	78	at	at	ADP
dti-2613	67	79	72	72	NUM
dti-2613	67	80	°	°	ADP
dti-2613	67	81	c	c	NOUN
dti-2613	67	82	for	for	ADP
dti-2613	67	83	60	60	NUM
dti-2613	67	84	seconds	second	NOUN
dti-2613	67	85	(	(	PUNCT
dti-2613	67	86	tab	tab	NOUN
dti-2613	67	87	.	.	PUNCT
dti-2613	67	88	ii	ii	PROPN
dti-2613	67	89	)	)	PUNCT
dti-2613	67	90	.	.	PUNCT
dti-2613	68	1	table	table	NOUN
dti-2613	68	2	ii	ii	PROPN
dti-2613	68	3	provides	provide	VERB
dti-2613	68	4	essential	essential	ADJ
dti-2613	68	5	information	information	NOUN
dti-2613	68	6	about	about	ADP
dti-2613	68	7	selected	select	VERB
dti-2613	68	8	genes	gene	NOUN
dti-2613	68	9	,	,	PUNCT
dti-2613	68	10	including	include	VERB
dti-2613	68	11	their	their	PRON
dti-2613	68	12	nucleotide	nucleotide	ADJ
dti-2613	68	13	sequences	sequence	NOUN
dti-2613	68	14	,	,	PUNCT
dti-2613	68	15	hybridization	hybridization	NOUN
dti-2613	68	16	temperatures	temperature	NOUN
dti-2613	68	17	,	,	PUNCT
dti-2613	68	18	amplicon	amplicon	NOUN
dti-2613	68	19	sizes	size	NOUN
dti-2613	68	20	.	.	PUNCT
dti-2613	69	1	the	the	DET
dti-2613	69	2	final	final	ADJ
dti-2613	69	3	extension	extension	NOUN
dti-2613	69	4	step	step	NOUN
dti-2613	69	5	was	be	AUX
dti-2613	69	6	carried	carry	VERB
dti-2613	69	7	out	out	ADP
dti-2613	69	8	at	at	ADP
dti-2613	69	9	72	72	NUM
dti-2613	69	10	°	°	ADP
dti-2613	69	11	c	c	NOUN
dti-2613	69	12	for	for	ADP
dti-2613	69	13	5	5	NUM
dti-2613	69	14	minutes	minute	NOUN
dti-2613	69	15	.	.	PUNCT
dti-2613	70	1	table	table	NOUN
dti-2613	70	2	ii	ii	PROPN
dti-2613	70	3	primer	primer	NOUN
dti-2613	70	4	sequences	sequence	NOUN
dti-2613	70	5	and	and	CCONJ
dti-2613	70	6	characteristics	characteristic	NOUN
dti-2613	70	7	of	of	ADP
dti-2613	70	8	selected	select	VERB
dti-2613	70	9	genes	gene	NOUN
dti-2613	70	10	gene	gene	NOUN
dti-2613	70	11	names	name	NOUN
dti-2613	70	12	nucleotide	nucleotide	VERB
dti-2613	70	13	sequences	sequence	NOUN
dti-2613	70	14	(	(	PUNCT
dti-2613	70	15	5ʹ	5ʹ	NOUN
dti-2613	70	16	→	→	SYM
dti-2613	70	17	3ʹ	3ʹ	NUM
dti-2613	70	18	)	)	PUNCT
dti-2613	70	19	hybridization	hybridization	NOUN
dti-2613	70	20	temperature	temperature	NOUN
dti-2613	70	21	amplicon	amplicon	NOUN
dti-2613	70	22	size	size	NOUN
dti-2613	70	23	reference	reference	NOUN
dti-2613	70	24	adhesin	adhesin	NOUN
dti-2613	70	25	genes	gene	VERB
dti-2613	70	26	22	22	NUM
dti-2613	70	27	bfp	bfp	PROPN
dti-2613	70	28	gac	gac	PROPN
dti-2613	70	29	acc	acc	PROPN
dti-2613	70	30	tca	tca	PROPN
dti-2613	70	31	ttg	ttg	PROPN
dti-2613	70	32	ctg	ctg	VERB
dti-2613	70	33	aag	aag	PROPN
dti-2613	70	34	tcg	tcg	PROPN
dti-2613	70	35	57	57	NUM
dti-2613	70	36	°	°	NOUN
dti-2613	70	37	c	c	NOUN
dti-2613	70	38	324	324	NUM
dti-2613	70	39	bp	bp	PROPN
dti-2613	70	40	cca	cca	PROPN
dti-2613	70	41	gaa	gaa	PROPN
dti-2613	70	42	cac	cac	PROPN
dti-2613	70	43	ctc	ctc	PROPN
dti-2613	70	44	cgt	cgt	PROPN
dti-2613	70	45	tat	tat	PROPN
dti-2613	70	46	gc	gc	PROPN
dti-2613	70	47	eae	eae	PROPN
dti-2613	70	48	tca	tca	PROPN
dti-2613	70	49	atg	atg	PROPN
dti-2613	70	50	cag	cag	PROPN
dti-2613	70	51	ttc	ttc	PROPN
dti-2613	70	52	cgt	cgt	PROPN
dti-2613	70	53	tat	tat	PROPN
dti-2613	70	54	cag	cag	PROPN
dti-2613	70	55	tt	tt	PROPN
dti-2613	70	56	65	65	NUM
dti-2613	70	57	°	°	PROPN
dti-2613	70	58	c	c	PROPN
dti-2613	70	59	494	494	NUM
dti-2613	70	60	bp	bp	PROPN
dti-2613	70	61	gta	gta	PROPN
dti-2613	70	62	aag	aag	PROPN
dti-2613	70	63	tcc	tcc	PROPN
dti-2613	70	64	gtt	gtt	PROPN
dti-2613	70	65	acc	acc	PROPN
dti-2613	70	66	cca	cca	PROPN
dti-2613	70	67	acc	acc	PROPN
dti-2613	71	1	tg	tg	PROPN
dti-2613	71	2	ipah	ipah	PROPN
dti-2613	71	3	gaa	gaa	PROPN
dti-2613	71	4	aac	aac	PROPN
dti-2613	71	5	ctc	ctc	PROPN
dti-2613	71	6	ctg	ctg	PROPN
dti-2613	71	7	gtc	gtc	PROPN
dti-2613	71	8	cat	cat	PROPN
dti-2613	71	9	cag	cag	PROPN
dti-2613	71	10	g	g	PROPN
dti-2613	71	11	53	53	NUM
dti-2613	71	12	°	°	PROPN
dti-2613	71	13	c	c	NOUN
dti-2613	71	14	424	424	NUM
dti-2613	71	15	bp	bp	PROPN
dti-2613	71	16	gcc	gcc	NOUN
dti-2613	71	17	ggt	ggt	PROPN
dti-2613	71	18	cag	cag	PROPN
dti-2613	71	19	cca	cca	PROPN
dti-2613	71	20	ccc	ccc	PROPN
dti-2613	71	21	tct	tct	PROPN
dti-2613	71	22	gag	gag	PROPN
dti-2613	71	23	agt	agt	PROPN
dti-2613	71	24	ac	ac	PROPN
dti-2613	71	25	eagg	eagg	PROPN
dti-2613	71	26	acg	acg	PROPN
dti-2613	71	27	cag	cag	PROPN
dti-2613	71	28	agt	agt	PROPN
dti-2613	71	29	tgc	tgc	PROPN
dti-2613	71	30	ctg	ctg	PROPN
dti-2613	71	31	ata	ata	PROPN
dti-2613	71	32	aag	aag	PROPN
dti-2613	71	33	53	53	NUM
dti-2613	71	34	°	°	PROPN
dti-2613	71	35	c	c	PROPN
dti-2613	71	36	630	630	NUM
dti-2613	71	37	bp	bp	PROPN
dti-2613	71	38	aat	aat	PROPN
dti-2613	71	39	aca	aca	PROPN
dti-2613	71	40	gaa	gaa	PROPN
dti-2613	71	41	tcg	tcg	PROPN
dti-2613	71	42	tca	tca	PROPN
dti-2613	71	43	gca	gca	PROPN
dti-2613	71	44	tca	tca	PROPN
dti-2613	71	45	gc	gc	PROPN
dti-2613	71	46	toxin	toxin	NOUN
dti-2613	71	47	genes	gene	NOUN
dti-2613	71	48	slt1	slt1	NOUN
dti-2613	71	49	ttt	ttt	PROPN
dti-2613	71	50	acg	acg	PROPN
dti-2613	71	51	ata	ata	PROPN
dti-2613	71	52	gca	gca	PROPN
dti-2613	71	53	ttc	ttc	PROPN
dti-2613	71	54	tcg	tcg	PROPN
dti-2613	71	55	ac	ac	PROPN
dti-2613	71	56	56	56	NUM
dti-2613	71	57	°	°	PROPN
dti-2613	71	58	c	c	PROPN
dti-2613	71	59	130	130	NUM
dti-2613	71	60	bp	bp	PROPN
dti-2613	71	61	cac	cac	PROPN
dti-2613	71	62	ata	ata	PROPN
dti-2613	71	63	taa	taa	PROPN
dti-2613	71	64	att	att	PROPN
dti-2613	71	65	att	att	PROPN
dti-2613	71	66	tcg	tcg	PROPN
dti-2613	71	67	ctc	ctc	PROPN
dti-2613	71	68	slt2	slt2	PROPN
dti-2613	71	69	ctt	ctt	PROPN
dti-2613	71	70	cac	cac	PROPN
dti-2613	71	71	gtc	gtc	PROPN
dti-2613	71	72	acc	acc	PROPN
dti-2613	71	73	ata	ata	PROPN
dti-2613	71	74	cat	cat	PROPN
dti-2613	71	75	at	at	ADP
dti-2613	71	76	56	56	NUM
dti-2613	71	77	°	°	NOUN
dti-2613	72	1	c	c	NOUN
dti-2613	72	2	346	346	NUM
dti-2613	72	3	bp	bp	PROPN
dti-2613	72	4	acg	acg	PROPN
dti-2613	72	5	atg	atg	PROPN
dti-2613	72	6	tgg	tgg	PROPN
dti-2613	72	7	ttt	ttt	PROPN
dti-2613	72	8	att	att	PROPN
dti-2613	72	9	ctg	ctg	PROPN
dti-2613	72	10	ga	ga	PROPN
dti-2613	72	11	lt	lt	PROPN
dti-2613	72	12	ggc	ggc	PROPN
dti-2613	72	13	gac	gac	PROPN
dti-2613	72	14	aga	aga	PROPN
dti-2613	72	15	tta	tta	PROPN
dti-2613	72	16	tac	tac	PROPN
dti-2613	72	17	cgt	cgt	PROPN
dti-2613	72	18	gc	gc	PROPN
dti-2613	72	19	56	56	NUM
dti-2613	72	20	°	°	PROPN
dti-2613	72	21	c	c	PROPN
dti-2613	72	22	707	707	NUM
dti-2613	72	23	bp	bp	PROPN
dti-2613	72	24	ccg	ccg	PROPN
dti-2613	72	25	aat	aat	PROPN
dti-2613	72	26	tct	tct	PROPN
dti-2613	72	27	gtt	gtt	PROPN
dti-2613	72	28	ata	ata	PROPN
dti-2613	72	29	tat	tat	PROPN
dti-2613	72	30	gtc	gtc	PROPN
dti-2613	72	31	sta	sta	PROPN
dti-2613	72	32	tta	tta	PROPN
dti-2613	72	33	ata	ata	PROPN
dti-2613	72	34	gca	gca	PROPN
dti-2613	72	35	ccc	ccc	PROPN
dti-2613	72	36	ggt	ggt	PROPN
dti-2613	72	37	aca	aca	PROPN
dti-2613	72	38	agc	agc	PROPN
dti-2613	72	39	agg	agg	PROPN
dti-2613	72	40	43	43	NUM
dti-2613	72	41	°	°	PROPN
dti-2613	72	42	c	c	PROPN
dti-2613	72	43	146	146	NUM
dti-2613	72	44	bp	bp	PROPN
dti-2613	72	45	ctt	ctt	PROPN
dti-2613	72	46	gac	gac	PROPN
dti-2613	72	47	tct	tct	PROPN
dti-2613	72	48	tca	tca	PROPN
dti-2613	72	49	aaa	aaa	PROPN
dti-2613	72	50	gag	gag	NOUN
dti-2613	72	51	aaa	aaa	PROPN
dti-2613	72	52	att	att	PROPN
dti-2613	72	53	ac	ac	PROPN
dti-2613	72	54	antibiotic	antibiotic	ADJ
dti-2613	72	55	resistance	resistance	NOUN
dti-2613	72	56	genes	gene	NOUN
dti-2613	72	57	int1	int1	NOUN
dti-2613	72	58	acatgtgatggcgacgca	acatgtgatggcgacgca	NOUN
dti-2613	72	59	cga	cga	PROPN
dti-2613	72	60	57	57	NUM
dti-2613	72	61	°	°	ADP
dti-2613	73	1	c	c	NOUN
dti-2613	73	2	580	580	NUM
dti-2613	73	3	bp	bp	PROPN
dti-2613	73	4	atttctgtcctggctggc	atttctgtcctggctggc	PROPN
dti-2613	73	5	ga	ga	PROPN
dti-2613	73	6	int2	int2	PROPN
dti-2613	73	7	gtagcaaacgactgacgaaat	gtagcaaacgactgacgaaat	ADV
dti-2613	73	8	g	g	ADP
dti-2613	73	9	62	62	NUM
dti-2613	73	10	°	°	ADP
dti-2613	73	11	c	c	PROPN
dti-2613	73	12	806	806	NUM
dti-2613	73	13	bp	bp	PROPN
dti-2613	73	14	cacggatatgcgacaaaa	cacggatatgcgacaaaa	PROPN
dti-2613	73	15	agg	agg	PROPN
dti-2613	73	16	t	t	PROPN
dti-2613	73	17	int3	int3	PROPN
dti-2613	73	18	gcc	gcc	PROPN
dti-2613	73	19	ccg	ccg	PROPN
dti-2613	73	20	gca	gca	PROPN
dti-2613	73	21	gcg	gcg	PROPN
dti-2613	73	22	act	act	PROPN
dti-2613	73	23	ttc	ttc	PROPN
dti-2613	73	24	ag	ag	PROPN
dti-2613	73	25	62	62	NUM
dti-2613	73	26	°	°	PROPN
dti-2613	73	27	c	c	PROPN
dti-2613	73	28	1200	1200	NUM
dti-2613	73	29	bp	bp	PROPN
dti-2613	73	30	acg	acg	PROPN
dti-2613	73	31	gct	gct	PROPN
dti-2613	73	32	ctg	ctg	PROPN
dti-2613	73	33	cca	cca	PROPN
dti-2613	73	34	aac	aac	PROPN
dti-2613	73	35	ctg	ctg	PROPN
dti-2613	73	36	act	act	PROPN
dti-2613	73	37	shv	shv	PROPN
dti-2613	73	38	ttatctccctgttagccacc	ttatctccctgttagccacc	PROPN
dti-2613	73	39	55	55	NUM
dti-2613	73	40	°	°	ADP
dti-2613	73	41	c	c	PROPN
dti-2613	73	42	800	800	NUM
dti-2613	73	43	bp	bp	PROPN
dti-2613	73	44	gatttgctgatttcgctcgg	gatttgctgatttcgctcgg	PROPN
dti-2613	73	45	tem	tem	PROPN
dti-2613	73	46	ataaaattcttgaagacgaaa	ataaaattcttgaagacgaaa	PROPN
dti-2613	73	47	55	55	NUM
dti-2613	73	48	°	°	NOUN
dti-2613	73	49	c	c	PROPN
dti-2613	73	50	850	850	NUM
dti-2613	73	51	bp	bp	PROPN
dti-2613	73	52	gacagttaccaatgcttaatc	gacagttaccaatgcttaatc	PROPN
dti-2613	73	53	kalambry	kalambry	PROPN
dti-2613	73	54	et	et	PROPN
dti-2613	73	55	al	al	PROPN
dti-2613	73	56	drug	drug	PROPN
dti-2613	73	57	target	target	NOUN
dti-2613	73	58	insights	insight	NOUN
dti-2613	73	59	2023	2023	NUM
dti-2613	73	60	;	;	PUNCT
dti-2613	73	61	17	17	NUM
dti-2613	73	62	:	:	SYM
dti-2613	73	63	95	95	NUM
dti-2613	73	64	©	©	PROPN
dti-2613	73	65	2023	2023	NUM
dti-2613	73	66	the	the	DET
dti-2613	73	67	authors	author	NOUN
dti-2613	73	68	.	.	PUNCT
dti-2613	74	1	published	publish	VERB
dti-2613	74	2	by	by	ADP
dti-2613	74	3	aboutscience	aboutscience	NOUN
dti-2613	74	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2613	74	5	each	each	DET
dti-2613	74	6	reaction	reaction	NOUN
dti-2613	74	7	was	be	AUX
dti-2613	74	8	carried	carry	VERB
dti-2613	74	9	out	out	ADP
dti-2613	74	10	in	in	ADP
dti-2613	74	11	a	a	DET
dti-2613	74	12	25	25	NUM
dti-2613	74	13	μl	μl	PRON
dti-2613	74	14	mixture	mixture	NOUN
dti-2613	74	15	prepared	prepare	VERB
dti-2613	74	16	as	as	SCONJ
dti-2613	74	17	described	describe	VERB
dti-2613	74	18	previously	previously	ADV
dti-2613	74	19	,	,	PUNCT
dti-2613	74	20	with	with	ADP
dti-2613	74	21	modifications	modification	NOUN
dti-2613	74	22	(	(	PUNCT
dti-2613	74	23	22	22	NUM
dti-2613	74	24	)	)	PUNCT
dti-2613	74	25	.	.	PUNCT
dti-2613	75	1	in	in	ADP
dti-2613	75	2	all	all	DET
dti-2613	75	3	reactions	reaction	NOUN
dti-2613	75	4	,	,	PUNCT
dti-2613	75	5	a	a	DET
dti-2613	75	6	negative	negative	ADJ
dti-2613	75	7	control	control	NOUN
dti-2613	75	8	(	(	PUNCT
dti-2613	75	9	water	water	NOUN
dti-2613	75	10	)	)	PUNCT
dti-2613	75	11	was	be	AUX
dti-2613	75	12	included	include	VERB
dti-2613	75	13	alongside	alongside	ADP
dti-2613	75	14	a	a	DET
dti-2613	75	15	positive	positive	ADJ
dti-2613	75	16	control	control	NOUN
dti-2613	75	17	consisting	consist	VERB
dti-2613	75	18	of	of	ADP
dti-2613	75	19	reference	reference	NOUN
dti-2613	75	20	isolates	isolate	NOUN
dti-2613	75	21	(	(	PUNCT
dti-2613	75	22	e2348	e2348	PROPN
dti-2613	75	23	-	-	PUNCT
dti-2613	75	24	69	69	NUM
dti-2613	75	25	,	,	PUNCT
dti-2613	75	26	m90	m90	PROPN
dti-2613	75	27	t	t	PROPN
dti-2613	75	28	,	,	PUNCT
dti-2613	75	29	edl	edl	PROPN
dti-2613	75	30	933	933	NUM
dti-2613	75	31	,	,	PUNCT
dti-2613	75	32	edl	edl	PROPN
dti-2613	75	33	1493	1493	NUM
dti-2613	75	34	,	,	PUNCT
dti-2613	75	35	r3	r3	PROPN
dti-2613	75	36	,	,	PUNCT
dti-2613	75	37	r4	r4	NOUN
dti-2613	75	38	,	,	PUNCT
dti-2613	75	39	r5	r5	PROPN
dti-2613	75	40	,	,	PUNCT
dti-2613	75	41	r6	r6	NOUN
dti-2613	75	42	,	,	PUNCT
dti-2613	75	43	and	and	CCONJ
dti-2613	75	44	r7	r7	NOUN
dti-2613	75	45	)	)	PUNCT
dti-2613	75	46	.	.	PUNCT
dti-2613	76	1	the	the	DET
dti-2613	76	2	sequence	sequence	NOUN
dti-2613	76	3	of	of	ADP
dti-2613	76	4	primers	primer	NOUN
dti-2613	76	5	used	use	VERB
dti-2613	76	6	for	for	ADP
dti-2613	76	7	amplification	amplification	NOUN
dti-2613	76	8	and	and	CCONJ
dti-2613	76	9	the	the	DET
dti-2613	76	10	expected	expect	VERB
dti-2613	76	11	amplicon	amplicon	NOUN
dti-2613	76	12	size	size	NOUN
dti-2613	76	13	are	be	AUX
dti-2613	76	14	detailed	detail	VERB
dti-2613	76	15	in	in	ADP
dti-2613	76	16	table	table	NOUN
dti-2613	76	17	ii	ii	PROPN
dti-2613	76	18	.	.	PUNCT
dti-2613	77	1	pcr	pcr	ADJ
dti-2613	77	2	products	product	NOUN
dti-2613	77	3	were	be	AUX
dti-2613	77	4	visualized	visualize	VERB
dti-2613	77	5	by	by	ADP
dti-2613	77	6	transillumination	transillumination	NOUN
dti-2613	77	7	after	after	ADP
dti-2613	77	8	migration	migration	NOUN
dti-2613	77	9	in	in	ADP
dti-2613	77	10	1.5	1.5	NUM
dti-2613	77	11	%	%	NOUN
dti-2613	77	12	tris	tris	NOUN
dti-2613	77	13	base	base	NOUN
dti-2613	77	14	,	,	PUNCT
dti-2613	77	15	acetic	acetic	ADJ
dti-2613	77	16	acid	acid	NOUN
dti-2613	77	17	and	and	CCONJ
dti-2613	77	18	edta	edta	NOUN
dti-2613	77	19	(	(	PUNCT
dti-2613	77	20	tae	tae	NOUN
dti-2613	77	21	)	)	PUNCT
dti-2613	77	22	buffer	buffer	NOUN
dti-2613	77	23	.	.	PUNCT
dti-2613	78	1	statistical	statistical	ADJ
dti-2613	78	2	analysis	analysis	NOUN
dti-2613	78	3	the	the	DET
dti-2613	78	4	data	datum	NOUN
dti-2613	78	5	were	be	AUX
dti-2613	78	6	analyzed	analyze	VERB
dti-2613	78	7	using	use	VERB
dti-2613	78	8	ibm	ibm	PROPN
dti-2613	78	9	spss	spss	PROPN
dti-2613	78	10	statistics	statistic	NOUN
dti-2613	78	11	for	for	ADP
dti-2613	78	12	windows	window	NOUN
dti-2613	78	13	,	,	PUNCT
dti-2613	78	14	version	version	NOUN
dti-2613	78	15	23.0	23.0	NUM
dti-2613	78	16	.	.	PUNCT
dti-2613	79	1	student	student	NOUN
dti-2613	79	2	’s	’s	PART
dti-2613	79	3	t	t	PROPN
dti-2613	79	4	-	-	PUNCT
dti-2613	79	5	test	test	NOUN
dti-2613	79	6	was	be	AUX
dti-2613	79	7	used	use	VERB
dti-2613	79	8	to	to	PART
dti-2613	79	9	compare	compare	VERB
dti-2613	79	10	mean	mean	ADJ
dti-2613	79	11	values	value	NOUN
dti-2613	79	12	of	of	ADP
dti-2613	79	13	continuous	continuous	ADJ
dti-2613	79	14	variables	variable	NOUN
dti-2613	79	15	,	,	PUNCT
dti-2613	79	16	while	while	SCONJ
dti-2613	79	17	chi	chi	ADJ
dti-2613	79	18	-	-	PUNCT
dti-2613	79	19	square	square	ADJ
dti-2613	79	20	test	test	NOUN
dti-2613	79	21	was	be	AUX
dti-2613	79	22	employed	employ	VERB
dti-2613	79	23	to	to	PART
dti-2613	79	24	analyze	analyze	VERB
dti-2613	79	25	categorical	categorical	ADJ
dti-2613	79	26	variables	variable	NOUN
dti-2613	79	27	.	.	PUNCT
dti-2613	80	1	a	a	DET
dti-2613	80	2	p	p	NOUN
dti-2613	80	3	-	-	PUNCT
dti-2613	80	4	value	value	NOUN
dti-2613	80	5	of	of	ADP
dti-2613	80	6	less	less	ADJ
dti-2613	80	7	than	than	ADP
dti-2613	80	8	0.05	0.05	NUM
dti-2613	80	9	was	be	AUX
dti-2613	80	10	considered	consider	VERB
dti-2613	80	11	to	to	PART
dti-2613	80	12	indicate	indicate	VERB
dti-2613	80	13	statistical	statistical	ADJ
dti-2613	80	14	significance	significance	NOUN
dti-2613	80	15	.	.	PUNCT
dti-2613	81	1	statistical	statistical	ADJ
dti-2613	81	2	analysis	analysis	NOUN
dti-2613	81	3	of	of	ADP
dti-2613	81	4	amr	amr	PROPN
dti-2613	81	5	data	datum	NOUN
dti-2613	81	6	was	be	AUX
dti-2613	81	7	performed	perform	VERB
dti-2613	81	8	using	use	VERB
dti-2613	81	9	the	the	DET
dti-2613	81	10	software	software	NOUN
dti-2613	81	11	r	r	NOUN
dti-2613	81	12	(	(	PUNCT
dti-2613	81	13	version	version	NOUN
dti-2613	81	14	4.3.0	4.3.0	NUM
dti-2613	81	15	)	)	PUNCT
dti-2613	81	16	and	and	CCONJ
dti-2613	81	17	the	the	DET
dti-2613	81	18	integrated	integrate	VERB
dti-2613	81	19	development	development	NOUN
dti-2613	81	20	environment	environment	NOUN
dti-2613	81	21	r	r	NOUN
dti-2613	81	22	studio	studio	NOUN
dti-2613	81	23	(	(	PUNCT
dti-2613	81	24	version	version	NOUN
dti-2613	81	25	2023.03.1	2023.03.1	NUM
dti-2613	81	26	+	+	NOUN
dti-2613	81	27	446	446	NUM
dti-2613	81	28	)	)	PUNCT
dti-2613	81	29	.	.	PUNCT
dti-2613	82	1	the	the	DET
dti-2613	82	2	package	package	NOUN
dti-2613	82	3	“	"	PUNCT
dti-2613	82	4	amr	amr	NOUN
dti-2613	82	5	”	"	PUNCT
dti-2613	82	6	was	be	AUX
dti-2613	82	7	employed	employ	VERB
dti-2613	82	8	for	for	ADP
dti-2613	82	9	amr	amr	PROPN
dti-2613	82	10	data	datum	NOUN
dti-2613	82	11	processing	processing	NOUN
dti-2613	82	12	(	(	PUNCT
dti-2613	82	13	23	23	NUM
dti-2613	82	14	)	)	PUNCT
dti-2613	82	15	.	.	PUNCT
dti-2613	83	1	ethical	ethical	ADJ
dti-2613	83	2	approval	approval	NOUN
dti-2613	83	3	written	write	VERB
dti-2613	83	4	consent	consent	NOUN
dti-2613	83	5	was	be	AUX
dti-2613	83	6	obtained	obtain	VERB
dti-2613	83	7	from	from	ADP
dti-2613	83	8	all	all	DET
dti-2613	83	9	included	include	VERB
dti-2613	83	10	participants	participant	NOUN
dti-2613	83	11	,	,	PUNCT
dti-2613	83	12	and	and	CCONJ
dti-2613	83	13	the	the	DET
dti-2613	83	14	study	study	NOUN
dti-2613	83	15	protocol	protocol	NOUN
dti-2613	83	16	was	be	AUX
dti-2613	83	17	subjected	subject	VERB
dti-2613	83	18	to	to	PART
dti-2613	83	19	review	review	VERB
dti-2613	83	20	and	and	CCONJ
dti-2613	83	21	approval	approval	NOUN
dti-2613	83	22	by	by	ADP
dti-2613	83	23	the	the	DET
dti-2613	83	24	ethics	ethic	NOUN
dti-2613	83	25	committee	committee	PROPN
dti-2613	83	26	of	of	ADP
dti-2613	83	27	the	the	DET
dti-2613	83	28	university	university	PROPN
dti-2613	83	29	of	of	ADP
dti-2613	83	30	sciences	science	NOUN
dti-2613	83	31	,	,	PUNCT
dti-2613	83	32	techniques	technique	NOUN
dti-2613	83	33	,	,	PUNCT
dti-2613	83	34	and	and	CCONJ
dti-2613	83	35	technologies	technology	NOUN
dti-2613	83	36	of	of	ADP
dti-2613	83	37	bamako	bamako	PROPN
dti-2613	83	38	.	.	PUNCT
dti-2613	84	1	the	the	DET
dti-2613	84	2	approval	approval	NOUN
dti-2613	84	3	was	be	AUX
dti-2613	84	4	granted	grant	VERB
dti-2613	84	5	under	under	ADP
dti-2613	84	6	reference	reference	NOUN
dti-2613	84	7	number	number	NOUN
dti-2613	84	8	2021/228/	2021/228/	NUM
dti-2613	84	9	usttb	usttb	NOUN
dti-2613	84	10	on	on	ADP
dti-2613	84	11	june	june	PROPN
dti-2613	84	12	9	9	NUM
dti-2613	84	13	,	,	PUNCT
dti-2613	84	14	2021	2021	NUM
dti-2613	84	15	.	.	PUNCT
dti-2613	85	1	results	result	VERB
dti-2613	85	2	sociodemographic	sociodemographic	ADJ
dti-2613	85	3	characteristics	characteristic	NOUN
dti-2613	85	4	of	of	ADP
dti-2613	85	5	patients	patient	NOUN
dti-2613	85	6	the	the	DET
dti-2613	85	7	study	study	NOUN
dti-2613	85	8	specifically	specifically	ADV
dti-2613	85	9	analyzed	analyze	VERB
dti-2613	85	10	pleural	pleural	ADJ
dti-2613	85	11	fluid	fluid	ADJ
dti-2613	85	12	samples	sample	NOUN
dti-2613	85	13	obtained	obtain	VERB
dti-2613	85	14	from	from	ADP
dti-2613	85	15	526	526	NUM
dti-2613	85	16	patients	patient	NOUN
dti-2613	85	17	with	with	ADP
dti-2613	85	18	pleurisy	pleurisy	PROPN
dti-2613	85	19	,	,	PUNCT
dti-2613	85	20	out	out	ADP
dti-2613	85	21	of	of	ADP
dti-2613	85	22	which	which	PRON
dti-2613	85	23	110	110	NUM
dti-2613	85	24	were	be	AUX
dti-2613	85	25	diagnosed	diagnose	VERB
dti-2613	85	26	with	with	ADP
dti-2613	85	27	enterobacterial	enterobacterial	ADJ
dti-2613	85	28	pleuritis	pleuritis	PROPN
dti-2613	85	29	(	(	PUNCT
dti-2613	85	30	tab	tab	PROPN
dti-2613	85	31	.	.	PUNCT
dti-2613	85	32	iii	iii	PROPN
dti-2613	85	33	)	)	PUNCT
dti-2613	85	34	.	.	PUNCT
dti-2613	86	1	table	table	NOUN
dti-2613	86	2	iii	iii	NOUN
dti-2613	86	3	provides	provide	VERB
dti-2613	86	4	an	an	DET
dti-2613	86	5	overview	overview	NOUN
dti-2613	86	6	of	of	ADP
dti-2613	86	7	patient	patient	ADJ
dti-2613	86	8	characteristics	characteristic	NOUN
dti-2613	86	9	and	and	CCONJ
dti-2613	86	10	their	their	PRON
dti-2613	86	11	distribution	distribution	NOUN
dti-2613	86	12	within	within	ADP
dti-2613	86	13	the	the	DET
dti-2613	86	14	thoracic	thoracic	NOUN
dti-2613	86	15	surgery	surgery	NOUN
dti-2613	86	16	and	and	CCONJ
dti-2613	86	17	pediatrics	pediatric	NOUN
dti-2613	86	18	’	'	PUNCT
dti-2613	86	19	ward	ward	NOUN
dti-2613	86	20	.	.	PUNCT
dti-2613	87	1	it	it	PRON
dti-2613	87	2	allows	allow	VERB
dti-2613	87	3	for	for	ADP
dti-2613	87	4	a	a	DET
dti-2613	87	5	comparison	comparison	NOUN
dti-2613	87	6	between	between	ADP
dti-2613	87	7	the	the	DET
dti-2613	87	8	two	two	NUM
dti-2613	87	9	groups	group	NOUN
dti-2613	87	10	and	and	CCONJ
dti-2613	87	11	helps	helps	AUX
dti-2613	87	12	identify	identify	VERB
dti-2613	87	13	any	any	DET
dti-2613	87	14	statistically	statistically	ADV
dti-2613	87	15	significant	significant	ADJ
dti-2613	87	16	differences	difference	NOUN
dti-2613	87	17	in	in	ADP
dti-2613	87	18	gene	gene	NOUN
dti-2613	87	19	names	name	NOUN
dti-2613	87	20	nucleotide	nucleotide	VERB
dti-2613	87	21	sequences	sequence	NOUN
dti-2613	87	22	(	(	PUNCT
dti-2613	87	23	5ʹ	5ʹ	NOUN
dti-2613	87	24	→	→	SYM
dti-2613	87	25	3ʹ	3ʹ	NUM
dti-2613	87	26	)	)	PUNCT
dti-2613	87	27	hybridization	hybridization	NOUN
dti-2613	87	28	temperature	temperature	NOUN
dti-2613	87	29	amplicon	amplicon	NOUN
dti-2613	87	30	size	size	NOUN
dti-2613	87	31	reference	reference	NOUN
dti-2613	87	32	cata1	cata1	NOUN
dti-2613	87	33	cctgccactcatcgcagtac	cctgccactcatcgcagtac	PROPN
dti-2613	87	34	57	57	NUM
dti-2613	87	35	°	°	ADP
dti-2613	87	36	c	c	PROPN
dti-2613	87	37	450	450	NUM
dti-2613	87	38	bp	bp	PROPN
dti-2613	87	39	ctgcctggacaacattgctt	ctgcctggacaacattgctt	PROPN
dti-2613	87	40	qnra	qnra	NOUN
dti-2613	87	41	tcagcacaagaggatttctc	tcagcacaagaggatttctc	NOUN
dti-2613	87	42	55	55	NUM
dti-2613	87	43	°	°	ADP
dti-2613	87	44	c	c	NOUN
dti-2613	87	45	657	657	NUM
dti-2613	87	46	bp	bp	PROPN
dti-2613	87	47	ggcagcactattactccca	ggcagcactattactccca	PROPN
dti-2613	87	48	qnrb	qnrb	PROPN
dti-2613	87	49	gatcgtgaaagccagaaagg	gatcgtgaaagccagaaagg	PROPN
dti-2613	87	50	55	55	NUM
dti-2613	87	51	°	°	PRON
dti-2613	87	52	c	c	PROPN
dti-2613	87	53	469	469	NUM
dti-2613	87	54	bp	bp	PROPN
dti-2613	87	55	acgatgcctggtagttgtcc	acgatgcctggtagttgtcc	NOUN
dti-2613	87	56	qnrs	qnrs	VERB
dti-2613	87	57	acgacattcgtcaactgcaa	acgacattcgtcaactgcaa	ADJ
dti-2613	87	58	55	55	NUM
dti-2613	87	59	°	°	NOUN
dti-2613	87	60	c	c	PROPN
dti-2613	87	61	417	417	NUM
dti-2613	87	62	bp	bp	PROPN
dti-2613	87	63	taaattggcaccctgtaggc	taaattggcaccctgtaggc	PROPN
dti-2613	87	64	carbapenemase	carbapenemase	PROPN
dti-2613	87	65	27	27	NUM
dti-2613	87	66	blakpc	blakpc	NOUN
dti-2613	87	67	cattcaagggctttcttgctgc	cattcaagggctttcttgctgc	VERB
dti-2613	87	68	55	55	NUM
dti-2613	87	69	°	°	NOUN
dti-2613	87	70	c	c	NOUN
dti-2613	87	71	538	538	NUM
dti-2613	87	72	bp	bp	PROPN
dti-2613	87	73	acgacggcatagtcatttgc	acgacggcatagtcatttgc	ADJ
dti-2613	87	74	blaoxa-48	blaoxa-48	NOUN
dti-2613	87	75	gcttgatcgccctcgatt	gcttgatcgccctcgatt	ADJ
dti-2613	87	76	55	55	NUM
dti-2613	87	77	°	°	ADP
dti-2613	87	78	c	c	NOUN
dti-2613	87	79	281	281	NUM
dti-2613	87	80	bp	bp	PROPN
dti-2613	87	81	gatttgctccgtggccgaaa	gatttgctccgtggccgaaa	NOUN
dti-2613	87	82	blandm-1	blandm-1	PROPN
dti-2613	87	83	atggaattgcccaatattatgcac	atggaattgcccaatattatgcac	PROPN
dti-2613	87	84	55	55	NUM
dti-2613	87	85	°	°	NOUN
dti-2613	87	86	c	c	NOUN
dti-2613	87	87	813	813	NUM
dti-2613	87	88	bp	bp	NOUN
dti-2613	87	89	tcagcgcagcttgtcggc	tcagcgcagcttgtcggc	PROPN
dti-2613	87	90	table	table	NOUN
dti-2613	87	91	iii	iii	NUM
dti-2613	87	92	patient	patient	ADJ
dti-2613	87	93	characteristics	characteristic	NOUN
dti-2613	87	94	and	and	CCONJ
dti-2613	87	95	distribution	distribution	NOUN
dti-2613	87	96	by	by	ADP
dti-2613	87	97	thoracic	thoracic	NOUN
dti-2613	87	98	surgery	surgery	NOUN
dti-2613	87	99	and	and	CCONJ
dti-2613	87	100	pediatric	pediatric	ADJ
dti-2613	87	101	wards	ward	NOUN
dti-2613	87	102	thoracic	thoracic	NOUN
dti-2613	87	103	surgery	surgery	NOUN
dti-2613	87	104	pediatrics	pediatric	NOUN
dti-2613	87	105	total	total	VERB
dti-2613	87	106	p	p	PROPN
dti-2613	87	107	characteristics	characteristic	NOUN
dti-2613	87	108	n	n	NOUN
dti-2613	87	109	=	=	SYM
dti-2613	87	110	92	92	NUM
dti-2613	87	111	(	(	PUNCT
dti-2613	87	112	%	%	NOUN
dti-2613	87	113	)	)	PUNCT
dti-2613	88	1	n	n	NOUN
dti-2613	88	2	=	=	SYM
dti-2613	88	3	18	18	NUM
dti-2613	88	4	(	(	PUNCT
dti-2613	88	5	%	%	NOUN
dti-2613	88	6	)	)	PUNCT
dti-2613	88	7	n	n	NOUN
dti-2613	88	8	=	=	SYM
dti-2613	88	9	110	110	NUM
dti-2613	88	10	(	(	PUNCT
dti-2613	88	11	%	%	INTJ
dti-2613	88	12	)	)	PUNCT
dti-2613	88	13	0.000	0.000	NUM
dti-2613	88	14	gender	gender	NOUN
dti-2613	88	15	1.000	1.000	NUM
dti-2613	88	16	 	 	SPACE
dti-2613	88	17	male	male	ADJ
dti-2613	88	18	gender	gender	NOUN
dti-2613	88	19	59	59	NUM
dti-2613	88	20	(	(	PUNCT
dti-2613	88	21	64.1	64.1	NUM
dti-2613	88	22	)	)	PUNCT
dti-2613	88	23	12	12	NUM
dti-2613	88	24	(	(	PUNCT
dti-2613	88	25	66.7	66.7	NUM
dti-2613	88	26	)	)	PUNCT
dti-2613	88	27	71	71	NUM
dti-2613	88	28	(	(	PUNCT
dti-2613	88	29	64.5	64.5	NUM
dti-2613	88	30	)	)	PUNCT
dti-2613	88	31	 	 	SPACE
dti-2613	88	32	female	female	ADJ
dti-2613	88	33	gender	gender	NOUN
dti-2613	88	34	33	33	NUM
dti-2613	88	35	(	(	PUNCT
dti-2613	88	36	35.9	35.9	NUM
dti-2613	88	37	)	)	PUNCT
dti-2613	88	38	6	6	NUM
dti-2613	88	39	(	(	PUNCT
dti-2613	88	40	33.3	33.3	NUM
dti-2613	88	41	)	)	PUNCT
dti-2613	88	42	39	39	NUM
dti-2613	88	43	(	(	PUNCT
dti-2613	88	44	35.5	35.5	NUM
dti-2613	88	45	)	)	PUNCT
dti-2613	88	46	 	 	SPACE
dti-2613	88	47	median	median	ADJ
dti-2613	88	48	age	age	NOUN
dti-2613	88	49	42	42	NUM
dti-2613	88	50	8.5	8.5	NUM
dti-2613	88	51	37.5	37.5	NUM
dti-2613	88	52	age	age	NOUN
dti-2613	88	53	group	group	NOUN
dti-2613	88	54	 	 	SPACE
dti-2613	88	55	0–4	0–4	NUM
dti-2613	88	56	–	–	PUNCT
dti-2613	88	57	13	13	NUM
dti-2613	88	58	(	(	PUNCT
dti-2613	88	59	72.2	72.2	NUM
dti-2613	88	60	)	)	PUNCT
dti-2613	88	61	0.000	0.000	NUM
dti-2613	88	62	 	 	SPACE
dti-2613	88	63	5–9	5–9	NUM
dti-2613	88	64	–	–	PUNCT
dti-2613	88	65	5	5	NUM
dti-2613	88	66	(	(	PUNCT
dti-2613	88	67	27.8	27.8	NUM
dti-2613	88	68	)	)	PUNCT
dti-2613	88	69	 	 	SPACE
dti-2613	88	70	10–14	10–14	NUM
dti-2613	88	71	–	–	PUNCT
dti-2613	88	72	 	 	SPACE
dti-2613	88	73	15–19	15–19	NUM
dti-2613	88	74	3	3	NUM
dti-2613	88	75	(	(	PUNCT
dti-2613	88	76	3.3	3.3	NUM
dti-2613	88	77	)	)	PUNCT
dti-2613	88	78	–	–	PUNCT
dti-2613	88	79	 	 	SPACE
dti-2613	88	80	20–24	20–24	NUM
dti-2613	88	81	3	3	NUM
dti-2613	88	82	(	(	PUNCT
dti-2613	88	83	3.3	3.3	NUM
dti-2613	88	84	)	)	PUNCT
dti-2613	88	85	–	–	PUNCT
dti-2613	88	86	 	 	SPACE
dti-2613	88	87	25–29	25–29	NUM
dti-2613	88	88	16	16	NUM
dti-2613	88	89	(	(	PUNCT
dti-2613	88	90	17.4	17.4	NUM
dti-2613	88	91	)	)	PUNCT
dti-2613	88	92	–	–	PUNCT
dti-2613	88	93	0.000	0.000	NUM
dti-2613	88	94	 	 	SPACE
dti-2613	88	95	30–34	30–34	NUM
dti-2613	88	96	12	12	NUM
dti-2613	88	97	(	(	PUNCT
dti-2613	88	98	13.0	13.0	NUM
dti-2613	88	99	)	)	PUNCT
dti-2613	88	100	–	–	PUNCT
dti-2613	88	101	 	 	SPACE
dti-2613	88	102	35–39	35–39	NUM
dti-2613	88	103	6	6	NUM
dti-2613	88	104	(	(	PUNCT
dti-2613	88	105	6.6	6.6	NUM
dti-2613	88	106	)	)	PUNCT
dti-2613	88	107	–	–	PUNCT
dti-2613	88	108	 	 	SPACE
dti-2613	88	109	40–44	40–44	NUM
dti-2613	88	110	10	10	NUM
dti-2613	88	111	(	(	PUNCT
dti-2613	88	112	10.9	10.9	NUM
dti-2613	88	113	)	)	PUNCT
dti-2613	88	114	–	–	PUNCT
dti-2613	88	115	 	 	SPACE
dti-2613	88	116	45–49	45–49	NUM
dti-2613	88	117	6	6	NUM
dti-2613	88	118	(	(	PUNCT
dti-2613	88	119	6.5	6.5	NUM
dti-2613	88	120	)	)	PUNCT
dti-2613	88	121	–	–	PUNCT
dti-2613	88	122	 	 	SPACE
dti-2613	88	123	50–54	50–54	NUM
dti-2613	88	124	10	10	NUM
dti-2613	88	125	(	(	PUNCT
dti-2613	88	126	10.9	10.9	NUM
dti-2613	88	127	)	)	PUNCT
dti-2613	88	128	–	–	PUNCT
dti-2613	88	129	 	 	SPACE
dti-2613	88	130	55–59	55–59	PROPN
dti-2613	88	131	9	9	NUM
dti-2613	88	132	(	(	PUNCT
dti-2613	88	133	9.8	9.8	NUM
dti-2613	88	134	)	)	PUNCT
dti-2613	88	135	–	–	PUNCT
dti-2613	88	136	 	 	SPACE
dti-2613	88	137	60–64	60–64	NUM
dti-2613	88	138	8	8	NUM
dti-2613	88	139	(	(	PUNCT
dti-2613	88	140	8.7	8.7	NUM
dti-2613	88	141	)	)	PUNCT
dti-2613	88	142	–	–	PUNCT
dti-2613	88	143	 	 	SPACE
dti-2613	88	144	65–69	65–69	NUM
dti-2613	88	145	4	4	NUM
dti-2613	88	146	(	(	PUNCT
dti-2613	88	147	4.3	4.3	NUM
dti-2613	88	148	)	)	PUNCT
dti-2613	88	149	–	–	PUNCT
dti-2613	88	150	 	 	SPACE
dti-2613	88	151	70–90	70–90	NUM
dti-2613	88	152	5	5	NUM
dti-2613	88	153	(	(	PUNCT
dti-2613	88	154	5.4	5.4	NUM
dti-2613	88	155	)	)	PUNCT
dti-2613	88	156	–	–	PUNCT
dti-2613	88	157	hôpital	hôpital	PROPN
dti-2613	88	158	du	du	PROPN
dti-2613	88	159	mali	mali	PROPN
dti-2613	88	160	:	:	PUNCT
dti-2613	88	161	antibiotic	antibiotic	ADJ
dti-2613	88	162	resistance	resistance	NOUN
dti-2613	88	163	in	in	ADP
dti-2613	88	164	ipes96	ipes96	NOUN
dti-2613	88	165	©	©	PROPN
dti-2613	88	166	2023	2023	NUM
dti-2613	88	167	the	the	DET
dti-2613	88	168	authors	author	NOUN
dti-2613	88	169	.	.	PUNCT
dti-2613	89	1	drug	drug	NOUN
dti-2613	89	2	target	target	NOUN
dti-2613	89	3	insights	insight	NOUN
dti-2613	89	4	issn	issn	VERB
dti-2613	89	5	1177	1177	NUM
dti-2613	89	6	-	-	SYM
dti-2613	89	7	3928	3928	NUM
dti-2613	89	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	NOUN
dti-2613	89	9	gender	gender	NOUN
dti-2613	89	10	,	,	PUNCT
dti-2613	89	11	age	age	NOUN
dti-2613	89	12	,	,	PUNCT
dti-2613	89	13	and	and	CCONJ
dti-2613	89	14	age	age	NOUN
dti-2613	89	15	group	group	NOUN
dti-2613	89	16	distribution	distribution	NOUN
dti-2613	89	17	.	.	PUNCT
dti-2613	90	1	a	a	DET
dti-2613	90	2	total	total	NOUN
dti-2613	90	3	of	of	ADP
dti-2613	90	4	71	71	NUM
dti-2613	90	5	(	(	PUNCT
dti-2613	90	6	64.5	64.5	NUM
dti-2613	90	7	%	%	NOUN
dti-2613	90	8	)	)	PUNCT
dti-2613	91	1	patients	patient	NOUN
dti-2613	91	2	were	be	AUX
dti-2613	91	3	men	man	NOUN
dti-2613	91	4	and	and	CCONJ
dti-2613	91	5	39	39	NUM
dti-2613	91	6	(	(	PUNCT
dti-2613	91	7	35.5	35.5	NUM
dti-2613	91	8	%	%	NOUN
dti-2613	91	9	)	)	PUNCT
dti-2613	91	10	were	be	AUX
dti-2613	91	11	women	woman	NOUN
dti-2613	91	12	with	with	ADP
dti-2613	91	13	a	a	DET
dti-2613	91	14	male	male	NOUN
dti-2613	91	15	-	-	PUNCT
dti-2613	91	16	to	to	ADP
dti-2613	91	17	-	-	PUNCT
dti-2613	91	18	female	female	ADJ
dti-2613	91	19	sex	sex	NOUN
dti-2613	91	20	ratio	ratio	NOUN
dti-2613	91	21	of	of	ADP
dti-2613	91	22	1.8	1.8	NUM
dti-2613	91	23	.	.	PUNCT
dti-2613	92	1	the	the	DET
dti-2613	92	2	majority	majority	NOUN
dti-2613	92	3	of	of	ADP
dti-2613	92	4	the	the	DET
dti-2613	92	5	patients	patient	NOUN
dti-2613	92	6	(	(	PUNCT
dti-2613	92	7	76/110	76/110	NUM
dti-2613	92	8	,	,	PUNCT
dti-2613	92	9	69.1	69.1	NUM
dti-2613	92	10	%	%	NOUN
dti-2613	92	11	)	)	PUNCT
dti-2613	92	12	resided	reside	VERB
dti-2613	92	13	in	in	ADP
dti-2613	92	14	urban	urban	ADJ
dti-2613	92	15	areas	area	NOUN
dti-2613	92	16	.	.	PUNCT
dti-2613	93	1	pediatric	pediatric	ADJ
dti-2613	93	2	patients	patient	NOUN
dti-2613	93	3	aged	age	VERB
dti-2613	93	4	0	0	NUM
dti-2613	93	5	-	-	SYM
dti-2613	93	6	4	4	NUM
dti-2613	93	7	years	year	NOUN
dti-2613	93	8	,	,	PUNCT
dti-2613	93	9	and	and	CCONJ
dti-2613	93	10	young	young	ADJ
dti-2613	93	11	adults	adult	NOUN
dti-2613	93	12	(	(	PUNCT
dti-2613	93	13	25	25	NUM
dti-2613	93	14	-	-	SYM
dti-2613	93	15	29	29	NUM
dti-2613	93	16	years	year	NOUN
dti-2613	93	17	)	)	PUNCT
dti-2613	93	18	constituted	constitute	VERB
dti-2613	93	19	72.2	72.2	NUM
dti-2613	93	20	%	%	NOUN
dti-2613	93	21	of	of	ADP
dti-2613	93	22	the	the	DET
dti-2613	93	23	cases	case	NOUN
dti-2613	93	24	,	,	PUNCT
dti-2613	93	25	highlighting	highlight	VERB
dti-2613	93	26	the	the	DET
dti-2613	93	27	vulnerability	vulnerability	NOUN
dti-2613	93	28	of	of	ADP
dti-2613	93	29	these	these	DET
dti-2613	93	30	age	age	NOUN
dti-2613	93	31	groups	group	NOUN
dti-2613	93	32	to	to	ADP
dti-2613	93	33	the	the	DET
dti-2613	93	34	condition	condition	NOUN
dti-2613	93	35	.	.	PUNCT
dti-2613	94	1	the	the	DET
dti-2613	94	2	observed	observe	VERB
dti-2613	94	3	distribution	distribution	NOUN
dti-2613	94	4	within	within	ADP
dti-2613	94	5	these	these	DET
dti-2613	94	6	age	age	NOUN
dti-2613	94	7	groups	group	NOUN
dti-2613	94	8	was	be	AUX
dti-2613	94	9	found	find	VERB
dti-2613	94	10	to	to	PART
dti-2613	94	11	be	be	AUX
dti-2613	94	12	statistically	statistically	ADV
dti-2613	94	13	significant	significant	ADJ
dti-2613	94	14	(	(	PUNCT
dti-2613	94	15	p	p	X
dti-2613	94	16	=	=	NOUN
dti-2613	94	17	0.000	0.000	NUM
dti-2613	94	18	)	)	PUNCT
dti-2613	94	19	.	.	PUNCT
dti-2613	95	1	bacterial	bacterial	ADJ
dti-2613	95	2	diversity	diversity	NOUN
dti-2613	95	3	and	and	CCONJ
dti-2613	95	4	antibiotics	antibiotic	NOUN
dti-2613	95	5	resistance	resistance	NOUN
dti-2613	95	6	profile	profile	VERB
dti-2613	95	7	the	the	DET
dti-2613	95	8	three	three	NUM
dti-2613	95	9	main	main	ADJ
dti-2613	95	10	pathogens	pathogen	NOUN
dti-2613	95	11	isolated	isolate	VERB
dti-2613	95	12	in	in	ADP
dti-2613	95	13	this	this	DET
dti-2613	95	14	study	study	NOUN
dti-2613	95	15	were	be	AUX
dti-2613	95	16	escherichia	escherichia	NOUN
dti-2613	95	17	coli	coli	NOUN
dti-2613	95	18	(	(	PUNCT
dti-2613	95	19	44.5	44.5	NUM
dti-2613	95	20	%	%	NOUN
dti-2613	95	21	;	;	PUNCT
dti-2613	95	22	n	n	PROPN
dti-2613	95	23	=	=	SYM
dti-2613	95	24	49	49	NUM
dti-2613	95	25	)	)	PUNCT
dti-2613	95	26	,	,	PUNCT
dti-2613	95	27	klebsiella	klebsiella	NOUN
dti-2613	95	28	pneumoniae	pneumoniae	ADJ
dti-2613	95	29	(	(	PUNCT
dti-2613	95	30	11.8	11.8	NUM
dti-2613	95	31	%	%	NOUN
dti-2613	95	32	;	;	PUNCT
dti-2613	95	33	n	n	PROPN
dti-2613	95	34	=	=	SYM
dti-2613	95	35	13	13	NUM
dti-2613	95	36	)	)	PUNCT
dti-2613	95	37	,	,	PUNCT
dti-2613	95	38	and	and	CCONJ
dti-2613	95	39	proteus	proteus	PROPN
dti-2613	95	40	mirabilis	mirabilis	PROPN
dti-2613	95	41	(	(	PUNCT
dti-2613	95	42	13.6	13.6	NUM
dti-2613	95	43	%	%	NOUN
dti-2613	95	44	;	;	PUNCT
dti-2613	95	45	n	n	NOUN
dti-2613	95	46	=	=	NUM
dti-2613	95	47	15	15	NUM
dti-2613	95	48	)	)	PUNCT
dti-2613	95	49	.	.	PUNCT
dti-2613	96	1	antibiotic	antibiotic	ADJ
dti-2613	96	2	resistance	resistance	NOUN
dti-2613	96	3	profile	profile	NOUN
dti-2613	96	4	of	of	ADP
dti-2613	96	5	e.	e.	PROPN
dti-2613	96	6	coli	coli	PROPN
dti-2613	96	7	,	,	PUNCT
dti-2613	96	8	p.	p.	NOUN
dti-2613	96	9	mirabilis	mirabilis	PROPN
dti-2613	96	10	,	,	PUNCT
dti-2613	96	11	and	and	CCONJ
dti-2613	96	12	k.	k.	PROPN
dti-2613	96	13	pneumoniae	pneumoniae	NOUN
dti-2613	96	14	was	be	AUX
dti-2613	96	15	assessed	assess	VERB
dti-2613	96	16	against	against	ADP
dti-2613	96	17	several	several	ADJ
dti-2613	96	18	antibiotics	antibiotic	NOUN
dti-2613	96	19	(	(	PUNCT
dti-2613	96	20	tab	tab	NOUN
dti-2613	96	21	.	.	PUNCT
dti-2613	97	1	i	i	PRON
dti-2613	97	2	)	)	PUNCT
dti-2613	97	3	.	.	PUNCT
dti-2613	98	1	results	result	NOUN
dti-2613	98	2	showed	show	VERB
dti-2613	98	3	marked	mark	VERB
dti-2613	98	4	differences	difference	NOUN
dti-2613	98	5	in	in	ADP
dti-2613	98	6	antibiotic	antibiotic	ADJ
dti-2613	98	7	susceptibility	susceptibility	NOUN
dti-2613	98	8	between	between	ADP
dti-2613	98	9	β	β	NOUN
dti-2613	98	10	-	-	NOUN
dti-2613	98	11	lactams	lactam	NOUN
dti-2613	98	12	,	,	PUNCT
dti-2613	98	13	cephalosporins	cephalosporin	NOUN
dti-2613	98	14	,	,	PUNCT
dti-2613	98	15	and	and	CCONJ
dti-2613	98	16	carbapenems	carbapenem	NOUN
dti-2613	98	17	.	.	PUNCT
dti-2613	99	1	β	β	X
dti-2613	99	2	-	-	PUNCT
dti-2613	99	3	lactams	lactam	NOUN
dti-2613	99	4	showed	show	VERB
dti-2613	99	5	no	no	DET
dti-2613	99	6	activity	activity	NOUN
dti-2613	99	7	against	against	ADP
dti-2613	99	8	the	the	DET
dti-2613	99	9	three	three	NUM
dti-2613	99	10	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	99	11	;	;	PUNCT
dti-2613	99	12	second	second	ADJ
dti-2613	99	13	-	-	PUNCT
dti-2613	99	14	generation	generation	NOUN
dti-2613	99	15	cephalosporins	cephalosporin	NOUN
dti-2613	99	16	had	have	AUX
dti-2613	99	17	shown	show	VERB
dti-2613	99	18	moderate	moderate	ADJ
dti-2613	99	19	activity	activity	NOUN
dti-2613	99	20	against	against	ADP
dti-2613	99	21	e.	e.	PROPN
dti-2613	99	22	coli	coli	PROPN
dti-2613	99	23	and	and	CCONJ
dti-2613	99	24	k.	k.	NOUN
dti-2613	99	25	pneumoniae	pneumoniae	ADJ
dti-2613	99	26	(	(	PUNCT
dti-2613	99	27	65.3	65.3	NUM
dti-2613	99	28	%	%	NOUN
dti-2613	99	29	and	and	CCONJ
dti-2613	99	30	53.8	53.8	NUM
dti-2613	99	31	%	%	NOUN
dti-2613	99	32	respectively	respectively	ADV
dti-2613	99	33	)	)	PUNCT
dti-2613	99	34	but	but	CCONJ
dti-2613	99	35	had	have	VERB
dti-2613	99	36	no	no	DET
dti-2613	99	37	activity	activity	NOUN
dti-2613	99	38	against	against	ADP
dti-2613	99	39	p.	p.	PROPN
dti-2613	99	40	mirabilis	mirabilis	PROPN
dti-2613	99	41	,	,	PUNCT
dti-2613	99	42	while	while	SCONJ
dti-2613	99	43	third	third	ADJ
dti-2613	99	44	-	-	PUNCT
dti-2613	99	45	generation	generation	NOUN
dti-2613	99	46	cephalosporins	cephalosporin	NOUN
dti-2613	99	47	showed	show	VERB
dti-2613	99	48	moderate	moderate	ADJ
dti-2613	99	49	activity	activity	NOUN
dti-2613	99	50	against	against	ADP
dti-2613	99	51	all	all	DET
dti-2613	99	52	three	three	NUM
dti-2613	99	53	types	type	NOUN
dti-2613	99	54	of	of	ADP
dti-2613	99	55	isolates	isolate	NOUN
dti-2613	99	56	,	,	PUNCT
dti-2613	99	57	with	with	ADP
dti-2613	99	58	susceptibility	susceptibility	NOUN
dti-2613	99	59	rates	rate	NOUN
dti-2613	99	60	ranging	range	VERB
dti-2613	99	61	from	from	ADP
dti-2613	99	62	8.2	8.2	NUM
dti-2613	99	63	%	%	NOUN
dti-2613	99	64	to	to	ADP
dti-2613	99	65	91.8	91.8	NUM
dti-2613	99	66	%	%	NOUN
dti-2613	99	67	.	.	PUNCT
dti-2613	100	1	in	in	ADP
dti-2613	100	2	contrast	contrast	NOUN
dti-2613	100	3	,	,	PUNCT
dti-2613	100	4	all	all	DET
dti-2613	100	5	carbapenems	carbapenem	NOUN
dti-2613	100	6	had	have	VERB
dti-2613	100	7	high	high	ADJ
dti-2613	100	8	activity	activity	NOUN
dti-2613	100	9	against	against	ADP
dti-2613	100	10	all	all	DET
dti-2613	100	11	three	three	NUM
dti-2613	100	12	types	type	NOUN
dti-2613	100	13	of	of	ADP
dti-2613	100	14	isolates	isolate	NOUN
dti-2613	100	15	.	.	PUNCT
dti-2613	101	1	in	in	ADP
dti-2613	101	2	terms	term	NOUN
dti-2613	101	3	of	of	ADP
dti-2613	101	4	efficacy	efficacy	NOUN
dti-2613	101	5	,	,	PUNCT
dti-2613	101	6	e.	e.	PROPN
dti-2613	101	7	coli	coli	PROPN
dti-2613	101	8	and	and	CCONJ
dti-2613	101	9	p.	p.	NOUN
dti-2613	101	10	mirabilis	mirabilis	PROPN
dti-2613	101	11	isolates	isolate	NOUN
dti-2613	101	12	exhibited	exhibit	VERB
dti-2613	101	13	higher	high	ADJ
dti-2613	101	14	susceptibility	susceptibility	NOUN
dti-2613	101	15	to	to	ADP
dti-2613	101	16	the	the	DET
dti-2613	101	17	combination	combination	NOUN
dti-2613	101	18	of	of	ADP
dti-2613	101	19	penicillins	penicillin	NOUN
dti-2613	101	20	and	and	CCONJ
dti-2613	101	21	β	β	NOUN
dti-2613	101	22	-	-	PUNCT
dti-2613	101	23	lactamase	lactamase	ADJ
dti-2613	101	24	inhibitors	inhibitor	NOUN
dti-2613	101	25	(	(	PUNCT
dti-2613	101	26	piperacillin	piperacillin	NOUN
dti-2613	101	27	/	/	SYM
dti-2613	101	28	tazobactam	tazobactam	NOUN
dti-2613	102	1	[	[	X
dti-2613	103	1	tzp	tzp	X
dti-2613	103	2	]	]	X
dti-2613	103	3	)	)	PUNCT
dti-2613	103	4	;	;	PUNCT
dti-2613	103	5	however	however	ADV
dti-2613	103	6	,	,	PUNCT
dti-2613	103	7	they	they	PRON
dti-2613	103	8	were	be	AUX
dti-2613	103	9	moderately	moderately	ADV
dti-2613	103	10	to	to	PART
dti-2613	103	11	highly	highly	ADV
dti-2613	103	12	resistant	resistant	ADJ
dti-2613	103	13	to	to	ADP
dti-2613	103	14	trimethoprim	trimethoprim	VERB
dti-2613	103	15	/	/	SYM
dti-2613	103	16	sulfamethoxazole	sulfamethoxazole	NOUN
dti-2613	103	17	(	(	PUNCT
dti-2613	103	18	tab	tab	NOUN
dti-2613	103	19	.	.	PUNCT
dti-2613	104	1	iv	iv	X
dti-2613	104	2	)	)	PUNCT
dti-2613	104	3	.	.	PUNCT
dti-2613	105	1	table	table	NOUN
dti-2613	105	2	iv	iv	PRON
dti-2613	105	3	provides	provide	VERB
dti-2613	105	4	valuable	valuable	ADJ
dti-2613	105	5	information	information	NOUN
dti-2613	105	6	on	on	ADP
dti-2613	105	7	the	the	DET
dti-2613	105	8	susceptibility	susceptibility	NOUN
dti-2613	105	9	patterns	pattern	NOUN
dti-2613	105	10	of	of	ADP
dti-2613	105	11	e.	e.	PROPN
dti-2613	105	12	coli	coli	PROPN
dti-2613	105	13	,	,	PUNCT
dti-2613	105	14	p.	p.	NOUN
dti-2613	105	15	mirabilis	mirabilis	PROPN
dti-2613	105	16	,	,	PUNCT
dti-2613	105	17	and	and	CCONJ
dti-2613	105	18	k.	k.	PROPN
dti-2613	105	19	pneumoniae	pneumoniae	ADJ
dti-2613	105	20	to	to	ADP
dti-2613	105	21	various	various	ADJ
dti-2613	105	22	antibiotics	antibiotic	NOUN
dti-2613	105	23	.	.	PUNCT
dti-2613	106	1	it	it	PRON
dti-2613	106	2	assists	assist	VERB
dti-2613	106	3	in	in	ADP
dti-2613	106	4	understanding	understand	VERB
dti-2613	106	5	the	the	DET
dti-2613	106	6	effectiveness	effectiveness	NOUN
dti-2613	106	7	of	of	ADP
dti-2613	106	8	different	different	ADJ
dti-2613	106	9	antibiotics	antibiotic	NOUN
dti-2613	106	10	against	against	ADP
dti-2613	106	11	these	these	DET
dti-2613	106	12	bacterial	bacterial	ADJ
dti-2613	106	13	species	specie	NOUN
dti-2613	106	14	,	,	PUNCT
dti-2613	106	15	aiding	aid	VERB
dti-2613	106	16	in	in	ADP
dti-2613	106	17	the	the	DET
dti-2613	106	18	selection	selection	NOUN
dti-2613	106	19	of	of	ADP
dti-2613	106	20	appropriate	appropriate	ADJ
dti-2613	106	21	treatment	treatment	NOUN
dti-2613	106	22	options	option	NOUN
dti-2613	106	23	.	.	PUNCT
dti-2613	107	1	the	the	DET
dti-2613	107	2	combination	combination	NOUN
dti-2613	107	3	disk	disk	NOUN
dti-2613	107	4	test	test	NOUN
dti-2613	107	5	method	method	NOUN
dti-2613	107	6	revealed	reveal	VERB
dti-2613	107	7	that	that	SCONJ
dti-2613	107	8	33.6	33.6	NUM
dti-2613	107	9	%	%	NOUN
dti-2613	107	10	(	(	PUNCT
dti-2613	107	11	n	n	NOUN
dti-2613	107	12	=	=	SYM
dti-2613	107	13	37	37	NUM
dti-2613	107	14	)	)	PUNCT
dti-2613	107	15	of	of	ADP
dti-2613	107	16	all	all	DET
dti-2613	107	17	isolates	isolate	NOUN
dti-2613	107	18	were	be	AUX
dti-2613	107	19	esbl	esbl	NOUN
dti-2613	107	20	producing	produce	VERB
dti-2613	107	21	.	.	PUNCT
dti-2613	108	1	e.	e.	PROPN
dti-2613	108	2	coli	coli	PROPN
dti-2613	108	3	had	have	VERB
dti-2613	108	4	the	the	DET
dti-2613	108	5	highest	high	ADJ
dti-2613	108	6	prevalence	prevalence	NOUN
dti-2613	108	7	at	at	ADP
dti-2613	108	8	24.5	24.5	NUM
dti-2613	108	9	%	%	NOUN
dti-2613	108	10	(	(	PUNCT
dti-2613	108	11	n	n	NOUN
dti-2613	108	12	=	=	SYM
dti-2613	108	13	27	27	NUM
dti-2613	108	14	)	)	PUNCT
dti-2613	108	15	,	,	PUNCT
dti-2613	108	16	followed	follow	VERB
dti-2613	108	17	by	by	ADP
dti-2613	108	18	k.	k.	PROPN
dti-2613	108	19	pneumoniae	pneumoniae	PROPN
dti-2613	108	20	,	,	PUNCT
dti-2613	108	21	enterobacter	enterobacter	ADJ
dti-2613	108	22	cloacae	cloacae	NOUN
dti-2613	108	23	,	,	PUNCT
dti-2613	108	24	and	and	CCONJ
dti-2613	108	25	others	other	NOUN
dti-2613	108	26	.	.	PUNCT
dti-2613	109	1	it	it	PRON
dti-2613	109	2	is	be	AUX
dti-2613	109	3	noteworthy	noteworthy	ADJ
dti-2613	109	4	that	that	SCONJ
dti-2613	109	5	a	a	DET
dti-2613	109	6	substantial	substantial	ADJ
dti-2613	109	7	proportion	proportion	NOUN
dti-2613	109	8	of	of	ADP
dti-2613	109	9	the	the	DET
dti-2613	109	10	patients	patient	NOUN
dti-2613	109	11	,	,	PUNCT
dti-2613	109	12	precisely	precisely	ADV
dti-2613	109	13	77.3	77.3	NUM
dti-2613	109	14	%	%	NOUN
dti-2613	109	15	(	(	PUNCT
dti-2613	109	16	85/110	85/110	NUM
dti-2613	109	17	)	)	PUNCT
dti-2613	109	18	,	,	PUNCT
dti-2613	109	19	had	have	AUX
dti-2613	109	20	previously	previously	ADV
dti-2613	109	21	undergone	undergo	VERB
dti-2613	109	22	at	at	ADP
dti-2613	109	23	least	least	ADV
dti-2613	109	24	one	one	NUM
dti-2613	109	25	course	course	NOUN
dti-2613	109	26	of	of	ADP
dti-2613	109	27	antibiotic	antibiotic	ADJ
dti-2613	109	28	treatment	treatment	NOUN
dti-2613	109	29	before	before	ADP
dti-2613	109	30	the	the	DET
dti-2613	109	31	sampling	sample	VERB
dti-2613	109	32	procedure	procedure	NOUN
dti-2613	109	33	.	.	PUNCT
dti-2613	110	1	moreover	moreover	ADV
dti-2613	110	2	,	,	PUNCT
dti-2613	110	3	an	an	DET
dti-2613	110	4	alarming	alarming	ADJ
dti-2613	110	5	94.5	94.5	NUM
dti-2613	110	6	%	%	NOUN
dti-2613	110	7	of	of	ADP
dti-2613	110	8	the	the	DET
dti-2613	110	9	isolates	isolate	NOUN
dti-2613	110	10	displayed	display	VERB
dti-2613	110	11	multidrug	multidrug	NOUN
dti-2613	110	12	-	-	PUNCT
dti-2613	110	13	resistant	resistant	ADJ
dti-2613	110	14	(	(	PUNCT
dti-2613	110	15	mdr	mdr	NOUN
dti-2613	110	16	)	)	PUNCT
dti-2613	110	17	profiles	profile	NOUN
dti-2613	110	18	,	,	PUNCT
dti-2613	110	19	as	as	ADP
dti-2613	110	20	per	per	ADP
dti-2613	110	21	the	the	DET
dti-2613	110	22	guidelines	guideline	NOUN
dti-2613	110	23	set	set	VERB
dti-2613	110	24	forth	forth	ADV
dti-2613	110	25	by	by	ADP
dti-2613	110	26	magiorakos	magiorakos	PROPN
dti-2613	110	27	et	et	PROPN
dti-2613	110	28	al	al	PROPN
dti-2613	110	29	(	(	PUNCT
dti-2613	110	30	24	24	NUM
dti-2613	110	31	)	)	PUNCT
dti-2613	110	32	.	.	PUNCT
dti-2613	111	1	molecular	molecular	ADJ
dti-2613	111	2	characterization	characterization	NOUN
dti-2613	111	3	of	of	ADP
dti-2613	111	4	genes	gene	NOUN
dti-2613	111	5	table	table	NOUN
dti-2613	111	6	v	v	NOUN
dti-2613	111	7	lists	list	VERB
dti-2613	111	8	the	the	DET
dti-2613	111	9	frequencies	frequency	NOUN
dti-2613	111	10	of	of	ADP
dti-2613	111	11	the	the	DET
dti-2613	111	12	virulence	virulence	NOUN
dti-2613	111	13	genes	gene	NOUN
dti-2613	111	14	identified	identify	VERB
dti-2613	111	15	in	in	ADP
dti-2613	111	16	e.	e.	PROPN
dti-2613	111	17	coli	coli	NOUN
dti-2613	111	18	isolates	isolate	NOUN
dti-2613	111	19	.	.	PUNCT
dti-2613	112	1	table	table	NOUN
dti-2613	112	2	v	v	NOUN
dti-2613	112	3	provides	provide	VERB
dti-2613	112	4	valuable	valuable	ADJ
dti-2613	112	5	information	information	NOUN
dti-2613	112	6	on	on	ADP
dti-2613	112	7	the	the	DET
dti-2613	112	8	presence	presence	NOUN
dti-2613	112	9	and	and	CCONJ
dti-2613	112	10	distribution	distribution	NOUN
dti-2613	112	11	of	of	ADP
dti-2613	112	12	genes	gene	NOUN
dti-2613	112	13	related	relate	VERB
dti-2613	112	14	to	to	ADP
dti-2613	112	15	adhesins	adhesin	NOUN
dti-2613	112	16	,	,	PUNCT
dti-2613	112	17	enteroxins	enteroxin	NOUN
dti-2613	112	18	,	,	PUNCT
dti-2613	112	19	antibiotic	antibiotic	ADJ
dti-2613	112	20	resistance	resistance	NOUN
dti-2613	112	21	,	,	PUNCT
dti-2613	112	22	and	and	CCONJ
dti-2613	112	23	carbapenemases	carbapenemase	NOUN
dti-2613	112	24	in	in	ADP
dti-2613	112	25	e.	e.	PROPN
dti-2613	112	26	coli	coli	PROPN
dti-2613	112	27	and	and	CCONJ
dti-2613	112	28	related	related	ADJ
dti-2613	112	29	species	specie	NOUN
dti-2613	112	30	.	.	PUNCT
dti-2613	113	1	it	it	PRON
dti-2613	113	2	helps	help	VERB
dti-2613	113	3	in	in	ADP
dti-2613	113	4	understanding	understand	VERB
dti-2613	113	5	the	the	DET
dti-2613	113	6	genetic	genetic	ADJ
dti-2613	113	7	characteristics	characteristic	NOUN
dti-2613	113	8	and	and	CCONJ
dti-2613	113	9	potential	potential	ADJ
dti-2613	113	10	resistance	resistance	NOUN
dti-2613	113	11	patterns	pattern	NOUN
dti-2613	113	12	of	of	ADP
dti-2613	113	13	these	these	DET
dti-2613	113	14	bacterial	bacterial	ADJ
dti-2613	113	15	strains	strain	NOUN
dti-2613	113	16	.	.	PUNCT
dti-2613	114	1	eagg	eagg	NOUN
dti-2613	114	2	was	be	AUX
dti-2613	114	3	found	find	VERB
dti-2613	114	4	in	in	ADP
dti-2613	114	5	6.1	6.1	NUM
dti-2613	114	6	%	%	NOUN
dti-2613	114	7	(	(	PUNCT
dti-2613	114	8	n	n	NOUN
dti-2613	114	9	=	=	SYM
dti-2613	114	10	3	3	NUM
dti-2613	114	11	)	)	PUNCT
dti-2613	114	12	of	of	ADP
dti-2613	114	13	the	the	DET
dti-2613	114	14	e.	e.	PROPN
dti-2613	114	15	coli	coli	PROPN
dti-2613	114	16	isolates	isolate	NOUN
dti-2613	114	17	while	while	SCONJ
dti-2613	114	18	bfp	bfp	PROPN
dti-2613	114	19	and	and	CCONJ
dti-2613	114	20	eae	eae	PROPN
dti-2613	114	21	were	be	AUX
dti-2613	114	22	not	not	PART
dti-2613	114	23	detected	detect	VERB
dti-2613	114	24	;	;	PUNCT
dti-2613	114	25	the	the	DET
dti-2613	114	26	gene	gene	NOUN
dti-2613	114	27	ipah	ipah	NOUN
dti-2613	114	28	was	be	AUX
dti-2613	114	29	found	find	VERB
dti-2613	114	30	in	in	ADP
dti-2613	114	31	a	a	DET
dti-2613	114	32	higher	high	ADJ
dti-2613	114	33	percentage	percentage	NOUN
dti-2613	114	34	(	(	PUNCT
dti-2613	114	35	n	n	NOUN
dti-2613	114	36	=	=	SYM
dti-2613	114	37	27	27	NUM
dti-2613	114	38	;	;	PUNCT
dti-2613	114	39	55.1	55.1	NUM
dti-2613	114	40	%	%	NOUN
dti-2613	114	41	)	)	PUNCT
dti-2613	114	42	.	.	PUNCT
dti-2613	115	1	among	among	ADP
dti-2613	115	2	isolates	isolate	NOUN
dti-2613	115	3	,	,	PUNCT
dti-2613	115	4	blatem	blatem	NOUN
dti-2613	115	5	was	be	AUX
dti-2613	115	6	the	the	DET
dti-2613	115	7	most	most	ADV
dti-2613	115	8	common	common	ADJ
dti-2613	115	9	esbl	esbl	NOUN
dti-2613	115	10	,	,	PUNCT
dti-2613	115	11	being	be	AUX
dti-2613	115	12	present	present	ADJ
dti-2613	115	13	in	in	ADP
dti-2613	115	14	29.7	29.7	NUM
dti-2613	115	15	%	%	NOUN
dti-2613	115	16	of	of	ADP
dti-2613	115	17	e.	e.	PROPN
dti-2613	115	18	coli	coli	PROPN
dti-2613	115	19	.	.	PUNCT
dti-2613	116	1	in	in	ADP
dti-2613	116	2	contrast	contrast	NOUN
dti-2613	116	3	,	,	PUNCT
dti-2613	116	4	blashv	blashv	NOUN
dti-2613	116	5	,	,	PUNCT
dti-2613	116	6	int2	int2	PROPN
dti-2613	116	7	,	,	PUNCT
dti-2613	116	8	int3	int3	PROPN
dti-2613	116	9	,	,	PUNCT
dti-2613	116	10	qnrs	qnrs	NOUN
dti-2613	116	11	,	,	PUNCT
dti-2613	116	12	qnra	qnra	NOUN
dti-2613	116	13	,	,	PUNCT
dti-2613	116	14	and	and	CCONJ
dti-2613	116	15	qnrb	qnrb	ADJ
dti-2613	116	16	genes	gene	NOUN
dti-2613	116	17	were	be	AUX
dti-2613	116	18	not	not	PART
dti-2613	116	19	detected	detect	VERB
dti-2613	116	20	.	.	PUNCT
dti-2613	117	1	in	in	ADP
dti-2613	117	2	terms	term	NOUN
dti-2613	117	3	of	of	ADP
dti-2613	117	4	carbapenemase	carbapenemase	NOUN
dti-2613	117	5	genes	gene	NOUN
dti-2613	117	6	,	,	PUNCT
dti-2613	117	7	blandm-1	blandm-1	PRON
dti-2613	117	8	was	be	AUX
dti-2613	117	9	detected	detect	VERB
dti-2613	117	10	(	(	PUNCT
dti-2613	117	11	tab	tab	NOUN
dti-2613	117	12	.	.	PUNCT
dti-2613	118	1	v	v	NOUN
dti-2613	118	2	)	)	PUNCT
dti-2613	118	3	.	.	PUNCT
dti-2613	119	1	table	table	NOUN
dti-2613	119	2	iv	iv	NUM
dti-2613	119	3	antibiotic	antibiotic	ADJ
dti-2613	119	4	susceptibility	susceptibility	NOUN
dti-2613	119	5	profiles	profile	NOUN
dti-2613	119	6	of	of	ADP
dti-2613	119	7	escherichia	escherichia	NOUN
dti-2613	119	8	coli	coli	NOUN
dti-2613	119	9	,	,	PUNCT
dti-2613	119	10	proteus	proteus	NOUN
dti-2613	119	11	mirabilis	mirabilis	PROPN
dti-2613	119	12	,	,	PUNCT
dti-2613	119	13	and	and	CCONJ
dti-2613	119	14	klebsiella	klebsiella	NOUN
dti-2613	119	15	pneumoniae	pneumoniae	ADJ
dti-2613	119	16	antibiotics	antibiotic	NOUN
dti-2613	119	17	e.	e.	PROPN
dti-2613	119	18	coli	coli	PROPN
dti-2613	119	19	p.	p.	PROPN
dti-2613	119	20	mirabilis	mirabilis	PROPN
dti-2613	120	1	k.	k.	PROPN
dti-2613	121	1	pneumoniae	pneumoniae	PROPN
dti-2613	121	2	s%	s%	PROPN
dti-2613	121	3	r%	r%	X
dti-2613	121	4	s%	s%	PROPN
dti-2613	121	5	r%	r%	PROPN
dti-2613	121	6	s%	s%	PROPN
dti-2613	121	7	r%	r%	VERB
dti-2613	121	8	amoxicillin	amoxicillin	PROPN
dti-2613	121	9	0	0	NUM
dti-2613	121	10	49	49	NUM
dti-2613	121	11	(	(	PUNCT
dti-2613	121	12	100	100	NUM
dti-2613	121	13	)	)	PUNCT
dti-2613	121	14	0	0	NUM
dti-2613	121	15	15	15	NUM
dti-2613	121	16	(	(	PUNCT
dti-2613	121	17	100	100	NUM
dti-2613	121	18	)	)	PUNCT
dti-2613	121	19	0	0	NUM
dti-2613	121	20	13	13	NUM
dti-2613	121	21	(	(	PUNCT
dti-2613	121	22	100	100	NUM
dti-2613	121	23	)	)	PUNCT
dti-2613	121	24	amoxi	amoxi	PROPN
dti-2613	121	25	+	+	CCONJ
dti-2613	121	26	clavulanic	clavulanic	ADJ
dti-2613	121	27	acid	acid	NOUN
dti-2613	121	28	4	4	NUM
dti-2613	121	29	(	(	PUNCT
dti-2613	121	30	8.2	8.2	NUM
dti-2613	121	31	)	)	PUNCT
dti-2613	121	32	45	45	NUM
dti-2613	121	33	(	(	PUNCT
dti-2613	121	34	91.8	91.8	NUM
dti-2613	121	35	)	)	PUNCT
dti-2613	121	36	0	0	NUM
dti-2613	121	37	15	15	NUM
dti-2613	121	38	(	(	PUNCT
dti-2613	121	39	100	100	NUM
dti-2613	121	40	)	)	SYM
dti-2613	121	41	2	2	NUM
dti-2613	121	42	(	(	PUNCT
dti-2613	121	43	15.4	15.4	NUM
dti-2613	121	44	)	)	PUNCT
dti-2613	121	45	11	11	NUM
dti-2613	121	46	(	(	PUNCT
dti-2613	121	47	84.6	84.6	NUM
dti-2613	121	48	)	)	PUNCT
dti-2613	121	49	piperacillin	piperacillin	NOUN
dti-2613	121	50	0	0	NUM
dti-2613	121	51	49	49	NUM
dti-2613	121	52	(	(	PUNCT
dti-2613	121	53	100	100	NUM
dti-2613	121	54	)	)	PUNCT
dti-2613	121	55	0	0	NUM
dti-2613	121	56	15	15	NUM
dti-2613	121	57	(	(	PUNCT
dti-2613	121	58	100	100	NUM
dti-2613	121	59	)	)	PUNCT
dti-2613	121	60	0	0	NUM
dti-2613	121	61	13	13	NUM
dti-2613	121	62	(	(	PUNCT
dti-2613	121	63	100	100	NUM
dti-2613	121	64	)	)	PUNCT
dti-2613	121	65	piperacillin	piperacillin	NOUN
dti-2613	122	1	+	+	CCONJ
dti-2613	122	2	tazobactam	tazobactam	NOUN
dti-2613	122	3	46	46	NUM
dti-2613	122	4	(	(	PUNCT
dti-2613	122	5	93.9	93.9	NUM
dti-2613	122	6	)	)	SYM
dti-2613	122	7	3	3	NUM
dti-2613	122	8	(	(	PUNCT
dti-2613	122	9	6.1	6.1	NUM
dti-2613	122	10	)	)	PUNCT
dti-2613	122	11	12	12	NUM
dti-2613	122	12	(	(	PUNCT
dti-2613	122	13	80	80	NUM
dti-2613	122	14	)	)	PUNCT
dti-2613	122	15	3	3	NUM
dti-2613	122	16	(	(	PUNCT
dti-2613	122	17	20	20	NUM
dti-2613	122	18	)	)	PUNCT
dti-2613	122	19	10	10	NUM
dti-2613	122	20	(	(	PUNCT
dti-2613	122	21	76.9	76.9	NUM
dti-2613	122	22	)	)	PUNCT
dti-2613	122	23	3	3	NUM
dti-2613	122	24	(	(	PUNCT
dti-2613	122	25	23.1	23.1	NUM
dti-2613	122	26	)	)	PUNCT
dti-2613	122	27	ticarcillin	ticarcillin	NOUN
dti-2613	122	28	0	0	NUM
dti-2613	122	29	49	49	NUM
dti-2613	122	30	(	(	PUNCT
dti-2613	122	31	100	100	NUM
dti-2613	122	32	)	)	PUNCT
dti-2613	122	33	2	2	NUM
dti-2613	122	34	(	(	PUNCT
dti-2613	122	35	13.3	13.3	NUM
dti-2613	122	36	)	)	PUNCT
dti-2613	122	37	13	13	NUM
dti-2613	122	38	(	(	PUNCT
dti-2613	122	39	86.7	86.7	NUM
dti-2613	122	40	)	)	PUNCT
dti-2613	122	41	0	0	NUM
dti-2613	122	42	13	13	NUM
dti-2613	122	43	(	(	PUNCT
dti-2613	122	44	100	100	NUM
dti-2613	122	45	)	)	PUNCT
dti-2613	122	46	aztreonam	aztreonam	NOUN
dti-2613	122	47	46	46	NUM
dti-2613	122	48	(	(	PUNCT
dti-2613	122	49	93.9	93.9	NUM
dti-2613	122	50	)	)	SYM
dti-2613	122	51	3	3	NUM
dti-2613	122	52	(	(	PUNCT
dti-2613	122	53	6.1	6.1	NUM
dti-2613	122	54	)	)	PUNCT
dti-2613	122	55	11	11	NUM
dti-2613	122	56	(	(	PUNCT
dti-2613	122	57	73.3	73.3	NUM
dti-2613	122	58	)	)	PUNCT
dti-2613	122	59	4	4	NUM
dti-2613	122	60	(	(	PUNCT
dti-2613	122	61	26.7	26.7	NUM
dti-2613	122	62	)	)	PUNCT
dti-2613	122	63	12	12	NUM
dti-2613	122	64	(	(	PUNCT
dti-2613	122	65	92.3	92.3	NUM
dti-2613	122	66	)	)	SYM
dti-2613	122	67	1	1	NUM
dti-2613	122	68	(	(	PUNCT
dti-2613	122	69	7.7	7.7	NUM
dti-2613	122	70	)	)	PUNCT
dti-2613	122	71	c2	c2	PROPN
dti-2613	122	72	g	g	PROPN
dti-2613	122	73	4	4	NUM
dti-2613	122	74	(	(	PUNCT
dti-2613	122	75	8.2	8.2	NUM
dti-2613	122	76	)	)	PUNCT
dti-2613	122	77	45	45	NUM
dti-2613	122	78	(	(	PUNCT
dti-2613	122	79	91.8	91.8	NUM
dti-2613	122	80	)	)	PUNCT
dti-2613	122	81	0	0	NUM
dti-2613	122	82	15	15	NUM
dti-2613	122	83	(	(	PUNCT
dti-2613	122	84	100	100	NUM
dti-2613	122	85	)	)	PUNCT
dti-2613	122	86	3	3	NUM
dti-2613	122	87	(	(	PUNCT
dti-2613	122	88	23.1	23.1	NUM
dti-2613	122	89	)	)	PUNCT
dti-2613	122	90	10	10	NUM
dti-2613	122	91	(	(	PUNCT
dti-2613	122	92	76.9	76.9	NUM
dti-2613	122	93	)	)	PUNCT
dti-2613	122	94	c3	c3	NOUN
dti-2613	122	95	g	g	PROPN
dti-2613	122	96	4	4	NUM
dti-2613	122	97	(	(	PUNCT
dti-2613	122	98	8.2	8.2	NUM
dti-2613	122	99	)	)	PUNCT
dti-2613	122	100	45	45	NUM
dti-2613	122	101	(	(	PUNCT
dti-2613	122	102	91.8	91.8	NUM
dti-2613	122	103	)	)	PUNCT
dti-2613	122	104	2	2	NUM
dti-2613	122	105	(	(	PUNCT
dti-2613	122	106	13.3	13.3	NUM
dti-2613	122	107	)	)	PUNCT
dti-2613	122	108	13	13	NUM
dti-2613	122	109	(	(	PUNCT
dti-2613	122	110	86.7	86.7	NUM
dti-2613	122	111	)	)	SYM
dti-2613	122	112	5	5	NUM
dti-2613	122	113	(	(	PUNCT
dti-2613	122	114	38.5	38.5	NUM
dti-2613	122	115	)	)	PUNCT
dti-2613	122	116	8	8	NUM
dti-2613	122	117	(	(	PUNCT
dti-2613	122	118	61.5	61.5	NUM
dti-2613	122	119	)	)	PUNCT
dti-2613	122	120	cefoxitin	cefoxitin	NOUN
dti-2613	122	121	32	32	NUM
dti-2613	122	122	(	(	PUNCT
dti-2613	122	123	65.3	65.3	NUM
dti-2613	122	124	)	)	PUNCT
dti-2613	122	125	17	17	NUM
dti-2613	122	126	(	(	PUNCT
dti-2613	122	127	34.7	34.7	NUM
dti-2613	122	128	)	)	PUNCT
dti-2613	122	129	0	0	NUM
dti-2613	122	130	15	15	NUM
dti-2613	122	131	(	(	PUNCT
dti-2613	122	132	100	100	NUM
dti-2613	122	133	)	)	PUNCT
dti-2613	122	134	7	7	NUM
dti-2613	122	135	(	(	PUNCT
dti-2613	122	136	53.8	53.8	NUM
dti-2613	122	137	)	)	PUNCT
dti-2613	122	138	6	6	NUM
dti-2613	122	139	(	(	PUNCT
dti-2613	122	140	46.2	46.2	NUM
dti-2613	122	141	)	)	PUNCT
dti-2613	122	142	ertapenem	ertapenem	PROPN
dti-2613	122	143	48	48	NUM
dti-2613	122	144	(	(	PUNCT
dti-2613	122	145	98.0	98.0	NUM
dti-2613	122	146	)	)	PUNCT
dti-2613	122	147	1	1	NUM
dti-2613	122	148	(	(	PUNCT
dti-2613	122	149	2.0	2.0	NUM
dti-2613	122	150	)	)	SYM
dti-2613	122	151	14	14	NUM
dti-2613	122	152	(	(	PUNCT
dti-2613	122	153	88.2	88.2	NUM
dti-2613	122	154	)	)	PUNCT
dti-2613	122	155	1	1	NUM
dti-2613	122	156	(	(	PUNCT
dti-2613	122	157	6.7	6.7	NUM
dti-2613	122	158	)	)	PUNCT
dti-2613	122	159	11	11	NUM
dti-2613	122	160	(	(	PUNCT
dti-2613	122	161	84.6	84.6	NUM
dti-2613	122	162	)	)	PUNCT
dti-2613	122	163	2	2	NUM
dti-2613	122	164	(	(	PUNCT
dti-2613	122	165	15.3	15.3	NUM
dti-2613	122	166	)	)	PUNCT
dti-2613	122	167	imipenem	imipenem	PROPN
dti-2613	122	168	46	46	NUM
dti-2613	122	169	(	(	PUNCT
dti-2613	122	170	93.9	93.9	NUM
dti-2613	122	171	)	)	SYM
dti-2613	122	172	3	3	NUM
dti-2613	122	173	(	(	PUNCT
dti-2613	122	174	6.1	6.1	NUM
dti-2613	122	175	)	)	PUNCT
dti-2613	122	176	11	11	NUM
dti-2613	122	177	(	(	PUNCT
dti-2613	122	178	73.3	73.3	NUM
dti-2613	122	179	)	)	PUNCT
dti-2613	122	180	4	4	NUM
dti-2613	122	181	(	(	PUNCT
dti-2613	122	182	26.7	26.7	NUM
dti-2613	122	183	)	)	PUNCT
dti-2613	122	184	11	11	NUM
dti-2613	122	185	(	(	PUNCT
dti-2613	122	186	84.6	84.6	NUM
dti-2613	122	187	)	)	PUNCT
dti-2613	122	188	2	2	NUM
dti-2613	122	189	(	(	PUNCT
dti-2613	122	190	15.3	15.3	NUM
dti-2613	122	191	)	)	PUNCT
dti-2613	122	192	amikacin	amikacin	PROPN
dti-2613	122	193	39	39	NUM
dti-2613	122	194	(	(	PUNCT
dti-2613	122	195	79.6	79.6	NUM
dti-2613	122	196	)	)	PUNCT
dti-2613	122	197	10	10	NUM
dti-2613	122	198	(	(	PUNCT
dti-2613	122	199	20.4	20.4	NUM
dti-2613	122	200	)	)	PUNCT
dti-2613	122	201	10	10	NUM
dti-2613	122	202	(	(	PUNCT
dti-2613	122	203	66.7	66.7	NUM
dti-2613	122	204	)	)	PUNCT
dti-2613	122	205	5	5	NUM
dti-2613	122	206	(	(	PUNCT
dti-2613	122	207	33.3	33.3	NUM
dti-2613	122	208	)	)	PUNCT
dti-2613	122	209	9	9	NUM
dti-2613	122	210	(	(	PUNCT
dti-2613	122	211	69.2	69.2	NUM
dti-2613	122	212	)	)	PUNCT
dti-2613	122	213	4	4	NUM
dti-2613	122	214	(	(	PUNCT
dti-2613	122	215	30.8	30.8	NUM
dti-2613	122	216	)	)	PUNCT
dti-2613	122	217	gentamicin	gentamicin	NOUN
dti-2613	122	218	12	12	NUM
dti-2613	122	219	(	(	PUNCT
dti-2613	122	220	24.5	24.5	NUM
dti-2613	122	221	)	)	PUNCT
dti-2613	122	222	37	37	NUM
dti-2613	122	223	(	(	PUNCT
dti-2613	122	224	75.5	75.5	NUM
dti-2613	122	225	)	)	SYM
dti-2613	122	226	2	2	NUM
dti-2613	122	227	(	(	PUNCT
dti-2613	122	228	13.3	13.3	NUM
dti-2613	122	229	)	)	PUNCT
dti-2613	122	230	13	13	NUM
dti-2613	122	231	(	(	PUNCT
dti-2613	122	232	86.7	86.7	NUM
dti-2613	122	233	)	)	SYM
dti-2613	122	234	5	5	NUM
dti-2613	122	235	(	(	PUNCT
dti-2613	122	236	38.5	38.5	NUM
dti-2613	122	237	)	)	PUNCT
dti-2613	122	238	8	8	NUM
dti-2613	122	239	(	(	PUNCT
dti-2613	122	240	61.5	61.5	NUM
dti-2613	122	241	)	)	PUNCT
dti-2613	122	242	tobramycin	tobramycin	NOUN
dti-2613	122	243	13	13	NUM
dti-2613	122	244	(	(	PUNCT
dti-2613	122	245	26.5	26.5	NUM
dti-2613	122	246	)	)	PUNCT
dti-2613	122	247	36	36	NUM
dti-2613	122	248	(	(	PUNCT
dti-2613	122	249	73.5	73.5	NUM
dti-2613	122	250	)	)	PUNCT
dti-2613	122	251	2	2	NUM
dti-2613	122	252	(	(	PUNCT
dti-2613	122	253	13.3	13.3	NUM
dti-2613	122	254	)	)	PUNCT
dti-2613	122	255	13	13	NUM
dti-2613	122	256	(	(	PUNCT
dti-2613	122	257	86.7	86.7	NUM
dti-2613	122	258	)	)	SYM
dti-2613	122	259	5	5	NUM
dti-2613	122	260	(	(	PUNCT
dti-2613	122	261	38.5	38.5	NUM
dti-2613	122	262	)	)	PUNCT
dti-2613	122	263	8	8	NUM
dti-2613	122	264	(	(	PUNCT
dti-2613	122	265	61.5	61.5	NUM
dti-2613	122	266	)	)	PUNCT
dti-2613	122	267	ciprofloxacin	ciprofloxacin	NOUN
dti-2613	122	268	5	5	NUM
dti-2613	122	269	(	(	PUNCT
dti-2613	122	270	10.2	10.2	NUM
dti-2613	122	271	)	)	PUNCT
dti-2613	122	272	44	44	NUM
dti-2613	122	273	(	(	PUNCT
dti-2613	122	274	89.8	89.8	NUM
dti-2613	122	275	)	)	PUNCT
dti-2613	122	276	6	6	NUM
dti-2613	122	277	(	(	PUNCT
dti-2613	122	278	40	40	NUM
dti-2613	122	279	)	)	PUNCT
dti-2613	122	280	9	9	NUM
dti-2613	122	281	(	(	PUNCT
dti-2613	122	282	60	60	NUM
dti-2613	122	283	)	)	PUNCT
dti-2613	122	284	4	4	NUM
dti-2613	122	285	(	(	PUNCT
dti-2613	122	286	30.7	30.7	NUM
dti-2613	122	287	)	)	PUNCT
dti-2613	122	288	9	9	NUM
dti-2613	122	289	(	(	PUNCT
dti-2613	122	290	69.2	69.2	NUM
dti-2613	122	291	)	)	PUNCT
dti-2613	122	292	trimethoprim	trimethoprim	NOUN
dti-2613	122	293	+	+	CCONJ
dti-2613	122	294	sulfamethoxazole	sulfamethoxazole	NOUN
dti-2613	122	295	2	2	NUM
dti-2613	122	296	(	(	PUNCT
dti-2613	122	297	4.1	4.1	NUM
dti-2613	122	298	)	)	PUNCT
dti-2613	122	299	47	47	NUM
dti-2613	122	300	(	(	PUNCT
dti-2613	122	301	95.9	95.9	NUM
dti-2613	122	302	)	)	PUNCT
dti-2613	122	303	6	6	NUM
dti-2613	122	304	(	(	PUNCT
dti-2613	122	305	40	40	NUM
dti-2613	122	306	)	)	PUNCT
dti-2613	122	307	9	9	NUM
dti-2613	122	308	(	(	PUNCT
dti-2613	122	309	60	60	NUM
dti-2613	122	310	)	)	PUNCT
dti-2613	122	311	3	3	NUM
dti-2613	122	312	(	(	PUNCT
dti-2613	122	313	23.1	23.1	NUM
dti-2613	122	314	)	)	PUNCT
dti-2613	122	315	10	10	NUM
dti-2613	122	316	(	(	PUNCT
dti-2613	122	317	76.9	76.9	NUM
dti-2613	122	318	)	)	PUNCT
dti-2613	122	319	kalambry	kalambry	NOUN
dti-2613	122	320	et	et	PROPN
dti-2613	122	321	al	al	PROPN
dti-2613	122	322	drug	drug	PROPN
dti-2613	122	323	target	target	NOUN
dti-2613	122	324	insights	insight	NOUN
dti-2613	122	325	2023	2023	NUM
dti-2613	122	326	;	;	PUNCT
dti-2613	122	327	17	17	NUM
dti-2613	122	328	:	:	SYM
dti-2613	122	329	97	97	NUM
dti-2613	122	330	©	©	PROPN
dti-2613	122	331	2023	2023	NUM
dti-2613	122	332	the	the	DET
dti-2613	122	333	authors	author	NOUN
dti-2613	122	334	.	.	PUNCT
dti-2613	123	1	published	publish	VERB
dti-2613	123	2	by	by	ADP
dti-2613	123	3	aboutscience	aboutscience	NOUN
dti-2613	123	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2613	123	5	based	base	VERB
dti-2613	123	6	on	on	ADP
dti-2613	123	7	molecular	molecular	ADJ
dti-2613	123	8	screening	screening	NOUN
dti-2613	123	9	,	,	PUNCT
dti-2613	123	10	only	only	ADV
dti-2613	123	11	one	one	NUM
dti-2613	123	12	carbapenemase	carbapenemase	NOUN
dti-2613	123	13	gene	gene	NOUN
dti-2613	123	14	,	,	PUNCT
dti-2613	123	15	blandm-1	blandm-1	PROPN
dti-2613	123	16	,	,	PUNCT
dti-2613	123	17	was	be	AUX
dti-2613	123	18	detected	detect	VERB
dti-2613	123	19	in	in	ADP
dti-2613	123	20	three	three	NUM
dti-2613	123	21	different	different	ADJ
dti-2613	123	22	isolates	isolate	NOUN
dti-2613	123	23	only	only	ADV
dti-2613	123	24	with	with	ADP
dti-2613	123	25	single	single	ADJ
dti-2613	123	26	occurrence	occurrence	NOUN
dti-2613	123	27	,	,	PUNCT
dti-2613	123	28	namely	namely	ADV
dti-2613	123	29	k.	k.	PROPN
dti-2613	123	30	pneumonia	pneumonia	NOUN
dti-2613	123	31	,	,	PUNCT
dti-2613	123	32	providencia	providencia	PROPN
dti-2613	123	33	rettgeri	rettgeri	NOUN
dti-2613	123	34	,	,	PUNCT
dti-2613	123	35	and	and	CCONJ
dti-2613	123	36	providencia	providencia	PROPN
dti-2613	123	37	penneri	penneri	NOUN
dti-2613	123	38	.	.	PUNCT
dti-2613	124	1	discussion	discussion	NOUN
dti-2613	124	2	the	the	DET
dti-2613	124	3	results	result	NOUN
dti-2613	124	4	reported	report	VERB
dti-2613	124	5	in	in	ADP
dti-2613	124	6	this	this	DET
dti-2613	124	7	study	study	NOUN
dti-2613	124	8	provide	provide	VERB
dti-2613	124	9	valuable	valuable	ADJ
dti-2613	124	10	insights	insight	NOUN
dti-2613	124	11	into	into	ADP
dti-2613	124	12	the	the	DET
dti-2613	124	13	bacteriology	bacteriology	NOUN
dti-2613	124	14	of	of	ADP
dti-2613	124	15	pis	pis	NOUN
dti-2613	124	16	in	in	ADP
dti-2613	124	17	mali	mali	PROPN
dti-2613	124	18	.	.	PUNCT
dti-2613	125	1	by	by	ADP
dti-2613	125	2	addressing	address	VERB
dti-2613	125	3	resistance	resistance	NOUN
dti-2613	125	4	rates	rate	NOUN
dti-2613	125	5	toward	toward	ADP
dti-2613	125	6	various	various	ADJ
dti-2613	125	7	antibiotics	antibiotic	NOUN
dti-2613	125	8	,	,	PUNCT
dti-2613	125	9	and	and	CCONJ
dti-2613	125	10	the	the	DET
dti-2613	125	11	frequency	frequency	NOUN
dti-2613	125	12	of	of	ADP
dti-2613	125	13	esbl	esbl	PROPN
dti-2613	125	14	,	,	PUNCT
dti-2613	125	15	carbapenemases	carbapenemase	NOUN
dti-2613	125	16	,	,	PUNCT
dti-2613	125	17	and	and	CCONJ
dti-2613	125	18	mdr	mdr	PROPN
dti-2613	125	19	bacteria	bacteria	NOUN
dti-2613	125	20	,	,	PUNCT
dti-2613	125	21	this	this	DET
dti-2613	125	22	study	study	NOUN
dti-2613	125	23	is	be	AUX
dti-2613	125	24	the	the	DET
dti-2613	125	25	first	first	ADJ
dti-2613	125	26	to	to	PART
dti-2613	125	27	comprehensively	comprehensively	ADV
dti-2613	125	28	analyze	analyze	VERB
dti-2613	125	29	these	these	DET
dti-2613	125	30	factors	factor	NOUN
dti-2613	125	31	and	and	CCONJ
dti-2613	125	32	lay	lie	VERB
dti-2613	125	33	the	the	DET
dti-2613	125	34	groundwork	groundwork	NOUN
dti-2613	125	35	for	for	ADP
dti-2613	125	36	future	future	ADJ
dti-2613	125	37	clinical	clinical	ADJ
dti-2613	125	38	studies	study	NOUN
dti-2613	125	39	to	to	PART
dti-2613	125	40	determine	determine	VERB
dti-2613	125	41	whether	whether	SCONJ
dti-2613	125	42	improved	improve	VERB
dti-2613	125	43	bacterial	bacterial	ADJ
dti-2613	125	44	diagnosis	diagnosis	NOUN
dti-2613	125	45	and	and	CCONJ
dti-2613	125	46	antibiotic	antibiotic	ADJ
dti-2613	125	47	selection	selection	NOUN
dti-2613	125	48	can	can	AUX
dti-2613	125	49	positively	positively	ADV
dti-2613	125	50	impact	impact	VERB
dti-2613	125	51	the	the	DET
dti-2613	125	52	outcomes	outcome	NOUN
dti-2613	125	53	of	of	ADP
dti-2613	125	54	pis	pis	PROPN
dti-2613	125	55	.	.	PUNCT
dti-2613	126	1	according	accord	VERB
dti-2613	126	2	to	to	ADP
dti-2613	126	3	the	the	DET
dti-2613	126	4	british	british	PROPN
dti-2613	126	5	thoracic	thoracic	NOUN
dti-2613	126	6	society	society	NOUN
dti-2613	126	7	(	(	PUNCT
dti-2613	126	8	bts	bts	NOUN
dti-2613	126	9	)	)	PUNCT
dti-2613	126	10	guidelines	guideline	NOUN
dti-2613	126	11	for	for	ADP
dti-2613	126	12	pleural	pleural	ADJ
dti-2613	126	13	disease	disease	NOUN
dti-2613	126	14	,	,	PUNCT
dti-2613	126	15	pi	pi	PROPN
dti-2613	126	16	was	be	AUX
dti-2613	126	17	clinically	clinically	ADV
dti-2613	126	18	addressed	address	VERB
dti-2613	126	19	in	in	ADP
dti-2613	126	20	this	this	DET
dti-2613	126	21	discussion	discussion	NOUN
dti-2613	126	22	as	as	SCONJ
dti-2613	126	23	a	a	DET
dti-2613	126	24	case	case	NOUN
dti-2613	126	25	of	of	ADP
dti-2613	126	26	cppe	cppe	PROPN
dti-2613	126	27	or	or	CCONJ
dti-2613	126	28	empyema	empyema	NOUN
dti-2613	126	29	and	and	CCONJ
dti-2613	126	30	literature	literature	NOUN
dti-2613	126	31	was	be	AUX
dti-2613	126	32	searched	search	VERB
dti-2613	126	33	accordingly	accordingly	ADV
dti-2613	126	34	(	(	PUNCT
dti-2613	126	35	20	20	NUM
dti-2613	126	36	)	)	PUNCT
dti-2613	126	37	.	.	PUNCT
dti-2613	127	1	out	out	ADP
dti-2613	127	2	of	of	ADP
dti-2613	127	3	the	the	DET
dti-2613	127	4	526	526	NUM
dti-2613	127	5	samples	sample	NOUN
dti-2613	127	6	analyzed	analyze	VERB
dti-2613	127	7	,	,	PUNCT
dti-2613	127	8	244	244	NUM
dti-2613	127	9	were	be	AUX
dti-2613	127	10	positive	positive	ADJ
dti-2613	127	11	to	to	ADP
dti-2613	127	12	culture	culture	VERB
dti-2613	127	13	;	;	PUNCT
dti-2613	127	14	of	of	ADP
dti-2613	127	15	which	which	PRON
dti-2613	127	16	110	110	NUM
dti-2613	127	17	cultures	culture	NOUN
dti-2613	127	18	tested	test	VERB
dti-2613	127	19	positive	positive	ADJ
dti-2613	127	20	for	for	ADP
dti-2613	127	21	entero	entero	PROPN
dti-2613	127	22	bacteriaceae	bacteriaceae	PROPN
dti-2613	127	23	,	,	PUNCT
dti-2613	127	24	indicating	indicate	VERB
dti-2613	127	25	a	a	DET
dti-2613	127	26	significant	significant	ADJ
dti-2613	127	27	number	number	NOUN
dti-2613	127	28	of	of	ADP
dti-2613	127	29	negative	negative	ADJ
dti-2613	127	30	results	result	NOUN
dti-2613	127	31	.	.	PUNCT
dti-2613	128	1	these	these	DET
dti-2613	128	2	results	result	NOUN
dti-2613	128	3	could	could	AUX
dti-2613	128	4	potentially	potentially	ADV
dti-2613	128	5	be	be	AUX
dti-2613	128	6	attributed	attribute	VERB
dti-2613	128	7	to	to	ADP
dti-2613	128	8	alternative	alternative	ADJ
dti-2613	128	9	etiologies	etiology	NOUN
dti-2613	128	10	or	or	CCONJ
dti-2613	128	11	could	could	AUX
dti-2613	128	12	be	be	AUX
dti-2613	128	13	a	a	DET
dti-2613	128	14	result	result	NOUN
dti-2613	128	15	of	of	ADP
dti-2613	128	16	previous	previous	ADJ
dti-2613	128	17	antibiotic	antibiotic	ADJ
dti-2613	128	18	utilization	utilization	NOUN
dti-2613	128	19	(	(	PUNCT
dti-2613	128	20	as	as	ADP
dti-2613	128	21	77.3	77.3	NUM
dti-2613	128	22	%	%	NOUN
dti-2613	128	23	of	of	ADP
dti-2613	128	24	our	our	PRON
dti-2613	128	25	patient	patient	NOUN
dti-2613	128	26	’s	’s	PART
dti-2613	128	27	population	population	NOUN
dti-2613	128	28	have	have	AUX
dti-2613	128	29	admittedly	admittedly	ADV
dti-2613	128	30	taken	take	VERB
dti-2613	128	31	at	at	ADV
dti-2613	128	32	least	least	ADV
dti-2613	128	33	one	one	NUM
dti-2613	128	34	antibiotic	antibiotic	ADJ
dti-2613	128	35	prior	prior	ADV
dti-2613	128	36	to	to	ADP
dti-2613	128	37	sampling	sampling	NOUN
dti-2613	128	38	)	)	PUNCT
dti-2613	128	39	.	.	PUNCT
dti-2613	129	1	in	in	ADP
dti-2613	129	2	the	the	DET
dti-2613	129	3	current	current	ADJ
dti-2613	129	4	study	study	NOUN
dti-2613	129	5	,	,	PUNCT
dti-2613	129	6	e.	e.	PROPN
dti-2613	129	7	coli	coli	PROPN
dti-2613	129	8	,	,	PUNCT
dti-2613	129	9	k.	k.	PROPN
dti-2613	129	10	pneumoniae	pneumoniae	PROPN
dti-2613	129	11	,	,	PUNCT
dti-2613	129	12	and	and	CCONJ
dti-2613	129	13	p.	p.	PROPN
dti-2613	129	14	mirabilis	mirabilis	PROPN
dti-2613	129	15	were	be	AUX
dti-2613	129	16	the	the	DET
dti-2613	129	17	main	main	ADJ
dti-2613	129	18	bacteria	bacteria	NOUN
dti-2613	129	19	identified	identify	VERB
dti-2613	129	20	,	,	PUNCT
dti-2613	129	21	indicating	indicate	VERB
dti-2613	129	22	their	their	PRON
dti-2613	129	23	significant	significant	ADJ
dti-2613	129	24	role	role	NOUN
dti-2613	129	25	as	as	ADP
dti-2613	129	26	causative	causative	ADJ
dti-2613	129	27	agents	agent	NOUN
dti-2613	129	28	of	of	ADP
dti-2613	129	29	pi	pi	NOUN
dti-2613	129	30	.	.	PUNCT
dti-2613	130	1	these	these	DET
dti-2613	130	2	findings	finding	NOUN
dti-2613	130	3	align	align	VERB
dti-2613	130	4	with	with	ADP
dti-2613	130	5	previous	previous	ADJ
dti-2613	130	6	studies	study	NOUN
dti-2613	130	7	that	that	PRON
dti-2613	130	8	have	have	AUX
dti-2613	130	9	also	also	ADV
dti-2613	130	10	identified	identify	VERB
dti-2613	130	11	the	the	DET
dti-2613	130	12	above	above	ADV
dti-2613	130	13	-	-	PUNCT
dti-2613	130	14	mentioned	mention	VERB
dti-2613	130	15	pathogens	pathogen	NOUN
dti-2613	130	16	as	as	ADP
dti-2613	130	17	the	the	DET
dti-2613	130	18	primary	primary	ADJ
dti-2613	130	19	contributors	contributor	NOUN
dti-2613	130	20	to	to	ADP
dti-2613	130	21	pi	pi	NOUN
dti-2613	130	22	(	(	PUNCT
dti-2613	130	23	25,26	25,26	NOUN
dti-2613	130	24	)	)	PUNCT
dti-2613	130	25	.	.	PUNCT
dti-2613	131	1	furthermore	furthermore	ADV
dti-2613	131	2	,	,	PUNCT
dti-2613	131	3	the	the	DET
dti-2613	131	4	study	study	NOUN
dti-2613	131	5	revealed	reveal	VERB
dti-2613	131	6	that	that	SCONJ
dti-2613	131	7	those	those	DET
dti-2613	131	8	pathogens	pathogen	NOUN
dti-2613	131	9	exhibited	exhibit	VERB
dti-2613	131	10	higher	high	ADJ
dti-2613	131	11	rate	rate	NOUN
dti-2613	131	12	of	of	ADP
dti-2613	131	13	resistance	resistance	NOUN
dti-2613	131	14	to	to	ADP
dti-2613	131	15	third	third	ADJ
dti-2613	131	16	-	-	PUNCT
dti-2613	131	17	generation	generation	NOUN
dti-2613	131	18	cephalosporins	cephalosporin	NOUN
dti-2613	131	19	,	,	PUNCT
dti-2613	131	20	indicating	indicate	VERB
dti-2613	131	21	their	their	PRON
dti-2613	131	22	classification	classification	NOUN
dti-2613	131	23	as	as	ADP
dti-2613	131	24	esbl	esbl	NOUN
dti-2613	131	25	phenotypes	phenotype	NOUN
dti-2613	131	26	.	.	PUNCT
dti-2613	132	1	the	the	DET
dti-2613	132	2	prevalence	prevalence	NOUN
dti-2613	132	3	rates	rate	NOUN
dti-2613	132	4	of	of	ADP
dti-2613	132	5	esbl	esbl	PROPN
dti-2613	132	6	reported	report	VERB
dti-2613	132	7	in	in	ADP
dti-2613	132	8	this	this	DET
dti-2613	132	9	study	study	NOUN
dti-2613	132	10	were	be	AUX
dti-2613	132	11	significantly	significantly	ADV
dti-2613	132	12	lower	low	ADJ
dti-2613	132	13	than	than	ADP
dti-2613	132	14	a	a	DET
dti-2613	132	15	study	study	NOUN
dti-2613	132	16	from	from	ADP
dti-2613	132	17	burkina	burkina	PROPN
dti-2613	132	18	faso	faso	PROPN
dti-2613	132	19	,	,	PUNCT
dti-2613	132	20	which	which	PRON
dti-2613	132	21	reported	report	VERB
dti-2613	132	22	70	70	NUM
dti-2613	132	23	%	%	NOUN
dti-2613	132	24	of	of	ADP
dti-2613	132	25	esbl	esbl	NOUN
dti-2613	132	26	-	-	PUNCT
dti-2613	132	27	producing	produce	VERB
dti-2613	132	28	isolates	isolate	NOUN
dti-2613	132	29	in	in	ADP
dti-2613	132	30	hospitalized	hospitalize	VERB
dti-2613	132	31	patients	patient	NOUN
dti-2613	132	32	(	(	PUNCT
dti-2613	132	33	27	27	NUM
dti-2613	132	34	)	)	PUNCT
dti-2613	132	35	.	.	PUNCT
dti-2613	133	1	genotypically	genotypically	ADV
dti-2613	133	2	,	,	PUNCT
dti-2613	133	3	the	the	DET
dti-2613	133	4	most	most	ADV
dti-2613	133	5	common	common	ADJ
dti-2613	133	6	esbl	esbl	NOUN
dti-2613	133	7	gene	gene	NOUN
dti-2613	133	8	was	be	AUX
dti-2613	133	9	blatem	blatem	ADJ
dti-2613	133	10	.	.	PUNCT
dti-2613	134	1	this	this	DET
dti-2613	134	2	finding	finding	NOUN
dti-2613	134	3	was	be	AUX
dti-2613	134	4	also	also	ADV
dti-2613	134	5	reported	report	VERB
dti-2613	134	6	by	by	ADP
dti-2613	134	7	sonda	sonda	NOUN
dti-2613	134	8	et	et	PROPN
dti-2613	134	9	al	al	PROPN
dti-2613	134	10	(	(	PUNCT
dti-2613	134	11	28	28	NUM
dti-2613	134	12	)	)	PUNCT
dti-2613	134	13	.	.	PUNCT
dti-2613	135	1	we	we	PRON
dti-2613	135	2	did	do	AUX
dti-2613	135	3	not	not	PART
dti-2613	135	4	detect	detect	VERB
dti-2613	135	5	blashv	blashv	NOUN
dti-2613	135	6	gene	gene	NOUN
dti-2613	135	7	.	.	PUNCT
dti-2613	136	1	the	the	DET
dti-2613	136	2	observed	observe	VERB
dti-2613	136	3	high	high	ADJ
dti-2613	136	4	resistance	resistance	NOUN
dti-2613	136	5	among	among	ADP
dti-2613	136	6	the	the	DET
dti-2613	136	7	most	most	ADV
dti-2613	136	8	common	common	ADJ
dti-2613	136	9	isolates	isolate	NOUN
dti-2613	136	10	to	to	ADP
dti-2613	136	11	penicillin	penicillin	NOUN
dti-2613	136	12	,	,	PUNCT
dti-2613	136	13	quinolones	quinolone	NOUN
dti-2613	136	14	,	,	PUNCT
dti-2613	136	15	cephalosporins	cephalosporin	NOUN
dti-2613	136	16	,	,	PUNCT
dti-2613	136	17	and	and	CCONJ
dti-2613	136	18	others	other	NOUN
dti-2613	136	19	is	be	AUX
dti-2613	136	20	likely	likely	ADV
dti-2613	136	21	attributed	attribute	VERB
dti-2613	136	22	to	to	ADP
dti-2613	136	23	the	the	DET
dti-2613	136	24	higher	high	ADJ
dti-2613	136	25	utilization	utilization	NOUN
dti-2613	136	26	of	of	ADP
dti-2613	136	27	those	those	DET
dti-2613	136	28	antibiotic	antibiotic	ADJ
dti-2613	136	29	classes	class	NOUN
dti-2613	136	30	in	in	ADP
dti-2613	136	31	hospital	hospital	NOUN
dti-2613	136	32	settings	setting	NOUN
dti-2613	136	33	.	.	PUNCT
dti-2613	137	1	the	the	DET
dti-2613	137	2	existence	existence	NOUN
dti-2613	137	3	of	of	ADP
dti-2613	137	4	such	such	ADJ
dti-2613	137	5	association	association	NOUN
dti-2613	137	6	between	between	ADP
dti-2613	137	7	antibiotic	antibiotic	ADJ
dti-2613	137	8	prescriptions	prescription	NOUN
dti-2613	137	9	and	and	CCONJ
dti-2613	137	10	susceptibility	susceptibility	NOUN
dti-2613	137	11	pattern	pattern	NOUN
dti-2613	137	12	was	be	AUX
dti-2613	137	13	previously	previously	ADV
dti-2613	137	14	highlighted	highlight	VERB
dti-2613	137	15	in	in	ADP
dti-2613	137	16	another	another	DET
dti-2613	137	17	hospital	hospital	NOUN
dti-2613	137	18	setting	setting	NOUN
dti-2613	137	19	in	in	ADP
dti-2613	137	20	eritrea	eritrea	PROPN
dti-2613	137	21	(	(	PUNCT
dti-2613	137	22	29	29	NUM
dti-2613	137	23	)	)	PUNCT
dti-2613	137	24	.	.	PUNCT
dti-2613	138	1	clinicians	clinician	NOUN
dti-2613	138	2	’	'	PUNCT
dti-2613	138	3	choice	choice	NOUN
dti-2613	138	4	of	of	ADP
dti-2613	138	5	broad	broad	ADJ
dti-2613	138	6	-	-	PUNCT
dti-2613	138	7	spectrum	spectrum	NOUN
dti-2613	138	8	antibiotics	antibiotic	NOUN
dti-2613	138	9	or	or	CCONJ
dti-2613	138	10	combination	combination	NOUN
dti-2613	138	11	therapy	therapy	NOUN
dti-2613	138	12	may	may	AUX
dti-2613	138	13	be	be	AUX
dti-2613	138	14	suggestive	suggestive	ADJ
dti-2613	138	15	of	of	ADP
dti-2613	138	16	the	the	DET
dti-2613	138	17	infection	infection	NOUN
dti-2613	138	18	being	be	AUX
dti-2613	138	19	acquired	acquire	VERB
dti-2613	138	20	in	in	ADP
dti-2613	138	21	a	a	DET
dti-2613	138	22	hospital	hospital	NOUN
dti-2613	138	23	setting	setting	NOUN
dti-2613	138	24	.	.	PUNCT
dti-2613	139	1	it	it	PRON
dti-2613	139	2	could	could	AUX
dti-2613	139	3	be	be	AUX
dti-2613	139	4	inferred	infer	VERB
dti-2613	139	5	that	that	SCONJ
dti-2613	139	6	despite	despite	SCONJ
dti-2613	139	7	the	the	DET
dti-2613	139	8	treatment	treatment	NOUN
dti-2613	139	9	recommendations	recommendation	NOUN
dti-2613	139	10	as	as	ADP
dti-2613	139	11	per	per	ADP
dti-2613	139	12	european	european	ADJ
dti-2613	139	13	respiratory	respiratory	ADJ
dti-2613	139	14	society	society	NOUN
dti-2613	139	15	(	(	PUNCT
dti-2613	139	16	ers	er	NOUN
dti-2613	139	17	)	)	PUNCT
dti-2613	139	18	and	and	CCONJ
dti-2613	139	19	american	american	PROPN
dti-2613	139	20	association	association	PROPN
dti-2613	139	21	for	for	ADP
dti-2613	139	22	thoracic	thoracic	NOUN
dti-2613	139	23	surgery	surgery	NOUN
dti-2613	139	24	(	(	PUNCT
dti-2613	139	25	aats	aat	NOUN
dti-2613	139	26	)	)	PUNCT
dti-2613	139	27	,	,	PUNCT
dti-2613	139	28	the	the	DET
dti-2613	139	29	selection	selection	NOUN
dti-2613	139	30	of	of	ADP
dti-2613	139	31	the	the	DET
dti-2613	139	32	treatment	treatment	NOUN
dti-2613	139	33	regimen	regiman	NOUN
dti-2613	139	34	must	must	AUX
dti-2613	139	35	typically	typically	ADV
dti-2613	139	36	depend	depend	VERB
dti-2613	139	37	on	on	ADP
dti-2613	139	38	infection	infection	NOUN
dti-2613	139	39	setting	setting	NOUN
dti-2613	139	40	,	,	PUNCT
dti-2613	139	41	the	the	DET
dti-2613	139	42	local	local	ADJ
dti-2613	139	43	prevalence	prevalence	NOUN
dti-2613	139	44	of	of	ADP
dti-2613	139	45	microorganisms	microorganism	NOUN
dti-2613	139	46	,	,	PUNCT
dti-2613	139	47	and	and	CCONJ
dti-2613	139	48	antibiotic	antibiotic	ADJ
dti-2613	139	49	resistance	resistance	NOUN
dti-2613	139	50	patterns	pattern	NOUN
dti-2613	139	51	(	(	PUNCT
dti-2613	139	52	30,31	30,31	NOUN
dti-2613	139	53	)	)	PUNCT
dti-2613	139	54	.	.	PUNCT
dti-2613	140	1	additionally	additionally	ADV
dti-2613	140	2	,	,	PUNCT
dti-2613	140	3	our	our	PRON
dti-2613	140	4	study	study	NOUN
dti-2613	140	5	reported	report	VERB
dti-2613	140	6	a	a	DET
dti-2613	140	7	high	high	ADJ
dti-2613	140	8	prevalence	prevalence	NOUN
dti-2613	140	9	of	of	ADP
dti-2613	140	10	mdr	mdr	PROPN
dti-2613	140	11	bacteria	bacteria	NOUN
dti-2613	140	12	.	.	PUNCT
dti-2613	141	1	this	this	DET
dti-2613	141	2	mdr	mdr	PROPN
dti-2613	141	3	rate	rate	PROPN
dti-2613	141	4	aligns	align	VERB
dti-2613	141	5	with	with	ADP
dti-2613	141	6	previous	previous	ADJ
dti-2613	141	7	study	study	NOUN
dti-2613	141	8	in	in	ADP
dti-2613	141	9	turkey	turkey	NOUN
dti-2613	141	10	reporting	report	VERB
dti-2613	141	11	the	the	DET
dti-2613	141	12	widespread	widespread	ADJ
dti-2613	141	13	occurrence	occurrence	NOUN
dti-2613	141	14	of	of	ADP
dti-2613	141	15	mdr	mdr	PROPN
dti-2613	141	16	bacteria	bacteria	NOUN
dti-2613	141	17	(	(	PUNCT
dti-2613	141	18	26	26	NUM
dti-2613	141	19	)	)	PUNCT
dti-2613	141	20	.	.	PUNCT
dti-2613	142	1	the	the	DET
dti-2613	142	2	study	study	NOUN
dti-2613	142	3	findings	finding	NOUN
dti-2613	142	4	revealed	reveal	VERB
dti-2613	142	5	a	a	DET
dti-2613	142	6	higher	high	ADJ
dti-2613	142	7	prevalence	prevalence	NOUN
dti-2613	142	8	of	of	ADP
dti-2613	142	9	carbapenem	carbapenem	PROPN
dti-2613	142	10	resistance	resistance	NOUN
dti-2613	142	11	(	(	PUNCT
dti-2613	142	12	7.2	7.2	NUM
dti-2613	142	13	%	%	NOUN
dti-2613	142	14	)	)	PUNCT
dti-2613	142	15	compared	compare	VERB
dti-2613	142	16	to	to	ADP
dti-2613	142	17	the	the	DET
dti-2613	142	18	previous	previous	ADJ
dti-2613	142	19	report	report	NOUN
dti-2613	142	20	by	by	ADP
dti-2613	142	21	dwomoh	dwomoh	PROPN
dti-2613	142	22	et	et	PROPN
dti-2613	142	23	al	al	PROPN
dti-2613	142	24	(	(	PUNCT
dti-2613	142	25	32	32	NUM
dti-2613	142	26	)	)	PUNCT
dti-2613	142	27	,	,	PUNCT
dti-2613	142	28	which	which	PRON
dti-2613	142	29	documented	document	VERB
dti-2613	142	30	a	a	DET
dti-2613	142	31	resistance	resistance	NOUN
dti-2613	142	32	rate	rate	NOUN
dti-2613	142	33	of	of	ADP
dti-2613	142	34	5.6	5.6	NUM
dti-2613	142	35	%	%	NOUN
dti-2613	142	36	.	.	PUNCT
dti-2613	143	1	hackman	hackman	PROPN
dti-2613	143	2	et	et	PROPN
dti-2613	143	3	al	al	PROPN
dti-2613	143	4	(	(	PUNCT
dti-2613	143	5	33	33	NUM
dti-2613	143	6	)	)	PUNCT
dti-2613	143	7	reported	report	VERB
dti-2613	143	8	a	a	DET
dti-2613	143	9	similar	similar	ADJ
dti-2613	143	10	rate	rate	NOUN
dti-2613	143	11	of	of	ADP
dti-2613	143	12	carbapenem	carbapenem	PROPN
dti-2613	143	13	resistance	resistance	NOUN
dti-2613	143	14	.	.	PUNCT
dti-2613	144	1	however	however	ADV
dti-2613	144	2	,	,	PUNCT
dti-2613	144	3	our	our	PRON
dti-2613	144	4	study	study	NOUN
dti-2613	144	5	observed	observe	VERB
dti-2613	144	6	significant	significant	ADJ
dti-2613	144	7	disparities	disparity	NOUN
dti-2613	144	8	in	in	ADP
dti-2613	144	9	the	the	DET
dti-2613	144	10	resistance	resistance	NOUN
dti-2613	144	11	rates	rate	NOUN
dti-2613	144	12	of	of	ADP
dti-2613	144	13	individual	individual	ADJ
dti-2613	144	14	carbapenems	carbapenem	NOUN
dti-2613	144	15	(	(	PUNCT
dti-2613	144	16	ertapenem	ertapenem	PROPN
dti-2613	144	17	,	,	PUNCT
dti-2613	144	18	imipenem	imipenem	PROPN
dti-2613	144	19	,	,	PUNCT
dti-2613	144	20	meropenem	meropenem	PROPN
dti-2613	144	21	)	)	PUNCT
dti-2613	144	22	as	as	ADV
dti-2613	144	23	well	well	ADV
dti-2613	144	24	as	as	ADP
dti-2613	144	25	the	the	DET
dti-2613	144	26	tzp	tzp	NOUN
dti-2613	144	27	combination	combination	NOUN
dti-2613	144	28	compared	compare	VERB
dti-2613	144	29	to	to	ADP
dti-2613	144	30	their	their	PRON
dti-2613	144	31	study	study	NOUN
dti-2613	144	32	.	.	PUNCT
dti-2613	145	1	these	these	DET
dti-2613	145	2	variances	variance	NOUN
dti-2613	145	3	can	can	AUX
dti-2613	145	4	be	be	AUX
dti-2613	145	5	attributed	attribute	VERB
dti-2613	145	6	to	to	ADP
dti-2613	145	7	our	our	PRON
dti-2613	145	8	study	study	NOUN
dti-2613	145	9	’s	’s	PART
dti-2613	145	10	focus	focus	NOUN
dti-2613	145	11	on	on	ADP
dti-2613	145	12	the	the	DET
dti-2613	145	13	three	three	NUM
dti-2613	145	14	predominant	predominant	ADJ
dti-2613	145	15	pathogens	pathogen	NOUN
dti-2613	145	16	isolated	isolate	VERB
dti-2613	145	17	(	(	PUNCT
dti-2613	145	18	e.	e.	PROPN
dti-2613	145	19	coli	coli	PROPN
dti-2613	145	20	,	,	PUNCT
dti-2613	145	21	k.	k.	PROPN
dti-2613	145	22	pneumoniae	pneumoniae	PROPN
dti-2613	145	23	,	,	PUNCT
dti-2613	145	24	p.	p.	NOUN
dti-2613	145	25	mirabilis	mirabilis	PROPN
dti-2613	145	26	)	)	PUNCT
dti-2613	145	27	.	.	PUNCT
dti-2613	146	1	on	on	ADP
dti-2613	146	2	the	the	DET
dti-2613	146	3	basis	basis	NOUN
dti-2613	146	4	of	of	ADP
dti-2613	146	5	available	available	ADJ
dti-2613	146	6	data	datum	NOUN
dti-2613	146	7	,	,	PUNCT
dti-2613	146	8	tzp	tzp	PROPN
dti-2613	146	9	and	and	CCONJ
dti-2613	146	10	carbapenems	carbapenem	NOUN
dti-2613	146	11	appear	appear	VERB
dti-2613	146	12	to	to	PART
dti-2613	146	13	maintain	maintain	VERB
dti-2613	146	14	significant	significant	ADJ
dti-2613	146	15	effectiveness	effectiveness	NOUN
dti-2613	146	16	against	against	ADP
dti-2613	146	17	the	the	DET
dti-2613	146	18	tested	test	VERB
dti-2613	146	19	pathogens	pathogen	NOUN
dti-2613	146	20	;	;	PUNCT
dti-2613	146	21	the	the	DET
dti-2613	146	22	results	result	NOUN
dti-2613	146	23	were	be	AUX
dti-2613	146	24	in	in	ADP
dti-2613	146	25	accordance	accordance	NOUN
dti-2613	146	26	with	with	ADP
dti-2613	146	27	those	those	PRON
dti-2613	146	28	of	of	ADP
dti-2613	146	29	a	a	DET
dti-2613	146	30	malaysian	malaysian	ADJ
dti-2613	146	31	observational	observational	ADJ
dti-2613	146	32	cohort	cohort	NOUN
dti-2613	146	33	study	study	NOUN
dti-2613	146	34	(	(	PUNCT
dti-2613	146	35	34	34	NUM
dti-2613	146	36	)	)	PUNCT
dti-2613	146	37	.	.	PUNCT
dti-2613	147	1	the	the	DET
dti-2613	147	2	recorded	recorded	ADJ
dti-2613	147	3	prevalence	prevalence	NOUN
dti-2613	147	4	aligns	align	VERB
dti-2613	147	5	with	with	ADP
dti-2613	147	6	other	other	ADJ
dti-2613	147	7	studies	study	NOUN
dti-2613	147	8	conducted	conduct	VERB
dti-2613	147	9	in	in	ADP
dti-2613	147	10	africa	africa	PROPN
dti-2613	147	11	,	,	PUNCT
dti-2613	147	12	such	such	ADJ
dti-2613	147	13	as	as	ADP
dti-2613	147	14	those	those	PRON
dti-2613	147	15	conducted	conduct	VERB
dti-2613	147	16	in	in	ADP
dti-2613	147	17	nigeria	nigeria	PROPN
dti-2613	147	18	(	(	PUNCT
dti-2613	147	19	35	35	NUM
dti-2613	147	20	)	)	PUNCT
dti-2613	147	21	and	and	CCONJ
dti-2613	147	22	south	south	PROPN
dti-2613	147	23	africa	africa	PROPN
dti-2613	147	24	(	(	PUNCT
dti-2613	147	25	36	36	NUM
dti-2613	147	26	)	)	PUNCT
dti-2613	147	27	.	.	PUNCT
dti-2613	148	1	however	however	ADV
dti-2613	148	2	,	,	PUNCT
dti-2613	148	3	egypt	egypt	PROPN
dti-2613	148	4	has	have	AUX
dti-2613	148	5	recently	recently	ADV
dti-2613	148	6	reported	report	VERB
dti-2613	148	7	a	a	DET
dti-2613	148	8	notably	notably	ADV
dti-2613	148	9	higher	high	ADJ
dti-2613	148	10	prevalence	prevalence	NOUN
dti-2613	148	11	of	of	ADP
dti-2613	148	12	carbapenem	carbapenem	PROPN
dti-2613	148	13	resistance	resistance	NOUN
dti-2613	148	14	(	(	PUNCT
dti-2613	148	15	37	37	NUM
dti-2613	148	16	)	)	PUNCT
dti-2613	148	17	.	.	PUNCT
dti-2613	149	1	table	table	NOUN
dti-2613	149	2	v	v	ADP
dti-2613	149	3	distribution	distribution	NOUN
dti-2613	149	4	of	of	ADP
dti-2613	149	5	genes	gene	NOUN
dti-2613	149	6	of	of	ADP
dti-2613	149	7	adhesins	adhesin	NOUN
dti-2613	149	8	,	,	PUNCT
dti-2613	149	9	enteroxins	enteroxin	NOUN
dti-2613	149	10	,	,	PUNCT
dti-2613	149	11	antibiotic	antibiotic	ADJ
dti-2613	149	12	resistance	resistance	NOUN
dti-2613	149	13	,	,	PUNCT
dti-2613	149	14	and	and	CCONJ
dti-2613	149	15	carbapenemases	carbapenemase	NOUN
dti-2613	149	16	in	in	ADP
dti-2613	149	17	escherichia	escherichia	NOUN
dti-2613	149	18	coli	coli	NOUN
dti-2613	149	19	and	and	CCONJ
dti-2613	149	20	related	relate	VERB
dti-2613	149	21	species	species	NOUN
dti-2613	149	22	genes	gene	NOUN
dti-2613	149	23	of	of	ADP
dti-2613	149	24	adhesins	adhesin	NOUN
dti-2613	149	25	escherichia	escherichia	NOUN
dti-2613	149	26	coli	coli	NOUN
dti-2613	149	27	n	n	NOUN
dti-2613	149	28	=	=	SYM
dti-2613	149	29	49	49	NUM
dti-2613	149	30	(	(	PUNCT
dti-2613	149	31	%	%	INTJ
dti-2613	149	32	)	)	PUNCT
dti-2613	149	33	eagg	eagg	NOUN
dti-2613	149	34	3	3	NUM
dti-2613	149	35	(	(	PUNCT
dti-2613	149	36	6.1	6.1	NUM
dti-2613	149	37	)	)	PUNCT
dti-2613	149	38	bfp	bfp	NOUN
dti-2613	149	39	0	0	NUM
dti-2613	150	1	eae	eae	PROPN
dti-2613	150	2	0	0	PROPN
dti-2613	150	3	ipah	ipah	NOUN
dti-2613	150	4	27	27	NUM
dti-2613	150	5	(	(	PUNCT
dti-2613	150	6	55.1	55.1	NUM
dti-2613	150	7	)	)	PUNCT
dti-2613	150	8	enteroxin	enteroxin	NOUN
dti-2613	150	9	genes	gene	NOUN
dti-2613	150	10	e.	e.	PROPN
dti-2613	150	11	coli	coli	PROPN
dti-2613	150	12	n	n	NOUN
dti-2613	150	13	=	=	SYM
dti-2613	150	14	49	49	NUM
dti-2613	150	15	(	(	PUNCT
dti-2613	150	16	%	%	INTJ
dti-2613	150	17	)	)	PUNCT
dti-2613	150	18	lt	lt	DET
dti-2613	150	19	1	1	NUM
dti-2613	150	20	(	(	PUNCT
dti-2613	150	21	2.0	2.0	NUM
dti-2613	150	22	)	)	PUNCT
dti-2613	150	23	slt1	slt1	NOUN
dti-2613	150	24	1	1	NUM
dti-2613	150	25	(	(	PUNCT
dti-2613	150	26	2.0	2.0	NUM
dti-2613	150	27	)	)	PUNCT
dti-2613	150	28	slt2	slt2	NOUN
dti-2613	150	29	0	0	NUM
dti-2613	150	30	sta	sta	NOUN
dti-2613	150	31	1	1	NUM
dti-2613	150	32	(	(	PUNCT
dti-2613	150	33	2.0	2.0	NUM
dti-2613	150	34	)	)	PUNCT
dti-2613	150	35	antibiotic	antibiotic	ADJ
dti-2613	150	36	resistance	resistance	NOUN
dti-2613	150	37	genes	gene	NOUN
dti-2613	150	38	n	n	NOUN
dti-2613	150	39	=	=	SYM
dti-2613	150	40	37	37	NUM
dti-2613	150	41	e.	e.	PROPN
dti-2613	150	42	coli	coli	PROPN
dti-2613	150	43	n	n	NOUN
dti-2613	150	44	=	=	SYM
dti-2613	150	45	27	27	NUM
dti-2613	150	46	klebsiella	klebsiella	NOUN
dti-2613	150	47	pneumoniae	pneumoniae	ADJ
dti-2613	150	48	n	n	NOUN
dti-2613	150	49	=	=	SYM
dti-2613	150	50	4	4	NUM
dti-2613	150	51	enterobacter	enterobacter	NOUN
dti-2613	150	52	cloacae	cloacae	NOUN
dti-2613	150	53	n	n	NOUN
dti-2613	150	54	=	=	SYM
dti-2613	150	55	2	2	NUM
dti-2613	150	56	others	other	NOUN
dti-2613	150	57	*	*	SYM
dti-2613	150	58	n	n	NOUN
dti-2613	150	59	=	=	SYM
dti-2613	150	60	4	4	NUM
dti-2613	150	61	tem	tem	NOUN
dti-2613	150	62	11	11	NUM
dti-2613	150	63	(	(	PUNCT
dti-2613	150	64	29.7	29.7	NUM
dti-2613	150	65	)	)	SYM
dti-2613	150	66	1	1	NUM
dti-2613	150	67	(	(	PUNCT
dti-2613	150	68	2.7	2.7	NUM
dti-2613	150	69	)	)	PUNCT
dti-2613	150	70	0	0	NUM
dti-2613	151	1	shv	shv	PROPN
dti-2613	151	2	0	0	NUM
dti-2613	151	3	–	–	PUNCT
dti-2613	151	4	–	–	PUNCT
dti-2613	151	5	0	0	NUM
dti-2613	151	6	int1	int1	NOUN
dti-2613	151	7	10	10	NUM
dti-2613	151	8	(	(	PUNCT
dti-2613	151	9	27.0	27.0	NUM
dti-2613	151	10	)	)	PUNCT
dti-2613	151	11	4	4	NUM
dti-2613	151	12	(	(	PUNCT
dti-2613	151	13	10.8	10.8	NUM
dti-2613	151	14	)	)	PUNCT
dti-2613	151	15	1	1	NUM
dti-2613	151	16	(	(	PUNCT
dti-2613	151	17	2.7	2.7	NUM
dti-2613	151	18	)	)	PUNCT
dti-2613	151	19	0	0	NUM
dti-2613	152	1	int2	int2	NOUN
dti-2613	152	2	0	0	NUM
dti-2613	152	3	0	0	NUM
dti-2613	152	4	0	0	NUM
dti-2613	152	5	0	0	NUM
dti-2613	153	1	int3	int3	NOUN
dti-2613	153	2	0	0	NUM
dti-2613	153	3	0	0	NUM
dti-2613	153	4	0	0	NUM
dti-2613	153	5	0	0	NUM
dti-2613	153	6	qnrs	qnrs	NOUN
dti-2613	153	7	0	0	NUM
dti-2613	153	8	0	0	NUM
dti-2613	153	9	0	0	NUM
dti-2613	153	10	0	0	NUM
dti-2613	153	11	qnra	qnra	NOUN
dti-2613	153	12	0	0	NUM
dti-2613	153	13	0	0	NUM
dti-2613	153	14	0	0	NUM
dti-2613	153	15	0	0	NUM
dti-2613	153	16	qnrb	qnrb	NOUN
dti-2613	153	17	0	0	NUM
dti-2613	153	18	0	0	NUM
dti-2613	153	19	0	0	NUM
dti-2613	153	20	0	0	NUM
dti-2613	153	21	cata1	cata1	NOUN
dti-2613	153	22	12	12	NUM
dti-2613	153	23	(	(	PUNCT
dti-2613	153	24	32.4	32.4	NUM
dti-2613	153	25	)	)	PUNCT
dti-2613	153	26	0	0	NUM
dti-2613	153	27	0	0	NUM
dti-2613	153	28	0	0	NUM
dti-2613	153	29	carbapenemase	carbapenemase	NOUN
dti-2613	153	30	n	n	NOUN
dti-2613	153	31	=	=	SYM
dti-2613	153	32	13	13	NUM
dti-2613	153	33	proteus	proteus	NOUN
dti-2613	153	34	penneri	penneri	NOUN
dti-2613	153	35	n	n	PROPN
dti-2613	153	36	=	=	SYM
dti-2613	153	37	1	1	NUM
dti-2613	153	38	(	(	PUNCT
dti-2613	153	39	%	%	NOUN
dti-2613	153	40	)	)	PUNCT
dti-2613	153	41	k.	k.	NOUN
dti-2613	153	42	pneumoniae	pneumoniae	VERB
dti-2613	153	43	n	n	NOUN
dti-2613	153	44	=	=	SYM
dti-2613	153	45	2	2	NUM
dti-2613	153	46	(	(	PUNCT
dti-2613	153	47	%	%	INTJ
dti-2613	153	48	)	)	PUNCT
dti-2613	153	49	providencia	providencia	PROPN
dti-2613	153	50	rettgeri	rettgeri	NOUN
dti-2613	153	51	n	n	NOUN
dti-2613	153	52	=	=	SYM
dti-2613	153	53	2	2	NUM
dti-2613	153	54	(	(	PUNCT
dti-2613	153	55	%	%	INTJ
dti-2613	153	56	)	)	PUNCT
dti-2613	153	57	others	other	NOUN
dti-2613	153	58	*	*	PUNCT
dti-2613	153	59	*	*	PUNCT
dti-2613	153	60	n	n	NOUN
dti-2613	153	61	=	=	SYM
dti-2613	153	62	8	8	NUM
dti-2613	153	63	kpc	kpc	NOUN
dti-2613	153	64	0	0	NUM
dti-2613	153	65	0	0	NUM
dti-2613	153	66	0	0	NUM
dti-2613	153	67	0	0	NUM
dti-2613	153	68	oxa-48	oxa-48	NOUN
dti-2613	153	69	0	0	NUM
dti-2613	153	70	0	0	NUM
dti-2613	153	71	0	0	NUM
dti-2613	153	72	0	0	NUM
dti-2613	153	73	ndm-1	ndm-1	NUM
dti-2613	153	74	1	1	NUM
dti-2613	153	75	(	(	PUNCT
dti-2613	153	76	7.7	7.7	NUM
dti-2613	153	77	)	)	PUNCT
dti-2613	153	78	1	1	NUM
dti-2613	153	79	(	(	PUNCT
dti-2613	153	80	7.7	7.7	NUM
dti-2613	153	81	)	)	PUNCT
dti-2613	153	82	1	1	NUM
dti-2613	153	83	(	(	PUNCT
dti-2613	153	84	7.7	7.7	NUM
dti-2613	153	85	)	)	PUNCT
dti-2613	153	86	0	0	NUM
dti-2613	153	87	hôpital	hôpital	PROPN
dti-2613	153	88	du	du	PROPN
dti-2613	153	89	mali	mali	PROPN
dti-2613	153	90	:	:	PUNCT
dti-2613	153	91	antibiotic	antibiotic	ADJ
dti-2613	153	92	resistance	resistance	NOUN
dti-2613	153	93	in	in	ADP
dti-2613	153	94	ipes98	ipes98	NOUN
dti-2613	153	95	©	©	PROPN
dti-2613	153	96	2023	2023	NUM
dti-2613	153	97	the	the	DET
dti-2613	153	98	authors	author	NOUN
dti-2613	153	99	.	.	PUNCT
dti-2613	154	1	drug	drug	NOUN
dti-2613	154	2	target	target	NOUN
dti-2613	154	3	insights	insight	NOUN
dti-2613	154	4	issn	issn	VERB
dti-2613	154	5	1177	1177	NUM
dti-2613	154	6	-	-	SYM
dti-2613	154	7	3928	3928	NUM
dti-2613	154	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2613	154	9	the	the	DET
dti-2613	154	10	relatively	relatively	ADV
dti-2613	154	11	low	low	ADJ
dti-2613	154	12	abundance	abundance	NOUN
dti-2613	154	13	of	of	ADP
dti-2613	154	14	carbapenem	carbapenem	PROPN
dti-2613	154	15	resistance	resistance	NOUN
dti-2613	154	16	genes	gene	NOUN
dti-2613	154	17	further	far	ADV
dti-2613	154	18	supports	support	VERB
dti-2613	154	19	this	this	DET
dti-2613	154	20	notion	notion	NOUN
dti-2613	154	21	,	,	PUNCT
dti-2613	154	22	indicating	indicate	VERB
dti-2613	154	23	that	that	SCONJ
dti-2613	154	24	the	the	DET
dti-2613	154	25	isolates	isolate	NOUN
dti-2613	154	26	in	in	ADP
dti-2613	154	27	this	this	DET
dti-2613	154	28	study	study	NOUN
dti-2613	154	29	may	may	AUX
dti-2613	154	30	not	not	PART
dti-2613	154	31	possess	possess	VERB
dti-2613	154	32	robust	robust	ADJ
dti-2613	154	33	mechanisms	mechanism	NOUN
dti-2613	154	34	of	of	ADP
dti-2613	154	35	resistance	resistance	NOUN
dti-2613	154	36	to	to	ADP
dti-2613	154	37	carbapenems	carbapenem	NOUN
dti-2613	154	38	.	.	PUNCT
dti-2613	155	1	we	we	PRON
dti-2613	155	2	did	do	AUX
dti-2613	155	3	not	not	PART
dti-2613	155	4	detect	detect	VERB
dti-2613	155	5	cases	case	NOUN
dti-2613	155	6	of	of	ADP
dti-2613	155	7	blakpc	blakpc	NOUN
dti-2613	155	8	and	and	CCONJ
dti-2613	155	9	blaoxa-48	blaoxa-48	NOUN
dti-2613	155	10	type	type	NOUN
dti-2613	155	11	of	of	ADP
dti-2613	155	12	carbapenemase	carbapenemase	NOUN
dti-2613	155	13	but	but	CCONJ
dti-2613	155	14	7.7	7.7	NUM
dti-2613	155	15	%	%	NOUN
dti-2613	155	16	of	of	ADP
dti-2613	155	17	blandm-1	blandm-1	PROPN
dti-2613	155	18	.	.	PUNCT
dti-2613	156	1	in	in	ADP
dti-2613	156	2	2022	2022	NUM
dti-2613	156	3	,	,	PUNCT
dti-2613	156	4	a	a	DET
dti-2613	156	5	study	study	NOUN
dti-2613	156	6	investigating	investigate	VERB
dti-2613	156	7	the	the	DET
dti-2613	156	8	global	global	ADJ
dti-2613	156	9	epidemiology	epidemiology	NOUN
dti-2613	156	10	of	of	ADP
dti-2613	156	11	oxa48	oxa48	NOUN
dti-2613	156	12	-	-	PUNCT
dti-2613	156	13	like	like	ADJ
dti-2613	156	14	β	β	NOUN
dti-2613	156	15	-	-	NOUN
dti-2613	156	16	lactamases	lactamase	NOUN
dti-2613	156	17	,	,	PUNCT
dti-2613	156	18	treatment	treatment	NOUN
dti-2613	156	19	option	option	NOUN
dti-2613	156	20	and	and	CCONJ
dti-2613	156	21	pipeline	pipeline	NOUN
dti-2613	156	22	development	development	NOUN
dti-2613	156	23	were	be	AUX
dti-2613	156	24	conducted	conduct	VERB
dti-2613	156	25	by	by	ADP
dti-2613	156	26	sara	sara	PROPN
dti-2613	156	27	e.	e.	PROPN
dti-2613	156	28	boyd	boyd	PROPN
dti-2613	156	29	et	et	PROPN
dti-2613	156	30	al	al	PROPN
dti-2613	156	31	(	(	PUNCT
dti-2613	156	32	38	38	NUM
dti-2613	156	33	)	)	PUNCT
dti-2613	156	34	.	.	PUNCT
dti-2613	157	1	the	the	DET
dti-2613	157	2	study	study	NOUN
dti-2613	157	3	found	find	VERB
dti-2613	157	4	that	that	SCONJ
dti-2613	157	5	the	the	DET
dti-2613	157	6	enzymes	enzyme	NOUN
dti-2613	157	7	of	of	ADP
dti-2613	157	8	blaoxa-48	blaoxa-48	NOUN
dti-2613	157	9	type	type	NOUN
dti-2613	157	10	are	be	AUX
dti-2613	157	11	the	the	DET
dti-2613	157	12	most	most	ADV
dti-2613	157	13	common	common	ADJ
dti-2613	157	14	carbapenemases	carbapenemase	NOUN
dti-2613	157	15	among	among	ADP
dti-2613	157	16	enterobacteriaceae	enterobacteriaceae	PROPN
dti-2613	157	17	in	in	ADP
dti-2613	157	18	much	much	ADJ
dti-2613	157	19	of	of	ADP
dti-2613	157	20	western	western	ADJ
dti-2613	157	21	europe	europe	PROPN
dti-2613	157	22	.	.	PUNCT
dti-2613	158	1	in	in	ADP
dti-2613	158	2	africa	africa	PROPN
dti-2613	158	3	,	,	PUNCT
dti-2613	158	4	the	the	DET
dti-2613	158	5	same	same	ADJ
dti-2613	158	6	study	study	NOUN
dti-2613	158	7	reported	report	VERB
dti-2613	158	8	circulation	circulation	NOUN
dti-2613	158	9	of	of	ADP
dti-2613	158	10	these	these	DET
dti-2613	158	11	types	type	NOUN
dti-2613	158	12	of	of	ADP
dti-2613	158	13	β	β	NOUN
dti-2613	158	14	-	-	NOUN
dti-2613	158	15	lactamase	lactamase	NOUN
dti-2613	158	16	in	in	ADP
dti-2613	158	17	tunisia	tunisia	PROPN
dti-2613	158	18	,	,	PUNCT
dti-2613	158	19	algeria	algeria	PROPN
dti-2613	158	20	,	,	PUNCT
dti-2613	158	21	egypt	egypt	PROPN
dti-2613	158	22	,	,	PUNCT
dti-2613	158	23	and	and	CCONJ
dti-2613	158	24	south	south	PROPN
dti-2613	158	25	africa	africa	PROPN
dti-2613	158	26	.	.	PUNCT
dti-2613	159	1	in	in	ADP
dti-2613	159	2	west	west	PROPN
dti-2613	159	3	africa	africa	PROPN
dti-2613	159	4	,	,	PUNCT
dti-2613	159	5	cases	case	NOUN
dti-2613	159	6	have	have	AUX
dti-2613	159	7	been	be	AUX
dti-2613	159	8	reported	report	VERB
dti-2613	159	9	in	in	ADP
dti-2613	159	10	senegal	senegal	PROPN
dti-2613	159	11	and	and	CCONJ
dti-2613	159	12	nigeria	nigeria	PROPN
dti-2613	159	13	.	.	PUNCT
dti-2613	160	1	mali	mali	PROPN
dti-2613	160	2	did	do	AUX
dti-2613	160	3	not	not	PART
dti-2613	160	4	provide	provide	VERB
dti-2613	160	5	data	datum	NOUN
dti-2613	160	6	probably	probably	ADV
dti-2613	160	7	due	due	ADJ
dti-2613	160	8	to	to	ADP
dti-2613	160	9	lack	lack	NOUN
dti-2613	160	10	of	of	ADP
dti-2613	160	11	adequate	adequate	ADJ
dti-2613	160	12	health	health	NOUN
dti-2613	160	13	care	care	NOUN
dti-2613	160	14	infrastructure	infrastructure	NOUN
dti-2613	160	15	and	and	CCONJ
dti-2613	160	16	limited	limit	VERB
dti-2613	160	17	molecular	molecular	ADJ
dti-2613	160	18	diagnostic	diagnostic	ADJ
dti-2613	160	19	capabilities	capability	NOUN
dti-2613	160	20	(	(	PUNCT
dti-2613	160	21	38	38	NUM
dti-2613	160	22	)	)	PUNCT
dti-2613	160	23	.	.	PUNCT
dti-2613	161	1	nabi	nabi	PROPN
dti-2613	161	2	jomehzadeh	jomehzadeh	PROPN
dti-2613	161	3	et	et	PROPN
dti-2613	161	4	al	al	PROPN
dti-2613	161	5	found	find	VERB
dti-2613	161	6	higher	high	ADJ
dti-2613	161	7	levels	level	NOUN
dti-2613	161	8	of	of	ADP
dti-2613	161	9	blandm-1	blandm-1	PROPN
dti-2613	161	10	(	(	PUNCT
dti-2613	161	11	31	31	NUM
dti-2613	161	12	%	%	NOUN
dti-2613	161	13	)	)	PUNCT
dti-2613	161	14	(	(	PUNCT
dti-2613	161	15	39	39	NUM
dti-2613	161	16	)	)	PUNCT
dti-2613	161	17	.	.	PUNCT
dti-2613	162	1	in	in	ADP
dti-2613	162	2	2020	2020	NUM
dti-2613	162	3	,	,	PUNCT
dti-2613	162	4	muggeo	muggeo	NOUN
dti-2613	162	5	et	et	PROPN
dti-2613	162	6	al	al	PROPN
dti-2613	162	7	reported	report	VERB
dti-2613	162	8	the	the	DET
dti-2613	162	9	first	first	ADJ
dti-2613	162	10	description	description	NOUN
dti-2613	162	11	of	of	ADP
dti-2613	162	12	blandm-5	blandm-5	PROPN
dti-2613	162	13	in	in	ADP
dti-2613	162	14	mali	mali	PROPN
dti-2613	162	15	(	(	PUNCT
dti-2613	162	16	18	18	NUM
dti-2613	162	17	)	)	PUNCT
dti-2613	162	18	.	.	PUNCT
dti-2613	163	1	overall	overall	ADJ
dti-2613	163	2	,	,	PUNCT
dti-2613	163	3	β	β	NOUN
dti-2613	163	4	-	-	NOUN
dti-2613	163	5	lactam	lactam	NOUN
dti-2613	163	6	/	/	SYM
dti-2613	163	7	β	β	NOUN
dti-2613	163	8	-	-	NOUN
dti-2613	163	9	lactam	lactam	NOUN
dti-2613	163	10	inhibitor	inhibitor	NOUN
dti-2613	163	11	combinations	combination	NOUN
dti-2613	163	12	and	and	CCONJ
dti-2613	163	13	carbapenems	carbapenem	NOUN
dti-2613	163	14	are	be	AUX
dti-2613	163	15	suitable	suitable	ADJ
dti-2613	163	16	choices	choice	NOUN
dti-2613	163	17	,	,	PUNCT
dti-2613	163	18	as	as	SCONJ
dti-2613	163	19	presented	present	VERB
dti-2613	163	20	previously	previously	ADV
dti-2613	163	21	in	in	ADP
dti-2613	163	22	observational	observational	ADJ
dti-2613	163	23	studies	study	NOUN
dti-2613	163	24	and	and	CCONJ
dti-2613	163	25	guidelines	guideline	NOUN
dti-2613	163	26	(	(	PUNCT
dti-2613	163	27	40	40	NUM
dti-2613	163	28	-	-	SYM
dti-2613	163	29	42	42	NUM
dti-2613	163	30	)	)	PUNCT
dti-2613	163	31	.	.	PUNCT
dti-2613	164	1	however	however	ADV
dti-2613	164	2	,	,	PUNCT
dti-2613	164	3	it	it	PRON
dti-2613	164	4	is	be	AUX
dti-2613	164	5	crucial	crucial	ADJ
dti-2613	164	6	to	to	PART
dti-2613	164	7	interpret	interpret	VERB
dti-2613	164	8	these	these	DET
dti-2613	164	9	results	result	NOUN
dti-2613	164	10	within	within	ADP
dti-2613	164	11	the	the	DET
dti-2613	164	12	context	context	NOUN
dti-2613	164	13	of	of	ADP
dti-2613	164	14	the	the	DET
dti-2613	164	15	provided	provide	VERB
dti-2613	164	16	data	datum	NOUN
dti-2613	164	17	.	.	PUNCT
dti-2613	165	1	the	the	DET
dti-2613	165	2	analysis	analysis	NOUN
dti-2613	165	3	is	be	AUX
dti-2613	165	4	limited	limit	VERB
dti-2613	165	5	to	to	ADP
dti-2613	165	6	the	the	DET
dti-2613	165	7	specific	specific	ADJ
dti-2613	165	8	isolates	isolate	NOUN
dti-2613	165	9	and	and	CCONJ
dti-2613	165	10	may	may	AUX
dti-2613	165	11	not	not	PART
dti-2613	165	12	be	be	AUX
dti-2613	165	13	representative	representative	ADJ
dti-2613	165	14	of	of	ADP
dti-2613	165	15	the	the	DET
dti-2613	165	16	broader	broad	ADJ
dti-2613	165	17	population	population	NOUN
dti-2613	165	18	or	or	CCONJ
dti-2613	165	19	other	other	ADJ
dti-2613	165	20	geographical	geographical	ADJ
dti-2613	165	21	regions	region	NOUN
dti-2613	165	22	.	.	PUNCT
dti-2613	166	1	according	accord	VERB
dti-2613	166	2	to	to	ADP
dti-2613	166	3	this	this	DET
dti-2613	166	4	study	study	NOUN
dti-2613	166	5	,	,	PUNCT
dti-2613	166	6	the	the	DET
dti-2613	166	7	presence	presence	NOUN
dti-2613	166	8	of	of	ADP
dti-2613	166	9	virulence	virulence	NOUN
dti-2613	166	10	factor	factor	NOUN
dti-2613	166	11	genes	gene	NOUN
dti-2613	166	12	in	in	ADP
dti-2613	166	13	e.	e.	PROPN
dti-2613	166	14	coli	coli	PROPN
dti-2613	166	15	isolates	isolate	NOUN
dti-2613	166	16	was	be	AUX
dti-2613	166	17	limited	limit	VERB
dti-2613	166	18	to	to	ADP
dti-2613	166	19	a	a	DET
dti-2613	166	20	specific	specific	ADJ
dti-2613	166	21	set	set	NOUN
dti-2613	166	22	.	.	PUNCT
dti-2613	167	1	the	the	DET
dti-2613	167	2	occurrence	occurrence	NOUN
dti-2613	167	3	of	of	ADP
dti-2613	167	4	these	these	DET
dti-2613	167	5	factors	factor	NOUN
dti-2613	167	6	varied	varied	ADJ
dti-2613	167	7	,	,	PUNCT
dti-2613	167	8	ranging	range	VERB
dti-2613	167	9	from	from	ADP
dti-2613	167	10	2	2	NUM
dti-2613	167	11	%	%	NOUN
dti-2613	167	12	for	for	ADP
dti-2613	167	13	genes	gene	NOUN
dti-2613	167	14	sta	sta	NOUN
dti-2613	167	15	,	,	PUNCT
dti-2613	167	16	slt	slt	PROPN
dti-2613	167	17	,	,	PUNCT
dti-2613	167	18	and	and	CCONJ
dti-2613	167	19	lt	lt	NOUN
dti-2613	167	20	,	,	PUNCT
dti-2613	167	21	to	to	ADP
dti-2613	167	22	55.1	55.1	NUM
dti-2613	167	23	%	%	NOUN
dti-2613	167	24	for	for	ADP
dti-2613	167	25	the	the	DET
dti-2613	167	26	ipah	ipah	NOUN
dti-2613	167	27	gene	gene	NOUN
dti-2613	167	28	.	.	PUNCT
dti-2613	168	1	the	the	DET
dti-2613	168	2	ipah	ipah	NOUN
dti-2613	168	3	gene	gene	NOUN
dti-2613	168	4	encodes	encode	VERB
dti-2613	168	5	invasion	invasion	NOUN
dti-2613	168	6	plasmid	plasmid	VERB
dti-2613	168	7	antigen	antigen	NOUN
dti-2613	168	8	and	and	CCONJ
dti-2613	168	9	is	be	AUX
dti-2613	168	10	closely	closely	ADV
dti-2613	168	11	linked	link	VERB
dti-2613	168	12	to	to	ADP
dti-2613	168	13	immune	immune	ADJ
dti-2613	168	14	system	system	NOUN
dti-2613	168	15	modulation	modulation	NOUN
dti-2613	168	16	in	in	ADP
dti-2613	168	17	the	the	DET
dti-2613	168	18	host	host	NOUN
dti-2613	168	19	and	and	CCONJ
dti-2613	168	20	bacterial	bacterial	ADJ
dti-2613	168	21	survival	survival	NOUN
dti-2613	168	22	.	.	PUNCT
dti-2613	169	1	it	it	PRON
dti-2613	169	2	is	be	AUX
dti-2613	169	3	commonly	commonly	ADV
dti-2613	169	4	detected	detect	VERB
dti-2613	169	5	in	in	ADP
dti-2613	169	6	the	the	DET
dti-2613	169	7	majority	majority	NOUN
dti-2613	169	8	of	of	ADP
dti-2613	169	9	eiec	eiec	NOUN
dti-2613	169	10	isolates	isolate	NOUN
dti-2613	169	11	(	(	PUNCT
dti-2613	169	12	43	43	NUM
dti-2613	169	13	)	)	PUNCT
dti-2613	169	14	.	.	PUNCT
dti-2613	170	1	the	the	DET
dti-2613	170	2	study	study	NOUN
dti-2613	170	3	has	have	VERB
dti-2613	170	4	certain	certain	ADJ
dti-2613	170	5	limitations	limitation	NOUN
dti-2613	170	6	.	.	PUNCT
dti-2613	171	1	firstly	firstly	ADV
dti-2613	171	2	,	,	PUNCT
dti-2613	171	3	it	it	PRON
dti-2613	171	4	was	be	AUX
dti-2613	171	5	conducted	conduct	VERB
dti-2613	171	6	in	in	ADP
dti-2613	171	7	a	a	DET
dti-2613	171	8	single	single	ADJ
dti-2613	171	9	center	center	NOUN
dti-2613	171	10	,	,	PUNCT
dti-2613	171	11	which	which	PRON
dti-2613	171	12	might	might	AUX
dti-2613	171	13	restrict	restrict	VERB
dti-2613	171	14	the	the	DET
dti-2613	171	15	applicability	applicability	NOUN
dti-2613	171	16	of	of	ADP
dti-2613	171	17	the	the	DET
dti-2613	171	18	results	result	NOUN
dti-2613	171	19	to	to	ADP
dti-2613	171	20	other	other	ADJ
dti-2613	171	21	populations	population	NOUN
dti-2613	171	22	or	or	CCONJ
dti-2613	171	23	settings	setting	NOUN
dti-2613	171	24	.	.	PUNCT
dti-2613	172	1	additionally	additionally	ADV
dti-2613	172	2	,	,	PUNCT
dti-2613	172	3	the	the	DET
dti-2613	172	4	sample	sample	NOUN
dti-2613	172	5	size	size	NOUN
dti-2613	172	6	was	be	AUX
dti-2613	172	7	relatively	relatively	ADV
dti-2613	172	8	small	small	ADJ
dti-2613	172	9	,	,	PUNCT
dti-2613	172	10	warranting	warrant	VERB
dti-2613	172	11	larger	large	ADJ
dti-2613	172	12	multicenter	multicenter	NOUN
dti-2613	172	13	studies	study	NOUN
dti-2613	172	14	to	to	PART
dti-2613	172	15	validate	validate	VERB
dti-2613	172	16	the	the	DET
dti-2613	172	17	findings	finding	NOUN
dti-2613	172	18	.	.	PUNCT
dti-2613	173	1	the	the	DET
dti-2613	173	2	study	study	NOUN
dti-2613	173	3	also	also	ADV
dti-2613	173	4	lacked	lack	VERB
dti-2613	173	5	detailed	detailed	ADJ
dti-2613	173	6	information	information	NOUN
dti-2613	173	7	on	on	ADP
dti-2613	173	8	patients	patient	NOUN
dti-2613	173	9	’	'	PUNCT
dti-2613	173	10	antibiotic	antibiotic	ADJ
dti-2613	173	11	exposure	exposure	NOUN
dti-2613	173	12	history	history	NOUN
dti-2613	173	13	and	and	CCONJ
dti-2613	173	14	prior	prior	ADJ
dti-2613	173	15	hospitalizations	hospitalization	NOUN
dti-2613	173	16	,	,	PUNCT
dti-2613	173	17	which	which	PRON
dti-2613	173	18	could	could	AUX
dti-2613	173	19	have	have	AUX
dti-2613	173	20	influenced	influence	VERB
dti-2613	173	21	the	the	DET
dti-2613	173	22	prevalence	prevalence	NOUN
dti-2613	173	23	of	of	ADP
dti-2613	173	24	antibiotic	antibiotic	ADJ
dti-2613	173	25	resistance	resistance	NOUN
dti-2613	173	26	.	.	PUNCT
dti-2613	174	1	despite	despite	SCONJ
dti-2613	174	2	these	these	DET
dti-2613	174	3	limitations	limitation	NOUN
dti-2613	174	4	,	,	PUNCT
dti-2613	174	5	the	the	DET
dti-2613	174	6	study	study	NOUN
dti-2613	174	7	emphasizes	emphasize	VERB
dti-2613	174	8	the	the	DET
dti-2613	174	9	significant	significant	ADJ
dti-2613	174	10	prevalence	prevalence	NOUN
dti-2613	174	11	of	of	ADP
dti-2613	174	12	antibiotic	antibiotic	ADJ
dti-2613	174	13	resistance	resistance	NOUN
dti-2613	174	14	in	in	ADP
dti-2613	174	15	the	the	DET
dti-2613	174	16	examined	examine	VERB
dti-2613	174	17	setting	setting	NOUN
dti-2613	174	18	and	and	CCONJ
dti-2613	174	19	underscores	underscore	VERB
dti-2613	174	20	the	the	DET
dti-2613	174	21	ongoing	ongoing	ADJ
dti-2613	174	22	need	need	NOUN
dti-2613	174	23	for	for	ADP
dti-2613	174	24	surveillance	surveillance	NOUN
dti-2613	174	25	and	and	CCONJ
dti-2613	174	26	efforts	effort	NOUN
dti-2613	174	27	in	in	ADP
dti-2613	174	28	antibiotic	antibiotic	ADJ
dti-2613	174	29	stewardship	stewardship	NOUN
dti-2613	174	30	to	to	PART
dti-2613	174	31	address	address	VERB
dti-2613	174	32	this	this	DET
dti-2613	174	33	critical	critical	ADJ
dti-2613	174	34	public	public	ADJ
dti-2613	174	35	health	health	NOUN
dti-2613	174	36	concern	concern	NOUN
dti-2613	174	37	.	.	PUNCT
dti-2613	175	1	further	further	ADJ
dti-2613	175	2	research	research	NOUN
dti-2613	175	3	involving	involve	VERB
dti-2613	175	4	larger	large	ADJ
dti-2613	175	5	sample	sample	NOUN
dti-2613	175	6	sizes	size	NOUN
dti-2613	175	7	,	,	PUNCT
dti-2613	175	8	multicenter	multicenter	NOUN
dti-2613	175	9	designs	design	NOUN
dti-2613	175	10	,	,	PUNCT
dti-2613	175	11	and	and	CCONJ
dti-2613	175	12	comprehensive	comprehensive	ADJ
dti-2613	175	13	patient	patient	NOUN
dti-2613	175	14	data	datum	NOUN
dti-2613	175	15	would	would	AUX
dti-2613	175	16	greatly	greatly	ADV
dti-2613	175	17	enhance	enhance	VERB
dti-2613	175	18	our	our	PRON
dti-2613	175	19	understanding	understanding	NOUN
dti-2613	175	20	and	and	CCONJ
dti-2613	175	21	approach	approach	NOUN
dti-2613	175	22	toward	toward	ADP
dti-2613	175	23	combating	combat	VERB
dti-2613	175	24	antibiotic	antibiotic	ADJ
dti-2613	175	25	resistance	resistance	NOUN
dti-2613	175	26	in	in	ADP
dti-2613	175	27	our	our	PRON
dti-2613	175	28	region	region	NOUN
dti-2613	175	29	.	.	PUNCT
dti-2613	176	1	in	in	ADP
dti-2613	176	2	countries	country	NOUN
dti-2613	176	3	with	with	ADP
dti-2613	176	4	limited	limited	ADJ
dti-2613	176	5	resources	resource	NOUN
dti-2613	176	6	such	such	ADJ
dti-2613	176	7	as	as	ADP
dti-2613	176	8	those	those	PRON
dti-2613	176	9	in	in	ADP
dti-2613	176	10	west	west	PROPN
dti-2613	176	11	africa	africa	PROPN
dti-2613	176	12	,	,	PUNCT
dti-2613	176	13	more	more	ADV
dti-2613	176	14	specific	specific	ADJ
dti-2613	176	15	socioeconomic	socioeconomic	ADJ
dti-2613	176	16	and	and	CCONJ
dti-2613	176	17	behavioral	behavioral	ADJ
dti-2613	176	18	factors	factor	NOUN
dti-2613	176	19	contribute	contribute	VERB
dti-2613	176	20	to	to	ADP
dti-2613	176	21	exacerbating	exacerbate	VERB
dti-2613	176	22	this	this	DET
dti-2613	176	23	threat	threat	NOUN
dti-2613	176	24	,	,	PUNCT
dti-2613	176	25	among	among	ADP
dti-2613	176	26	others	other	NOUN
dti-2613	176	27	:	:	PUNCT
dti-2613	176	28	(	(	PUNCT
dti-2613	176	29	i	i	NOUN
dti-2613	176	30	)	)	PUNCT
dti-2613	176	31	certain	certain	ADJ
dti-2613	176	32	common	common	ADJ
dti-2613	176	33	societal	societal	ADJ
dti-2613	176	34	practices	practice	NOUN
dti-2613	176	35	such	such	ADJ
dti-2613	176	36	as	as	ADP
dti-2613	176	37	self	self	NOUN
dti-2613	176	38	-	-	PUNCT
dti-2613	176	39	medication	medication	NOUN
dti-2613	176	40	;	;	PUNCT
dti-2613	176	41	(	(	PUNCT
dti-2613	176	42	ii	ii	NOUN
dti-2613	176	43	)	)	PUNCT
dti-2613	176	44	a	a	DET
dti-2613	176	45	failing	fail	VERB
dti-2613	176	46	medical	medical	ADJ
dti-2613	176	47	sector	sector	NOUN
dti-2613	176	48	with	with	ADP
dti-2613	176	49	insufficiently	insufficiently	ADV
dti-2613	176	50	trained	train	VERB
dti-2613	176	51	prescribers	prescriber	NOUN
dti-2613	176	52	and	and	CCONJ
dti-2613	176	53	inefficient	inefficient	ADJ
dti-2613	176	54	diagnostic	diagnostic	ADJ
dti-2613	176	55	tools	tool	NOUN
dti-2613	176	56	;	;	PUNCT
dti-2613	176	57	or	or	CCONJ
dti-2613	176	58	(	(	PUNCT
dti-2613	176	59	iii	iii	X
dti-2613	176	60	)	)	PUNCT
dti-2613	176	61	an	an	DET
dti-2613	176	62	uncontrolled	uncontrolled	ADJ
dti-2613	176	63	drug	drug	NOUN
dti-2613	176	64	chain	chain	NOUN
dti-2613	176	65	with	with	ADP
dti-2613	176	66	over	over	ADP
dti-2613	176	67	-	-	PUNCT
dti-2613	176	68	the	the	DET
dti-2613	176	69	-	-	PUNCT
dti-2613	176	70	counter	counter	NOUN
dti-2613	176	71	,	,	PUNCT
dti-2613	176	72	improperly	improperly	ADV
dti-2613	176	73	stored	store	VERB
dti-2613	176	74	,	,	PUNCT
dti-2613	176	75	counterfeit	counterfeit	ADJ
dti-2613	176	76	,	,	PUNCT
dti-2613	176	77	and/or	and/or	CCONJ
dti-2613	176	78	expired	expire	VERB
dti-2613	176	79	antibiotics	antibiotic	NOUN
dti-2613	176	80	favor	favor	VERB
dti-2613	176	81	the	the	DET
dti-2613	176	82	emergence	emergence	NOUN
dti-2613	176	83	of	of	ADP
dti-2613	176	84	resistance	resistance	NOUN
dti-2613	176	85	.	.	PUNCT
dti-2613	177	1	this	this	DET
dti-2613	177	2	study	study	NOUN
dti-2613	177	3	on	on	ADP
dti-2613	177	4	the	the	DET
dti-2613	177	5	prevalence	prevalence	NOUN
dti-2613	177	6	and	and	CCONJ
dti-2613	177	7	characteristics	characteristic	NOUN
dti-2613	177	8	of	of	ADP
dti-2613	177	9	esbl	esbl	NOUN
dti-2613	177	10	and	and	CCONJ
dti-2613	177	11	carbapenemase	carbapenemase	NOUN
dti-2613	177	12	-	-	PUNCT
dti-2613	177	13	producing	produce	VERB
dti-2613	177	14	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	177	15	in	in	ADP
dti-2613	177	16	pleural	pleural	ADJ
dti-2613	177	17	effusion	effusion	NOUN
dti-2613	177	18	in	in	ADP
dti-2613	177	19	mali	mali	PROPN
dti-2613	177	20	holds	hold	VERB
dti-2613	177	21	great	great	ADJ
dti-2613	177	22	significance	significance	NOUN
dti-2613	177	23	for	for	ADP
dti-2613	177	24	lowand	lowand	ADJ
dti-2613	177	25	middle	middle	ADJ
dti-2613	177	26	-	-	PUNCT
dti-2613	177	27	income	income	NOUN
dti-2613	177	28	countries	country	NOUN
dti-2613	177	29	.	.	PUNCT
dti-2613	178	1	by	by	ADP
dti-2613	178	2	providing	provide	VERB
dti-2613	178	3	critical	critical	ADJ
dti-2613	178	4	insights	insight	NOUN
dti-2613	178	5	into	into	ADP
dti-2613	178	6	the	the	DET
dti-2613	178	7	extent	extent	NOUN
dti-2613	178	8	of	of	ADP
dti-2613	178	9	resistance	resistance	NOUN
dti-2613	178	10	and	and	CCONJ
dti-2613	178	11	molecular	molecular	ADJ
dti-2613	178	12	epidemiology	epidemiology	NOUN
dti-2613	178	13	,	,	PUNCT
dti-2613	178	14	this	this	DET
dti-2613	178	15	research	research	NOUN
dti-2613	178	16	will	will	AUX
dti-2613	178	17	facilitate	facilitate	VERB
dti-2613	178	18	the	the	DET
dti-2613	178	19	development	development	NOUN
dti-2613	178	20	of	of	ADP
dti-2613	178	21	effective	effective	ADJ
dti-2613	178	22	strategies	strategy	NOUN
dti-2613	178	23	to	to	PART
dti-2613	178	24	combat	combat	VERB
dti-2613	178	25	amr	amr	NOUN
dti-2613	178	26	,	,	PUNCT
dti-2613	178	27	improve	improve	VERB
dti-2613	178	28	patient	patient	ADJ
dti-2613	178	29	outcomes	outcome	NOUN
dti-2613	178	30	,	,	PUNCT
dti-2613	178	31	and	and	CCONJ
dti-2613	178	32	safeguard	safeguard	VERB
dti-2613	178	33	public	public	ADJ
dti-2613	178	34	health	health	NOUN
dti-2613	178	35	in	in	ADP
dti-2613	178	36	mali	mali	PROPN
dti-2613	178	37	.	.	PUNCT
dti-2613	179	1	acknowledgments	acknowledgment	NOUN
dti-2613	179	2	the	the	DET
dti-2613	179	3	authors	author	NOUN
dti-2613	179	4	would	would	AUX
dti-2613	179	5	like	like	VERB
dti-2613	179	6	to	to	PART
dti-2613	179	7	thank	thank	VERB
dti-2613	179	8	the	the	DET
dti-2613	179	9	managers	manager	NOUN
dti-2613	179	10	of	of	ADP
dti-2613	179	11	the	the	DET
dti-2613	179	12	molecular	molecular	ADJ
dti-2613	179	13	biology	biology	NOUN
dti-2613	179	14	laboratories	laboratory	NOUN
dti-2613	179	15	of	of	ADP
dti-2613	179	16	the	the	DET
dti-2613	179	17	national	national	PROPN
dti-2613	179	18	institute	institute	PROPN
dti-2613	179	19	of	of	ADP
dti-2613	179	20	public	public	ADJ
dti-2613	179	21	health	health	NOUN
dti-2613	179	22	and	and	CCONJ
dti-2613	179	23	the	the	DET
dti-2613	179	24	university	university	NOUN
dti-2613	179	25	clinical	clinical	ADJ
dti-2613	179	26	research	research	NOUN
dti-2613	179	27	center	center	NOUN
dti-2613	179	28	.	.	PUNCT
dti-2613	180	1	the	the	DET
dti-2613	180	2	authors	author	NOUN
dti-2613	180	3	would	would	AUX
dti-2613	180	4	also	also	ADV
dti-2613	180	5	like	like	VERB
dti-2613	180	6	to	to	PART
dti-2613	180	7	express	express	VERB
dti-2613	180	8	their	their	PRON
dti-2613	180	9	sincere	sincere	ADJ
dti-2613	180	10	gratitude	gratitude	NOUN
dti-2613	180	11	to	to	ADP
dti-2613	180	12	the	the	DET
dti-2613	180	13	fogarty	fogarty	PROPN
dti-2613	180	14	international	international	PROPN
dti-2613	180	15	center	center	PROPN
dti-2613	180	16	for	for	ADP
dti-2613	180	17	funding	fund	VERB
dti-2613	180	18	the	the	DET
dti-2613	180	19	registration	registration	NOUN
dti-2613	180	20	of	of	ADP
dti-2613	180	21	phd	phd	NOUN
dti-2613	180	22	student	student	NOUN
dti-2613	180	23	aimé	aimé	NOUN
dti-2613	180	24	césaire	césaire	PROPN
dti-2613	180	25	kalambry	kalambry	PROPN
dti-2613	180	26	through	through	ADP
dti-2613	180	27	grant	grant	PROPN
dti-2613	180	28	d43tw008652	d43tw008652	PROPN
dti-2613	180	29	.	.	PUNCT
dti-2613	181	1	their	their	PRON
dti-2613	181	2	support	support	NOUN
dti-2613	181	3	has	have	AUX
dti-2613	181	4	been	be	AUX
dti-2613	181	5	instrumental	instrumental	ADJ
dti-2613	181	6	in	in	ADP
dti-2613	181	7	the	the	DET
dti-2613	181	8	advancement	advancement	NOUN
dti-2613	181	9	of	of	ADP
dti-2613	181	10	our	our	PRON
dti-2613	181	11	understanding	understanding	NOUN
dti-2613	181	12	in	in	ADP
dti-2613	181	13	this	this	DET
dti-2613	181	14	field	field	NOUN
dti-2613	181	15	and	and	CCONJ
dti-2613	181	16	has	have	AUX
dti-2613	181	17	contributed	contribute	VERB
dti-2613	181	18	significantly	significantly	ADV
dti-2613	181	19	to	to	ADP
dti-2613	181	20	the	the	DET
dti-2613	181	21	successful	successful	ADJ
dti-2613	181	22	completion	completion	NOUN
dti-2613	181	23	of	of	ADP
dti-2613	181	24	this	this	DET
dti-2613	181	25	manuscript	manuscript	NOUN
dti-2613	181	26	.	.	PUNCT
dti-2613	182	1	disclosures	disclosure	VERB
dti-2613	182	2	conflict	conflict	NOUN
dti-2613	182	3	of	of	ADP
dti-2613	182	4	interest	interest	NOUN
dti-2613	182	5	:	:	PUNCT
dti-2613	182	6	the	the	DET
dti-2613	182	7	authors	author	NOUN
dti-2613	182	8	declare	declare	VERB
dti-2613	182	9	no	no	DET
dti-2613	182	10	conflict	conflict	NOUN
dti-2613	182	11	of	of	ADP
dti-2613	182	12	interest	interest	NOUN
dti-2613	182	13	.	.	PUNCT
dti-2613	183	1	financial	financial	ADJ
dti-2613	183	2	support	support	NOUN
dti-2613	183	3	:	:	PUNCT
dti-2613	183	4	this	this	DET
dti-2613	183	5	research	research	NOUN
dti-2613	183	6	is	be	AUX
dti-2613	183	7	part	part	NOUN
dti-2613	183	8	of	of	ADP
dti-2613	183	9	a	a	DET
dti-2613	183	10	phd	phd	NOUN
dti-2613	183	11	study	study	NOUN
dti-2613	183	12	whose	whose	DET
dti-2613	183	13	phd	phd	NOUN
dti-2613	183	14	program	program	NOUN
dti-2613	183	15	received	receive	VERB
dti-2613	183	16	financial	financial	ADJ
dti-2613	183	17	support	support	NOUN
dti-2613	183	18	from	from	ADP
dti-2613	183	19	the	the	DET
dti-2613	183	20	fogarty	fogarty	PROPN
dti-2613	183	21	international	international	PROPN
dti-2613	183	22	center	center	NOUN
dti-2613	183	23	to	to	PART
dti-2613	183	24	cover	cover	VERB
dti-2613	183	25	the	the	DET
dti-2613	183	26	student	student	NOUN
dti-2613	183	27	’s	’s	PART
dti-2613	183	28	registration	registration	NOUN
dti-2613	183	29	fees	fee	NOUN
dti-2613	183	30	only	only	ADV
dti-2613	183	31	.	.	PUNCT
dti-2613	184	1	no	no	DET
dti-2613	184	2	specific	specific	ADJ
dti-2613	184	3	funds	fund	NOUN
dti-2613	184	4	were	be	AUX
dti-2613	184	5	allocated	allocate	VERB
dti-2613	184	6	to	to	ADP
dti-2613	184	7	this	this	DET
dti-2613	184	8	particular	particular	ADJ
dti-2613	184	9	research	research	NOUN
dti-2613	184	10	project	project	NOUN
dti-2613	184	11	.	.	PUNCT
dti-2613	185	1	the	the	DET
dti-2613	185	2	funding	funding	NOUN
dti-2613	185	3	agency	agency	NOUN
dti-2613	185	4	played	play	VERB
dti-2613	185	5	no	no	DET
dti-2613	185	6	role	role	NOUN
dti-2613	185	7	in	in	ADP
dti-2613	185	8	the	the	DET
dti-2613	185	9	study	study	NOUN
dti-2613	185	10	design	design	NOUN
dti-2613	185	11	,	,	PUNCT
dti-2613	185	12	data	data	NOUN
dti-2613	185	13	collection	collection	NOUN
dti-2613	185	14	,	,	PUNCT
dti-2613	185	15	analysis	analysis	NOUN
dti-2613	185	16	,	,	PUNCT
dti-2613	185	17	decision	decision	NOUN
dti-2613	185	18	to	to	PART
dti-2613	185	19	publish	publish	VERB
dti-2613	185	20	,	,	PUNCT
dti-2613	185	21	or	or	CCONJ
dti-2613	185	22	preparation	preparation	NOUN
dti-2613	185	23	of	of	ADP
dti-2613	185	24	the	the	DET
dti-2613	185	25	manuscript	manuscript	NOUN
dti-2613	185	26	.	.	PUNCT
dti-2613	186	1	references	reference	NOUN
dti-2613	186	2	1	1	NUM
dti-2613	186	3	.	.	PUNCT
dti-2613	187	1	li	li	PROPN
dti-2613	187	2	p	p	PROPN
dti-2613	187	3	,	,	PUNCT
dti-2613	187	4	an	an	DET
dti-2613	187	5	j	j	PROPN
dti-2613	187	6	,	,	PUNCT
dti-2613	187	7	wang	wang	PROPN
dti-2613	187	8	s	s	PROPN
dti-2613	187	9	,	,	PUNCT
dti-2613	187	10	et	et	PROPN
dti-2613	187	11	al	al	PROPN
dti-2613	187	12	.	.	PROPN
dti-2613	187	13	incidence	incidence	NOUN
dti-2613	187	14	and	and	CCONJ
dti-2613	187	15	prognostic	prognostic	ADJ
dti-2613	187	16	role	role	NOUN
dti-2613	187	17	of	of	ADP
dti-2613	187	18	pleural	pleural	ADJ
dti-2613	187	19	effusion	effusion	NOUN
dti-2613	187	20	in	in	ADP
dti-2613	187	21	patients	patient	NOUN
dti-2613	187	22	with	with	ADP
dti-2613	187	23	pulmonary	pulmonary	ADJ
dti-2613	187	24	embolism	embolism	NOUN
dti-2613	187	25	:	:	PUNCT
dti-2613	187	26	a	a	DET
dti-2613	187	27	systematic	systematic	ADJ
dti-2613	187	28	review	review	NOUN
dti-2613	187	29	and	and	CCONJ
dti-2613	187	30	meta	meta	ADJ
dti-2613	187	31	-	-	PUNCT
dti-2613	187	32	analysis	analysis	NOUN
dti-2613	187	33	.	.	PUNCT
dti-2613	188	1	j	j	PROPN
dti-2613	188	2	clin	clin	PROPN
dti-2613	188	3	med	me	VERB
dti-2613	188	4	.	.	PUNCT
dti-2613	189	1	2023:12(6):2315	2023:12(6):2315	NUM
dti-2613	189	2	.	.	PUNCT
dti-2613	190	1	crossref	crossref	PROPN
dti-2613	190	2	2	2	NUM
dti-2613	190	3	.	.	PUNCT
dti-2613	191	1	arnold	arnold	PROPN
dti-2613	191	2	dt	dt	PROPN
dti-2613	191	3	,	,	PUNCT
dti-2613	191	4	hamilton	hamilton	PROPN
dti-2613	191	5	fw	fw	PROPN
dti-2613	191	6	,	,	PUNCT
dti-2613	191	7	morris	morris	PROPN
dti-2613	191	8	tt	tt	PROPN
dti-2613	191	9	,	,	PUNCT
dti-2613	191	10	et	et	PROPN
dti-2613	191	11	al	al	PROPN
dti-2613	191	12	.	.	PUNCT
dti-2613	192	1	epidemiology	epidemiology	NOUN
dti-2613	192	2	of	of	ADP
dti-2613	192	3	pleural	pleural	ADJ
dti-2613	192	4	empyema	empyema	NOUN
dti-2613	192	5	in	in	ADP
dti-2613	192	6	english	english	ADJ
dti-2613	192	7	hospitals	hospital	NOUN
dti-2613	192	8	and	and	CCONJ
dti-2613	192	9	the	the	DET
dti-2613	192	10	impact	impact	NOUN
dti-2613	192	11	of	of	ADP
dti-2613	192	12	influenza	influenza	NOUN
dti-2613	192	13	.	.	PUNCT
dti-2613	193	1	eur	eur	PROPN
dti-2613	193	2	respir	respir	PROPN
dti-2613	193	3	j.	j.	PROPN
dti-2613	193	4	2021;57(6):57	2021;57(6):57	PROPN
dti-2613	193	5	.	.	PUNCT
dti-2613	194	1	crossref	crossref	PROPN
dti-2613	194	2	pubmed	pubmed	PROPN
dti-2613	194	3	3	3	PROPN
dti-2613	194	4	.	.	PUNCT
dti-2613	195	1	brims	brims	PROPN
dti-2613	195	2	f	f	PROPN
dti-2613	195	3	,	,	PUNCT
dti-2613	195	4	popowicz	popowicz	VERB
dti-2613	195	5	n	n	SYM
dti-2613	195	6	,	,	PUNCT
dti-2613	195	7	rosenstengel	rosenstengel	NOUN
dti-2613	195	8	a	a	NOUN
dti-2613	195	9	,	,	PUNCT
dti-2613	195	10	et	et	PROPN
dti-2613	195	11	al	al	PROPN
dti-2613	195	12	.	.	PROPN
dti-2613	195	13	bacteriology	bacteriology	PROPN
dti-2613	195	14	and	and	CCONJ
dti-2613	195	15	clinical	clinical	ADJ
dti-2613	195	16	outcomes	outcome	NOUN
dti-2613	195	17	of	of	ADP
dti-2613	195	18	patients	patient	NOUN
dti-2613	195	19	with	with	ADP
dti-2613	195	20	culture	culture	NOUN
dti-2613	195	21	-	-	PUNCT
dti-2613	195	22	positive	positive	ADJ
dti-2613	195	23	pleural	pleural	ADJ
dti-2613	195	24	infection	infection	NOUN
dti-2613	195	25	in	in	ADP
dti-2613	195	26	western	western	ADJ
dti-2613	195	27	australia	australia	PROPN
dti-2613	195	28	:	:	PUNCT
dti-2613	195	29	a	a	DET
dti-2613	195	30	6	6	NUM
dti-2613	195	31	-	-	PUNCT
dti-2613	195	32	year	year	NOUN
dti-2613	195	33	analysis	analysis	NOUN
dti-2613	195	34	.	.	PUNCT
dti-2613	196	1	respirology	respirology	NOUN
dti-2613	196	2	.	.	PUNCT
dti-2613	197	1	2019;24(2):171	2019;24(2):171	NUM
dti-2613	197	2	-	-	PUNCT
dti-2613	197	3	178	178	NUM
dti-2613	197	4	.	.	PUNCT
dti-2613	198	1	crossref	crossref	PROPN
dti-2613	198	2	pubmed	pubmed	PROPN
dti-2613	198	3	4	4	PROPN
dti-2613	198	4	.	.	PUNCT
dti-2613	198	5	white	white	PROPN
dti-2613	198	6	hd	hd	PROPN
dti-2613	198	7	,	,	PUNCT
dti-2613	198	8	white	white	PROPN
dti-2613	198	9	baa	baa	PROPN
dti-2613	198	10	,	,	PUNCT
dti-2613	198	11	song	song	NOUN
dti-2613	198	12	j	j	PROPN
dti-2613	198	13	,	,	PUNCT
dti-2613	198	14	fader	fader	NOUN
dti-2613	198	15	r	r	NOUN
dti-2613	198	16	,	,	PUNCT
dti-2613	198	17	quiroga	quiroga	NOUN
dti-2613	198	18	p	p	NOUN
dti-2613	198	19	,	,	PUNCT
dti-2613	198	20	arroliga	arroliga	ADV
dti-2613	198	21	ac	ac	PROPN
dti-2613	198	22	.	.	PUNCT
dti-2613	199	1	pleural	pleural	ADJ
dti-2613	199	2	infections	infection	NOUN
dti-2613	199	3	:	:	PUNCT
dti-2613	199	4	a	a	DET
dti-2613	199	5	9	9	NUM
dti-2613	199	6	-	-	PUNCT
dti-2613	199	7	year	year	NOUN
dti-2613	199	8	review	review	NOUN
dti-2613	199	9	of	of	ADP
dti-2613	199	10	bacteriology	bacteriology	NOUN
dti-2613	199	11	,	,	PUNCT
dti-2613	199	12	case	case	NOUN
dti-2613	199	13	characteristics	characteristic	NOUN
dti-2613	199	14	and	and	CCONJ
dti-2613	199	15	mortality	mortality	NOUN
dti-2613	199	16	.	.	PUNCT
dti-2613	200	1	am	be	AUX
dti-2613	200	2	j	j	PROPN
dti-2613	200	3	med	med	PROPN
dti-2613	200	4	sci	sci	PROPN
dti-2613	200	5	.	.	PROPN
dti-2613	200	6	2013;345(5):349	2013;345(5):349	NUM
dti-2613	200	7	-	-	SYM
dti-2613	200	8	354	354	NUM
dti-2613	200	9	.	.	PUNCT
dti-2613	201	1	crossref	crossref	PROPN
dti-2613	201	2	pubmed	pubmed	PROPN
dti-2613	201	3	5	5	NUM
dti-2613	201	4	.	.	PUNCT
dti-2613	202	1	markatis	markatis	PROPN
dti-2613	202	2	e	e	NOUN
dti-2613	202	3	,	,	PUNCT
dti-2613	202	4	perlepe	perlepe	ADJ
dti-2613	202	5	g	g	NOUN
dti-2613	202	6	,	,	PUNCT
dti-2613	202	7	afthinos	afthinos	VERB
dti-2613	202	8	a	a	PRON
dti-2613	202	9	,	,	PUNCT
dti-2613	202	10	et	et	PROPN
dti-2613	202	11	al	al	PROPN
dti-2613	202	12	.	.	PUNCT
dti-2613	202	13	mortality	mortality	NOUN
dti-2613	202	14	among	among	ADP
dti-2613	202	15	hospitalized	hospitalize	VERB
dti-2613	202	16	patients	patient	NOUN
dti-2613	202	17	with	with	ADP
dti-2613	202	18	pleural	pleural	ADJ
dti-2613	202	19	effusions	effusion	NOUN
dti-2613	202	20	.	.	PUNCT
dti-2613	203	1	a	a	DET
dti-2613	203	2	multicenter	multicenter	NOUN
dti-2613	203	3	,	,	PUNCT
dti-2613	203	4	observational	observational	ADJ
dti-2613	203	5	,	,	PUNCT
dti-2613	203	6	prospective	prospective	ADJ
dti-2613	203	7	study	study	NOUN
dti-2613	203	8	.	.	PUNCT
dti-2613	204	1	front	front	ADJ
dti-2613	204	2	med	med	PROPN
dti-2613	204	3	(	(	PUNCT
dti-2613	204	4	lausanne	lausanne	PROPN
dti-2613	204	5	)	)	PUNCT
dti-2613	204	6	.	.	PUNCT
dti-2613	205	1	2022;9:828783	2022;9:828783	NOUN
dti-2613	205	2	.	.	PUNCT
dti-2613	206	1	crossref	crossref	PROPN
dti-2613	206	2	pubmed	pubmed	PROPN
dti-2613	206	3	6	6	NUM
dti-2613	206	4	.	.	PUNCT
dti-2613	207	1	tapia	tapia	PROPN
dti-2613	207	2	md	md	PROPN
dti-2613	207	3	,	,	PUNCT
dti-2613	207	4	sylla	sylla	PROPN
dti-2613	207	5	m	m	PROPN
dti-2613	207	6	,	,	PUNCT
dti-2613	207	7	driscoll	driscoll	PROPN
dti-2613	207	8	aj	aj	PROPN
dti-2613	207	9	,	,	PUNCT
dti-2613	207	10	et	et	PROPN
dti-2613	207	11	al	al	PROPN
dti-2613	207	12	.	.	PUNCT
dti-2613	208	1	the	the	DET
dti-2613	208	2	etiology	etiology	NOUN
dti-2613	208	3	of	of	ADP
dti-2613	208	4	childhood	childhood	ADJ
dti-2613	208	5	pneumonia	pneumonia	NOUN
dti-2613	208	6	in	in	ADP
dti-2613	208	7	mali	mali	PROPN
dti-2613	208	8	:	:	PUNCT
dti-2613	208	9	findings	finding	NOUN
dti-2613	208	10	from	from	ADP
dti-2613	208	11	the	the	DET
dti-2613	208	12	pneumonia	pneumonia	NOUN
dti-2613	208	13	etiology	etiology	NOUN
dti-2613	208	14	research	research	NOUN
dti-2613	208	15	for	for	ADP
dti-2613	208	16	child	child	NOUN
dti-2613	208	17	health	health	NOUN
dti-2613	208	18	(	(	PUNCT
dti-2613	208	19	perch	perch	NOUN
dti-2613	208	20	)	)	PUNCT
dti-2613	208	21	study	study	NOUN
dti-2613	208	22	.	.	PUNCT
dti-2613	209	1	pediatr	pediatr	PROPN
dti-2613	209	2	infect	infect	VERB
dti-2613	209	3	dis	dis	PROPN
dti-2613	209	4	j.	j.	PROPN
dti-2613	209	5	2021;40(9s):s18	2021;40(9s):s18	PROPN
dti-2613	209	6	-	-	PUNCT
dti-2613	209	7	s28	s28	PROPN
dti-2613	209	8	.	.	PUNCT
dti-2613	210	1	crossref	crossref	PROPN
dti-2613	210	2	pubmed	pubmed	PROPN
dti-2613	210	3	7	7	PROPN
dti-2613	210	4	.	.	PUNCT
dti-2613	211	1	singh	singh	PROPN
dti-2613	211	2	sr	sr	PROPN
dti-2613	211	3	,	,	PUNCT
dti-2613	211	4	teo	teo	PROPN
dti-2613	211	5	akj	akj	PROPN
dti-2613	211	6	,	,	PUNCT
dti-2613	211	7	prem	prem	PROPN
dti-2613	211	8	k	k	PROPN
dti-2613	211	9	,	,	PUNCT
dti-2613	211	10	et	et	PROPN
dti-2613	211	11	al	al	PROPN
dti-2613	211	12	.	.	PUNCT
dti-2613	212	1	epidemiology	epidemiology	NOUN
dti-2613	212	2	of	of	ADP
dti-2613	212	3	extendedspectrum	extendedspectrum	ADP
dti-2613	212	4	beta	beta	NOUN
dti-2613	212	5	-	-	PUNCT
dti-2613	212	6	lactamase	lactamase	NOUN
dti-2613	212	7	and	and	CCONJ
dti-2613	212	8	carbapenemase	carbapenemase	NOUN
dti-2613	212	9	-	-	PUNCT
dti-2613	212	10	producing	produce	VERB
dti-2613	212	11	enterobacterales	enterobacterale	NOUN
dti-2613	212	12	in	in	ADP
dti-2613	212	13	the	the	DET
dti-2613	212	14	greater	great	ADJ
dti-2613	212	15	mekong	mekong	NOUN
dti-2613	212	16	subregion	subregion	NOUN
dti-2613	212	17	:	:	PUNCT
dti-2613	212	18	a	a	DET
dti-2613	212	19	systematic	systematic	ADJ
dti-2613	212	20	review	review	NOUN
dti-2613	212	21	and	and	CCONJ
dti-2613	212	22	meta	meta	ADJ
dti-2613	212	23	-	-	PUNCT
dti-2613	212	24	analysis	analysis	NOUN
dti-2613	212	25	of	of	ADP
dti-2613	212	26	risk	risk	NOUN
dti-2613	212	27	factors	factor	NOUN
dti-2613	212	28	associated	associate	VERB
dti-2613	212	29	with	with	ADP
dti-2613	212	30	extended	extend	VERB
dti-2613	212	31	-	-	PUNCT
dti-2613	212	32	spectrum	spectrum	NOUN
dti-2613	212	33	beta	beta	NOUN
dti-2613	212	34	-	-	PUNCT
dti-2613	212	35	lactamase	lactamase	NOUN
dti-2613	212	36	and	and	CCONJ
dti-2613	212	37	carbapenemase	carbapenemase	NOUN
dti-2613	212	38	isolation	isolation	NOUN
dti-2613	212	39	.	.	PUNCT
dti-2613	213	1	front	front	PROPN
dti-2613	213	2	microbiol	microbiol	PROPN
dti-2613	213	3	.	.	PUNCT
dti-2613	214	1	2021;12:695027	2021;12:695027	NUM
dti-2613	214	2	.	.	PUNCT
dti-2613	215	1	crossref	crossref	PROPN
dti-2613	215	2	8	8	NUM
dti-2613	215	3	.	.	PUNCT
dti-2613	216	1	mustafai	mustafai	PROPN
dti-2613	216	2	mm	mm	PROPN
dti-2613	216	3	,	,	PUNCT
dti-2613	216	4	hafeez	hafeez	PROPN
dti-2613	216	5	m	m	PROPN
dti-2613	216	6	,	,	PUNCT
dti-2613	216	7	munawar	munawar	PROPN
dti-2613	216	8	s	s	PROPN
dti-2613	216	9	,	,	PUNCT
dti-2613	216	10	et	et	PROPN
dti-2613	216	11	al	al	PROPN
dti-2613	216	12	.	.	PUNCT
dti-2613	217	1	prevalence	prevalence	NOUN
dti-2613	217	2	of	of	ADP
dti-2613	217	3	carbapenemase	carbapenemase	NOUN
dti-2613	217	4	and	and	CCONJ
dti-2613	217	5	extended	extend	VERB
dti-2613	217	6	-	-	PUNCT
dti-2613	217	7	spectrum	spectrum	NOUN
dti-2613	217	8	β	β	NOUN
dti-2613	217	9	-	-	PUNCT
dti-2613	217	10	lactamase	lactamase	ADJ
dti-2613	217	11	producing	produce	VERB
dti-2613	217	12	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	217	13	:	:	PUNCT
dti-2613	217	14	a	a	DET
dti-2613	217	15	cross	cross	ADJ
dti-2613	217	16	-	-	ADJ
dti-2613	217	17	sectional	sectional	ADJ
dti-2613	217	18	study	study	NOUN
dti-2613	217	19	.	.	PUNCT
dti-2613	218	1	antibiotics	antibiotic	NOUN
dti-2613	218	2	(	(	PUNCT
dti-2613	218	3	basel	basel	PROPN
dti-2613	218	4	)	)	PUNCT
dti-2613	218	5	.	.	PUNCT
dti-2613	219	1	2023;12(1):12	2023;12(1):12	X
dti-2613	219	2	.	.	PROPN
dti-2613	219	3	crossref	crossref	PROPN
dti-2613	219	4	pubmed	pubmed	PROPN
dti-2613	219	5	https://doi.org/10.3390/jcm12062315	https://doi.org/10.3390/jcm12062315	PROPN
dti-2613	219	6	https://doi.org/10.1183/13993003.03546-2020	https://doi.org/10.1183/13993003.03546-2020	X
dti-2613	219	7	https://www.ncbi.nlm.nih.gov/pubmed/33334937	https://www.ncbi.nlm.nih.gov/pubmed/33334937	PROPN
dti-2613	219	8	https://doi.org/10.1111/resp.13395	https://doi.org/10.1111/resp.13395	PROPN
dti-2613	219	9	https://www.ncbi.nlm.nih.gov/pubmed/30187976	https://www.ncbi.nlm.nih.gov/pubmed/30187976	NUM
dti-2613	219	10	https://doi.org/10.1097/maj.0b013e318259bd24	https://doi.org/10.1097/maj.0b013e318259bd24	PROPN
dti-2613	219	11	https://www.ncbi.nlm.nih.gov/pubmed/23044652	https://www.ncbi.nlm.nih.gov/pubmed/23044652	PROPN
dti-2613	220	1	https://doi.org/10.3389/fmed.2022.828783	https://doi.org/10.3389/fmed.2022.828783	PROPN
dti-2613	220	2	https://www.ncbi.nlm.nih.gov/pubmed/35280903	https://www.ncbi.nlm.nih.gov/pubmed/35280903	NOUN
dti-2613	220	3	https://doi.org/10.1097/inf.0000000000002767	https://doi.org/10.1097/inf.0000000000002767	NOUN
dti-2613	220	4	https://www.ncbi.nlm.nih.gov/pubmed/34448741	https://www.ncbi.nlm.nih.gov/pubmed/34448741	ADP
dti-2613	220	5	https://doi.org/10.3389/fmicb.2021.695027	https://doi.org/10.3389/fmicb.2021.695027	PROPN
dti-2613	220	6	https://doi.org/10.3390/antibiotics12010148	https://doi.org/10.3390/antibiotics12010148	PROPN
dti-2613	220	7	https://www.ncbi.nlm.nih.gov/pubmed/36671350	https://www.ncbi.nlm.nih.gov/pubmed/36671350	PROPN
dti-2613	220	8	kalambry	kalambry	PROPN
dti-2613	220	9	et	et	PROPN
dti-2613	220	10	al	al	PROPN
dti-2613	220	11	drug	drug	PROPN
dti-2613	220	12	target	target	NOUN
dti-2613	220	13	insights	insight	NOUN
dti-2613	220	14	2023	2023	NUM
dti-2613	220	15	;	;	PUNCT
dti-2613	220	16	17	17	NUM
dti-2613	220	17	:	:	SYM
dti-2613	220	18	99	99	NUM
dti-2613	220	19	©	©	PROPN
dti-2613	220	20	2023	2023	NUM
dti-2613	220	21	the	the	DET
dti-2613	220	22	authors	author	NOUN
dti-2613	220	23	.	.	PUNCT
dti-2613	221	1	published	publish	VERB
dti-2613	221	2	by	by	ADP
dti-2613	221	3	aboutscience	aboutscience	NOUN
dti-2613	221	4	www.aboutscience.eu	www.aboutscience.eu	NOUN
dti-2613	221	5	9	9	NUM
dti-2613	221	6	.	.	PUNCT
dti-2613	222	1	sawa	sawa	PROPN
dti-2613	222	2	t	t	PROPN
dti-2613	222	3	,	,	PUNCT
dti-2613	222	4	kooguchi	kooguchi	PROPN
dti-2613	222	5	k	k	PROPN
dti-2613	222	6	,	,	PUNCT
dti-2613	222	7	moriyama	moriyama	PROPN
dti-2613	222	8	k.	k.	PROPN
dti-2613	222	9	molecular	molecular	ADJ
dti-2613	222	10	diversity	diversity	NOUN
dti-2613	222	11	of	of	ADP
dti-2613	222	12	extended	extend	VERB
dti-2613	222	13	-	-	PUNCT
dti-2613	222	14	spectrum	spectrum	NOUN
dti-2613	222	15	β	β	NOUN
dti-2613	222	16	-	-	NOUN
dti-2613	222	17	lactamases	lactamase	NOUN
dti-2613	222	18	and	and	CCONJ
dti-2613	222	19	carbapenemases	carbapenemase	NOUN
dti-2613	222	20	,	,	PUNCT
dti-2613	222	21	and	and	CCONJ
dti-2613	222	22	antimicrobial	antimicrobial	ADJ
dti-2613	222	23	resistance	resistance	NOUN
dti-2613	222	24	.	.	PUNCT
dti-2613	223	1	j	j	PROPN
dti-2613	223	2	intensive	intensive	ADJ
dti-2613	223	3	care	care	NOUN
dti-2613	223	4	.	.	PUNCT
dti-2613	224	1	2020;8:13	2020;8:13	PROPN
dti-2613	224	2	.	.	PUNCT
dti-2613	225	1	crossref	crossref	PROPN
dti-2613	225	2	10	10	NUM
dti-2613	225	3	.	.	PUNCT
dti-2613	226	1	castanheira	castanheira	PROPN
dti-2613	226	2	m	m	PROPN
dti-2613	226	3	,	,	PUNCT
dti-2613	226	4	simner	simner	PROPN
dti-2613	226	5	pj	pj	PROPN
dti-2613	226	6	,	,	PUNCT
dti-2613	226	7	bradford	bradford	PROPN
dti-2613	226	8	pa	pa	PROPN
dti-2613	226	9	.	.	PROPN
dti-2613	226	10	extended	extend	VERB
dti-2613	226	11	-	-	PUNCT
dti-2613	226	12	spectrum	spectrum	NOUN
dti-2613	226	13	β	β	NOUN
dti-2613	226	14	-	-	NOUN
dti-2613	226	15	lactamases	lactamase	NOUN
dti-2613	226	16	:	:	PUNCT
dti-2613	226	17	an	an	DET
dti-2613	226	18	update	update	NOUN
dti-2613	226	19	on	on	ADP
dti-2613	226	20	their	their	PRON
dti-2613	226	21	characteristics	characteristic	NOUN
dti-2613	226	22	,	,	PUNCT
dti-2613	226	23	epidemiology	epidemiology	NOUN
dti-2613	226	24	and	and	CCONJ
dti-2613	226	25	detection	detection	NOUN
dti-2613	226	26	.	.	PUNCT
dti-2613	227	1	jac	jac	PROPN
dti-2613	227	2	antimicrob	antimicrob	PROPN
dti-2613	227	3	resist	resist	VERB
dti-2613	227	4	.	.	PUNCT
dti-2613	228	1	2021;3(3):dlab092	2021;3(3):dlab092	NUM
dti-2613	228	2	.	.	PUNCT
dti-2613	229	1	crossref	crossref	NOUN
dti-2613	229	2	11	11	NUM
dti-2613	229	3	.	.	PUNCT
dti-2613	230	1	world	world	PROPN
dti-2613	230	2	health	health	PROPN
dti-2613	230	3	organization	organization	PROPN
dti-2613	230	4	.	.	PUNCT
dti-2613	231	1	who	who	PRON
dti-2613	231	2	publishes	publish	VERB
dti-2613	231	3	list	list	NOUN
dti-2613	231	4	of	of	ADP
dti-2613	231	5	bacteria	bacteria	NOUN
dti-2613	231	6	for	for	ADP
dti-2613	231	7	which	which	PRON
dti-2613	231	8	new	new	ADJ
dti-2613	231	9	antibiotics	antibiotic	NOUN
dti-2613	231	10	are	be	AUX
dti-2613	231	11	urgently	urgently	ADV
dti-2613	231	12	needed	need	VERB
dti-2613	231	13	.	.	PUNCT
dti-2613	232	1	online	online	INTJ
dti-2613	232	2	.	.	PUNCT
dti-2613	233	1	accessed	access	VERB
dti-2613	233	2	july	july	PROPN
dti-2613	233	3	12	12	NUM
dti-2613	233	4	,	,	PUNCT
dti-2613	233	5	2023	2023	NUM
dti-2613	233	6	.	.	PUNCT
dti-2613	234	1	12	12	NUM
dti-2613	234	2	.	.	PUNCT
dti-2613	235	1	phungoen	phungoen	VERB
dti-2613	235	2	p	p	NOUN
dti-2613	235	3	,	,	PUNCT
dti-2613	235	4	sarunyaparit	sarunyaparit	PROPN
dti-2613	235	5	j	j	PROPN
dti-2613	235	6	,	,	PUNCT
dti-2613	235	7	apiratwarakul	apiratwarakul	PROPN
dti-2613	235	8	k	k	PROPN
dti-2613	235	9	,	,	PUNCT
dti-2613	235	10	wonglakorn	wonglakorn	ADJ
dti-2613	235	11	l	l	NOUN
dti-2613	235	12	,	,	PUNCT
dti-2613	235	13	meesing	meese	VERB
dti-2613	235	14	a	a	DET
dti-2613	235	15	,	,	PUNCT
dti-2613	235	16	sawanyawisuth	sawanyawisuth	PROPN
dti-2613	235	17	k.	k.	PROPN
dti-2613	236	1	the	the	DET
dti-2613	236	2	association	association	PROPN
dti-2613	236	3	of	of	ADP
dti-2613	236	4	esbl	esbl	PROPN
dti-2613	236	5	escherichia	escherichia	NOUN
dti-2613	236	6	coli	coli	NOUN
dti-2613	236	7	with	with	ADP
dti-2613	236	8	mortality	mortality	NOUN
dti-2613	236	9	in	in	ADP
dti-2613	236	10	patients	patient	NOUN
dti-2613	236	11	with	with	ADP
dti-2613	236	12	escherichia	escherichia	NOUN
dti-2613	236	13	coli	coli	NOUN
dti-2613	236	14	bacteremia	bacteremia	NOUN
dti-2613	236	15	at	at	ADP
dti-2613	236	16	the	the	DET
dti-2613	236	17	emergency	emergency	NOUN
dti-2613	236	18	department	department	NOUN
dti-2613	236	19	.	.	PUNCT
dti-2613	237	1	drug	drug	NOUN
dti-2613	237	2	target	target	NOUN
dti-2613	237	3	insights	insight	NOUN
dti-2613	237	4	.	.	PUNCT
dti-2613	238	1	2022;16(1):12	2022;16(1):12	NUM
dti-2613	238	2	-	-	SYM
dti-2613	238	3	16	16	NUM
dti-2613	238	4	.	.	PUNCT
dti-2613	239	1	crossref	crossref	PROPN
dti-2613	239	2	pubmed	pubmed	PROPN
dti-2613	239	3	13	13	NUM
dti-2613	239	4	.	.	PUNCT
dti-2613	240	1	shamsrizi	shamsrizi	PROPN
dti-2613	240	2	p	p	NOUN
dti-2613	240	3	,	,	PUNCT
dti-2613	240	4	gladstone	gladstone	PROPN
dti-2613	240	5	bp	bp	PROPN
dti-2613	240	6	,	,	PUNCT
dti-2613	240	7	carrara	carrara	ADJ
dti-2613	240	8	e	e	NOUN
dti-2613	240	9	,	,	PUNCT
dti-2613	240	10	et	et	PROPN
dti-2613	240	11	al	al	PROPN
dti-2613	240	12	.	.	PROPN
dti-2613	240	13	variation	variation	NOUN
dti-2613	240	14	of	of	ADP
dti-2613	240	15	effect	effect	NOUN
dti-2613	240	16	estimates	estimate	NOUN
dti-2613	240	17	in	in	ADP
dti-2613	240	18	the	the	DET
dti-2613	240	19	analysis	analysis	NOUN
dti-2613	240	20	of	of	ADP
dti-2613	240	21	mortality	mortality	NOUN
dti-2613	240	22	and	and	CCONJ
dti-2613	240	23	length	length	NOUN
dti-2613	240	24	of	of	ADP
dti-2613	240	25	hospital	hospital	NOUN
dti-2613	240	26	stay	stay	NOUN
dti-2613	240	27	in	in	ADP
dti-2613	240	28	patients	patient	NOUN
dti-2613	240	29	with	with	ADP
dti-2613	240	30	infections	infection	NOUN
dti-2613	240	31	caused	cause	VERB
dti-2613	240	32	by	by	ADP
dti-2613	240	33	bacteria	bacteria	NOUN
dti-2613	240	34	-	-	PUNCT
dti-2613	240	35	producing	produce	VERB
dti-2613	240	36	extended	extend	VERB
dti-2613	240	37	-	-	PUNCT
dti-2613	240	38	spectrum	spectrum	NOUN
dti-2613	240	39	beta	beta	NOUN
dti-2613	240	40	-	-	PUNCT
dti-2613	240	41	lactamases	lactamase	NOUN
dti-2613	240	42	:	:	PUNCT
dti-2613	240	43	a	a	DET
dti-2613	240	44	systematic	systematic	ADJ
dti-2613	240	45	review	review	NOUN
dti-2613	240	46	and	and	CCONJ
dti-2613	240	47	meta	meta	ADJ
dti-2613	240	48	-	-	PUNCT
dti-2613	240	49	analysis	analysis	NOUN
dti-2613	240	50	.	.	PUNCT
dti-2613	241	1	bmj	bmj	PROPN
dti-2613	241	2	open	open	ADJ
dti-2613	241	3	.	.	PUNCT
dti-2613	242	1	2020;10(1):e030266	2020;10(1):e030266	X
dti-2613	242	2	.	.	PUNCT
dti-2613	243	1	crossref	crossref	PROPN
dti-2613	243	2	pubmed	pubmed	PROPN
dti-2613	243	3	14	14	PROPN
dti-2613	243	4	.	.	PUNCT
dti-2613	244	1	gao	gao	PROPN
dti-2613	244	2	y	y	PROPN
dti-2613	244	3	,	,	PUNCT
dti-2613	244	4	chen	chen	PROPN
dti-2613	244	5	m	m	PROPN
dti-2613	244	6	,	,	PUNCT
dti-2613	244	7	cai	cai	PROPN
dti-2613	244	8	m	m	PROPN
dti-2613	244	9	,	,	PUNCT
dti-2613	244	10	et	et	PROPN
dti-2613	244	11	al	al	PROPN
dti-2613	244	12	.	.	PUNCT
dti-2613	245	1	an	an	DET
dti-2613	245	2	analysis	analysis	NOUN
dti-2613	245	3	of	of	ADP
dti-2613	245	4	risk	risk	NOUN
dti-2613	245	5	factors	factor	NOUN
dti-2613	245	6	for	for	ADP
dti-2613	245	7	carbapenem	carbapenem	NOUN
dti-2613	245	8	-	-	PUNCT
dti-2613	245	9	resistant	resistant	ADJ
dti-2613	245	10	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	245	11	infection	infection	NOUN
dti-2613	245	12	.	.	PUNCT
dti-2613	246	1	j	j	PROPN
dti-2613	246	2	glob	glob	PROPN
dti-2613	246	3	antimicrob	antimicrob	PROPN
dti-2613	246	4	resist	resist	VERB
dti-2613	246	5	.	.	PUNCT
dti-2613	247	1	2022;30:191	2022;30:191	X
dti-2613	247	2	-	-	SYM
dti-2613	247	3	198	198	NUM
dti-2613	247	4	.	.	PUNCT
dti-2613	248	1	crossref	crossref	PROPN
dti-2613	248	2	pubmed	pubmed	PROPN
dti-2613	248	3	15	15	PROPN
dti-2613	248	4	.	.	PUNCT
dti-2613	249	1	vance	vance	PROPN
dti-2613	249	2	mk	mk	PROPN
dti-2613	249	3	,	,	PUNCT
dti-2613	249	4	cretella	cretella	PROPN
dti-2613	249	5	da	da	PROPN
dti-2613	249	6	,	,	PUNCT
dti-2613	249	7	ward	ward	NOUN
dti-2613	249	8	lm	lm	PROPN
dti-2613	249	9	,	,	PUNCT
dti-2613	249	10	vijayvargiya	vijayvargiya	NOUN
dti-2613	249	11	p	p	X
dti-2613	249	12	,	,	PUNCT
dti-2613	249	13	garrigos	garrigo	NOUN
dti-2613	249	14	ze	ze	PROPN
dti-2613	249	15	,	,	PUNCT
dti-2613	249	16	wingler	wingler	NOUN
dti-2613	249	17	mjb	mjb	PROPN
dti-2613	249	18	.	.	PROPN
dti-2613	249	19	risk	risk	NOUN
dti-2613	249	20	factors	factor	NOUN
dti-2613	249	21	for	for	ADP
dti-2613	249	22	bloodstream	bloodstream	NOUN
dti-2613	249	23	infections	infection	NOUN
dti-2613	249	24	due	due	ADJ
dti-2613	249	25	to	to	ADP
dti-2613	249	26	esbl	esbl	NOUN
dti-2613	249	27	-	-	PUNCT
dti-2613	249	28	producing	produce	VERB
dti-2613	249	29	escherichia	escherichia	NOUN
dti-2613	249	30	coli	coli	NOUN
dti-2613	249	31	,	,	PUNCT
dti-2613	249	32	klebsiella	klebsiella	PROPN
dti-2613	249	33	spp	spp	PROPN
dti-2613	249	34	.	.	PROPN
dti-2613	249	35	,	,	PUNCT
dti-2613	249	36	and	and	CCONJ
dti-2613	249	37	proteus	proteus	PROPN
dti-2613	249	38	mirabilis	mirabilis	PROPN
dti-2613	249	39	.	.	PUNCT
dti-2613	250	1	pharmacy	pharmacy	NOUN
dti-2613	250	2	(	(	PUNCT
dti-2613	250	3	basel	basel	PROPN
dti-2613	250	4	)	)	PUNCT
dti-2613	250	5	.	.	PUNCT
dti-2613	251	1	2023;11(2):74	2023;11(2):74	X
dti-2613	251	2	.	.	PUNCT
dti-2613	252	1	crossref	crossref	PROPN
dti-2613	252	2	pubmed	pubmed	PROPN
dti-2613	252	3	16	16	NUM
dti-2613	252	4	.	.	PUNCT
dti-2613	253	1	ouchar	ouchar	PROPN
dti-2613	253	2	mahamat	mahamat	PROPN
dti-2613	253	3	o	o	PROPN
dti-2613	253	4	,	,	PUNCT
dti-2613	253	5	kempf	kempf	PROPN
dti-2613	253	6	m	m	PROPN
dti-2613	253	7	,	,	PUNCT
dti-2613	253	8	lounnas	lounnas	PROPN
dti-2613	253	9	m	m	PROPN
dti-2613	253	10	,	,	PUNCT
dti-2613	253	11	et	et	PROPN
dti-2613	253	12	al	al	PROPN
dti-2613	253	13	.	.	PUNCT
dti-2613	253	14	epidemiology	epidemiology	NOUN
dti-2613	253	15	and	and	CCONJ
dti-2613	253	16	prevalence	prevalence	NOUN
dti-2613	253	17	of	of	ADP
dti-2613	253	18	extended	extend	VERB
dti-2613	253	19	-	-	PUNCT
dti-2613	253	20	spectrum	spectrum	NOUN
dti-2613	253	21	β	β	NOUN
dti-2613	253	22	-	-	PUNCT
dti-2613	253	23	lactamaseand	lactamaseand	NOUN
dti-2613	253	24	carbapenemase	carbapenemase	NOUN
dti-2613	253	25	-	-	PUNCT
dti-2613	253	26	producing	produce	VERB
dti-2613	253	27	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	253	28	in	in	ADP
dti-2613	253	29	humans	human	NOUN
dti-2613	253	30	,	,	PUNCT
dti-2613	253	31	animals	animal	NOUN
dti-2613	253	32	and	and	CCONJ
dti-2613	253	33	the	the	DET
dti-2613	253	34	environment	environment	NOUN
dti-2613	253	35	in	in	ADP
dti-2613	253	36	west	west	NOUN
dti-2613	253	37	and	and	CCONJ
dti-2613	253	38	central	central	PROPN
dti-2613	253	39	africa	africa	PROPN
dti-2613	253	40	.	.	PUNCT
dti-2613	254	1	int	int	PROPN
dti-2613	254	2	j	j	PROPN
dti-2613	254	3	antimicrob	antimicrob	PROPN
dti-2613	254	4	agents	agent	NOUN
dti-2613	254	5	.	.	PUNCT
dti-2613	255	1	2021;57(1):106203	2021;57(1):106203	X
dti-2613	255	2	.	.	PUNCT
dti-2613	256	1	crossref	crossref	PROPN
dti-2613	256	2	pubmed	pubmed	PROPN
dti-2613	256	3	17	17	NUM
dti-2613	256	4	.	.	PUNCT
dti-2613	257	1	kalambry	kalambry	PROPN
dti-2613	257	2	a	a	DET
dti-2613	257	3	,	,	PUNCT
dti-2613	257	4	gaudré	gaudré	ADJ
dti-2613	257	5	n	n	CCONJ
dti-2613	257	6	,	,	PUNCT
dti-2613	257	7	drame	drame	NOUN
dti-2613	257	8	bs	bs	PROPN
dti-2613	257	9	,	,	PUNCT
dti-2613	257	10	et	et	PROPN
dti-2613	257	11	al	al	PROPN
dti-2613	257	12	.	.	PUNCT
dti-2613	257	13	profil	profil	PROPN
dti-2613	257	14	de	de	X
dti-2613	257	15	résistance	résistance	PROPN
dti-2613	257	16	aux	aux	PROPN
dti-2613	257	17	bêta	bêta	NOUN
dti-2613	257	18	-	-	PUNCT
dti-2613	257	19	lactamines	lactamine	NOUN
dti-2613	257	20	des	des	PROPN
dti-2613	257	21	entérobactéries	entérobactéries	PROPN
dti-2613	257	22	isolées	isolées	PROPN
dti-2613	257	23	des	des	PROPN
dti-2613	257	24	prélèvements	prélèvements	PROPN
dti-2613	257	25	urinaires	urinaires	PROPN
dti-2613	257	26	à	à	X
dti-2613	257	27	l’hôpital	l’hôpital	PROPN
dti-2613	257	28	du	du	PROPN
dti-2613	257	29	mali	mali	PROPN
dti-2613	257	30	.	.	PUNCT
dti-2613	258	1	rev	rev	PROPN
dti-2613	258	2	mali	mali	PROPN
dti-2613	258	3	infectiol	infectiol	PROPN
dti-2613	258	4	microbiol	microbiol	PROPN
dti-2613	258	5	.	.	PUNCT
dti-2613	259	1	2019;14(2):6	2019;14(2):6	NUM
dti-2613	259	2	-	-	SYM
dti-2613	259	3	13	13	NUM
dti-2613	259	4	.	.	PUNCT
dti-2613	260	1	crossref	crossref	PROPN
dti-2613	260	2	18	18	NUM
dti-2613	260	3	.	.	PUNCT
dti-2613	261	1	muggeo	muggeo	PROPN
dti-2613	261	2	a	a	PRON
dti-2613	261	3	,	,	PUNCT
dti-2613	261	4	maiga	maiga	ADJ
dti-2613	261	5	a	a	X
dti-2613	261	6	,	,	PUNCT
dti-2613	261	7	maiga	maiga	PROPN
dti-2613	261	8	i	i	PROPN
dti-2613	261	9	,	,	PUNCT
dti-2613	261	10	et	et	PROPN
dti-2613	261	11	al	al	PROPN
dti-2613	261	12	.	.	PUNCT
dti-2613	262	1	first	first	ADJ
dti-2613	262	2	description	description	NOUN
dti-2613	262	3	of	of	ADP
dti-2613	262	4	incx3	incx3	NOUN
dti-2613	262	5	ndm-5	ndm-5	ADV
dti-2613	262	6	-	-	PUNCT
dti-2613	262	7	producing	produce	VERB
dti-2613	262	8	plasmid	plasmid	NOUN
dti-2613	262	9	within	within	ADP
dti-2613	262	10	escherichia	escherichia	NOUN
dti-2613	262	11	coli	coli	NOUN
dti-2613	262	12	st448	st448	PROPN
dti-2613	262	13	in	in	ADP
dti-2613	262	14	mali	mali	PROPN
dti-2613	262	15	.	.	PUNCT
dti-2613	263	1	j	j	PROPN
dti-2613	263	2	med	med	PROPN
dti-2613	263	3	microbiol	microbiol	PROPN
dti-2613	263	4	.	.	PUNCT
dti-2613	264	1	2020;69(5):685	2020;69(5):685	NUM
dti-2613	264	2	-	-	PUNCT
dti-2613	264	3	688	688	NUM
dti-2613	264	4	.	.	PUNCT
dti-2613	265	1	crossref	crossref	PROPN
dti-2613	265	2	pubmed	pubmed	PROPN
dti-2613	265	3	19	19	NUM
dti-2613	265	4	.	.	PUNCT
dti-2613	266	1	sangare	sangare	PROPN
dti-2613	266	2	sa	sa	PROPN
dti-2613	266	3	,	,	PUNCT
dti-2613	266	4	rondinaud	rondinaud	NOUN
dti-2613	266	5	e	e	NOUN
dti-2613	266	6	,	,	PUNCT
dti-2613	266	7	maataoui	maataoui	NOUN
dti-2613	266	8	n	n	CCONJ
dti-2613	266	9	,	,	PUNCT
dti-2613	266	10	et	et	PROPN
dti-2613	266	11	al	al	PROPN
dti-2613	266	12	.	.	PUNCT
dti-2613	267	1	very	very	ADV
dti-2613	267	2	high	high	ADJ
dti-2613	267	3	prevalence	prevalence	NOUN
dti-2613	267	4	of	of	ADP
dti-2613	267	5	extended	extend	VERB
dti-2613	267	6	-	-	PUNCT
dti-2613	267	7	spectrum	spectrum	NOUN
dti-2613	267	8	beta	beta	NOUN
dti-2613	267	9	-	-	PUNCT
dti-2613	267	10	lactamase	lactamase	NOUN
dti-2613	267	11	-	-	PUNCT
dti-2613	267	12	producing	produce	VERB
dti-2613	267	13	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	267	14	in	in	ADP
dti-2613	267	15	bacteriemic	bacteriemic	ADJ
dti-2613	267	16	patients	patient	NOUN
dti-2613	267	17	hospitalized	hospitalize	VERB
dti-2613	267	18	in	in	ADP
dti-2613	267	19	teaching	teach	VERB
dti-2613	267	20	hospitals	hospital	NOUN
dti-2613	267	21	in	in	ADP
dti-2613	267	22	bamako	bamako	PROPN
dti-2613	267	23	,	,	PUNCT
dti-2613	267	24	mali	mali	PROPN
dti-2613	267	25	.	.	PUNCT
dti-2613	268	1	plos	plos	PROPN
dti-2613	268	2	one	one	NUM
dti-2613	268	3	.	.	PUNCT
dti-2613	269	1	2017;12(2	2017;12(2	NUM
dti-2613	269	2	):	):	PUNCT
dti-2613	270	1	e0172652	e0172652	PROPN
dti-2613	270	2	.	.	PUNCT
dti-2613	271	1	crossref	crossref	PROPN
dti-2613	271	2	pubmed	pubmed	PROPN
dti-2613	271	3	20	20	NUM
dti-2613	271	4	.	.	PUNCT
dti-2613	272	1	davies	davy	NOUN
dti-2613	272	2	he	he	PRON
dti-2613	272	3	,	,	PUNCT
dti-2613	272	4	davies	davies	PROPN
dti-2613	272	5	rjo	rjo	PROPN
dti-2613	272	6	,	,	PUNCT
dti-2613	272	7	davies	davy	NOUN
dti-2613	272	8	cwh	cwh	VERB
dti-2613	272	9	;	;	PUNCT
dti-2613	272	10	bts	bt	NOUN
dti-2613	272	11	pleural	pleural	ADJ
dti-2613	272	12	disease	disease	NOUN
dti-2613	272	13	guideline	guideline	NOUN
dti-2613	272	14	group	group	NOUN
dti-2613	272	15	.	.	PUNCT
dti-2613	273	1	management	management	NOUN
dti-2613	273	2	of	of	ADP
dti-2613	273	3	pleural	pleural	ADJ
dti-2613	273	4	infection	infection	NOUN
dti-2613	273	5	in	in	ADP
dti-2613	273	6	adults	adult	NOUN
dti-2613	273	7	:	:	PUNCT
dti-2613	273	8	british	british	ADJ
dti-2613	273	9	thoracic	thoracic	NOUN
dti-2613	273	10	society	society	NOUN
dti-2613	273	11	pleural	pleural	ADJ
dti-2613	273	12	disease	disease	NOUN
dti-2613	273	13	guideline	guideline	NOUN
dti-2613	273	14	2010	2010	NUM
dti-2613	273	15	.	.	PUNCT
dti-2613	274	1	thorax	thorax	NOUN
dti-2613	274	2	.	.	PUNCT
dti-2613	275	1	2010;65(suppl	2010;65(suppl	PROPN
dti-2613	276	1	2):ii41	2):ii41	PROPN
dti-2613	276	2	-	-	PUNCT
dti-2613	276	3	ii53	ii53	PROPN
dti-2613	276	4	.	.	PUNCT
dti-2613	276	5	crossref	crossref	PROPN
dti-2613	276	6	pubmed	pubmed	PROPN
dti-2613	276	7	21	21	NUM
dti-2613	276	8	.	.	PUNCT
dti-2613	277	1	casfm	casfm	PROPN
dti-2613	277	2	/	/	SYM
dti-2613	277	3	eucast	eucast	NOUN
dti-2613	277	4	.	.	PUNCT
dti-2613	278	1	2020	2020	NUM
dti-2613	278	2	.	.	PUNCT
dti-2613	279	1	casfm	casfm	PROPN
dti-2613	279	2	/	/	SYM
dti-2613	279	3	eucast	eucast	VERB
dti-2613	279	4	v1.2	v1.2	CCONJ
dti-2613	279	5	octobre	octobre	PROPN
dti-2613	279	6	2020	2020	NUM
dti-2613	279	7	.	.	PUNCT
dti-2613	280	1	société	société	PROPN
dti-2613	280	2	française	française	PROPN
dti-2613	280	3	de	de	X
dti-2613	280	4	microbiologie	microbiologie	PROPN
dti-2613	280	5	.	.	PUNCT
dti-2613	281	1	online	online	PROPN
dti-2613	281	2	.	.	PUNCT
dti-2613	282	1	accessed	access	VERB
dti-2613	282	2	may	may	PROPN
dti-2613	282	3	11	11	NUM
dti-2613	282	4	,	,	PUNCT
dti-2613	282	5	2023	2023	NUM
dti-2613	282	6	.	.	PUNCT
dti-2613	283	1	22	22	NUM
dti-2613	283	2	.	.	PUNCT
dti-2613	284	1	guindo	guindo	PROPN
dti-2613	284	2	i	i	PRON
dti-2613	284	3	,	,	PUNCT
dti-2613	284	4	dicko	dicko	PROPN
dti-2613	284	5	aa	aa	PROPN
dti-2613	284	6	,	,	PUNCT
dti-2613	284	7	konaté	konaté	PROPN
dti-2613	284	8	i	i	PROPN
dti-2613	284	9	,	,	PUNCT
dti-2613	284	10	et	et	PROPN
dti-2613	284	11	al	al	PROPN
dti-2613	284	12	.	.	PROPN
dti-2613	284	13	facteurs	facteurs	PROPN
dti-2613	284	14	de	de	X
dti-2613	284	15	pathogénicité	pathogénicité	PROPN
dti-2613	284	16	et	et	NOUN
dti-2613	284	17	résistance	résistance	PROPN
dti-2613	284	18	aux	aux	PROPN
dti-2613	284	19	antibiotiques	antibiotiques	PROPN
dti-2613	284	20	des	des	PROPN
dti-2613	284	21	souches	souche	VERB
dti-2613	284	22	d’escherichia	d’escherichia	NOUN
dti-2613	284	23	coli	coli	NOUN
dti-2613	284	24	isolées	isolées	NOUN
dti-2613	284	25	chez	chez	PROPN
dti-2613	284	26	les	les	PROPN
dti-2613	284	27	enfants	enfants	X
dti-2613	284	28	diarrhéiques	diarrhéique	NOUN
dti-2613	284	29	de	de	X
dti-2613	284	30	0	0	X
dti-2613	284	31	à	à	X
dti-2613	284	32	59	59	NUM
dti-2613	284	33	mois	mois	X
dti-2613	284	34	en	en	X
dti-2613	284	35	milieu	milieu	PROPN
dti-2613	284	36	communautaire	communautaire	PROPN
dti-2613	284	37	à	à	X
dti-2613	284	38	bamako	bamako	PROPN
dti-2613	284	39	.	.	PUNCT
dti-2613	285	1	health	health	PROPN
dti-2613	285	2	sci	sci	PROPN
dti-2613	285	3	dis	dis	PROPN
dti-2613	285	4	.	.	PUNCT
dti-2613	286	1	2022;23(5):49	2022;23(5):49	NUM
dti-2613	286	2	-	-	SYM
dti-2613	286	3	56	56	NUM
dti-2613	286	4	.	.	NOUN
dti-2613	286	5	23	23	NUM
dti-2613	286	6	.	.	PUNCT
dti-2613	287	1	berends	berend	VERB
dti-2613	287	2	ms	ms	PROPN
dti-2613	287	3	,	,	PUNCT
dti-2613	287	4	luz	luz	PROPN
dti-2613	287	5	cf	cf	NOUN
dti-2613	287	6	,	,	PUNCT
dti-2613	287	7	friedrich	friedrich	PROPN
dti-2613	287	8	aw	aw	INTJ
dti-2613	287	9	,	,	PUNCT
dti-2613	287	10	sinha	sinha	PROPN
dti-2613	287	11	bnm	bnm	PROPN
dti-2613	287	12	,	,	PUNCT
dti-2613	287	13	albers	albers	PROPN
dti-2613	287	14	cj	cj	PROPN
dti-2613	287	15	,	,	PUNCT
dti-2613	287	16	glasner	glasner	PROPN
dti-2613	287	17	c.	c.	PROPN
dti-2613	287	18	amr	amr	PROPN
dti-2613	287	19	–	–	PUNCT
dti-2613	287	20	an	an	DET
dti-2613	287	21	r	r	NOUN
dti-2613	287	22	package	package	NOUN
dti-2613	287	23	for	for	ADP
dti-2613	287	24	working	work	VERB
dti-2613	287	25	with	with	ADP
dti-2613	287	26	antimicrobial	antimicrobial	ADJ
dti-2613	287	27	resistance	resistance	NOUN
dti-2613	287	28	data	datum	NOUN
dti-2613	287	29	.	.	PUNCT
dti-2613	288	1	crossref	crossref	PROPN
dti-2613	288	2	.	.	PROPN
dti-2613	289	1	accessed	access	VERB
dti-2613	289	2	may	may	PROPN
dti-2613	289	3	26	26	NUM
dti-2613	289	4	,	,	PUNCT
dti-2613	289	5	2023	2023	NUM
dti-2613	289	6	.	.	PUNCT
dti-2613	290	1	24	24	NUM
dti-2613	290	2	.	.	PUNCT
dti-2613	291	1	magiorakos	magiorakos	PROPN
dti-2613	291	2	ap	ap	PROPN
dti-2613	291	3	,	,	PUNCT
dti-2613	291	4	srinivasan	srinivasan	PROPN
dti-2613	291	5	a	a	PROPN
dti-2613	291	6	,	,	PUNCT
dti-2613	291	7	carey	carey	PROPN
dti-2613	291	8	rb	rb	PROPN
dti-2613	291	9	,	,	PUNCT
dti-2613	291	10	et	et	PROPN
dti-2613	291	11	al	al	PROPN
dti-2613	291	12	.	.	PROPN
dti-2613	291	13	multidrugresistant	multidrugresistant	PROPN
dti-2613	291	14	,	,	PUNCT
dti-2613	291	15	extensively	extensively	ADV
dti-2613	291	16	drug	drug	NOUN
dti-2613	291	17	-	-	PUNCT
dti-2613	291	18	resistant	resistant	ADJ
dti-2613	291	19	and	and	CCONJ
dti-2613	291	20	pandrug	pandrug	ADJ
dti-2613	291	21	-	-	PUNCT
dti-2613	291	22	resistant	resistant	ADJ
dti-2613	291	23	bacteria	bacteria	NOUN
dti-2613	291	24	:	:	PUNCT
dti-2613	291	25	an	an	DET
dti-2613	291	26	international	international	ADJ
dti-2613	291	27	expert	expert	NOUN
dti-2613	291	28	proposal	proposal	NOUN
dti-2613	291	29	for	for	ADP
dti-2613	291	30	interim	interim	ADJ
dti-2613	291	31	standard	standard	ADJ
dti-2613	291	32	definitions	definition	NOUN
dti-2613	291	33	for	for	ADP
dti-2613	291	34	acquired	acquire	VERB
dti-2613	291	35	resistance	resistance	NOUN
dti-2613	291	36	.	.	PUNCT
dti-2613	292	1	clin	clin	PROPN
dti-2613	292	2	microbiol	microbiol	PROPN
dti-2613	292	3	infect	infect	PROPN
dti-2613	292	4	.	.	PUNCT
dti-2613	293	1	2012;18(3):268	2012;18(3):268	NUM
dti-2613	293	2	-	-	PUNCT
dti-2613	293	3	281	281	NUM
dti-2613	293	4	.	.	PUNCT
dti-2613	294	1	crossref	crossref	PROPN
dti-2613	294	2	pubmed	pubmed	PROPN
dti-2613	294	3	25	25	NUM
dti-2613	294	4	.	.	PUNCT
dti-2613	295	1	kpoda	kpoda	PROPN
dti-2613	295	2	ds	ds	PROPN
dti-2613	295	3	,	,	PUNCT
dti-2613	295	4	guessennd	guessennd	NOUN
dti-2613	295	5	n	n	CCONJ
dti-2613	295	6	,	,	PUNCT
dti-2613	295	7	bonkoungou	bonkoungou	PROPN
dti-2613	295	8	ji	ji	PROPN
dti-2613	295	9	,	,	PUNCT
dti-2613	295	10	et	et	PROPN
dti-2613	295	11	al	al	PROPN
dti-2613	295	12	.	.	PUNCT
dti-2613	296	1	prevalence	prevalence	NOUN
dti-2613	296	2	and	and	CCONJ
dti-2613	296	3	resistance	resistance	NOUN
dti-2613	296	4	profile	profile	NOUN
dti-2613	296	5	of	of	ADP
dti-2613	296	6	extended	extend	VERB
dti-2613	296	7	-	-	PUNCT
dti-2613	296	8	spectrum	spectrum	NOUN
dti-2613	296	9	β	β	NOUN
dti-2613	296	10	-	-	ADJ
dti-2613	296	11	lactamasesproducing	lactamasesproduce	VERB
dti-2613	296	12	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	296	13	in	in	ADP
dti-2613	296	14	ouagadougou	ouagadougou	PROPN
dti-2613	296	15	,	,	PUNCT
dti-2613	296	16	burkina	burkina	PROPN
dti-2613	296	17	faso	faso	PROPN
dti-2613	296	18	.	.	PUNCT
dti-2613	297	1	afr	afr	PROPN
dti-2613	297	2	j	j	PROPN
dti-2613	297	3	microbiol	microbiol	PROPN
dti-2613	297	4	res	re	NOUN
dti-2613	297	5	.	.	PUNCT
dti-2613	298	1	2017;11(27):1120	2017;11(27):1120	NUM
dti-2613	298	2	-	-	SYM
dti-2613	298	3	1126	1126	NUM
dti-2613	298	4	.	.	PUNCT
dti-2613	299	1	crossref	crossref	PROPN
dti-2613	299	2	26	26	NUM
dti-2613	299	3	.	.	PUNCT
dti-2613	300	1	bora	bora	PROPN
dti-2613	300	2	g	g	PROPN
dti-2613	300	3	,	,	PUNCT
dti-2613	300	4	akgül	akgül	NOUN
dti-2613	300	5	ö	ö	NOUN
dti-2613	300	6	,	,	PUNCT
dti-2613	300	7	gülaçar	gülaçar	NOUN
dti-2613	300	8	e	e	NOUN
dti-2613	300	9	,	,	PUNCT
dti-2613	300	10	sayir	sayir	PROPN
dti-2613	300	11	f.	f.	PROPN
dti-2613	301	1	the	the	DET
dti-2613	301	2	molecular	molecular	ADJ
dti-2613	301	3	analysis	analysis	NOUN
dti-2613	301	4	of	of	ADP
dti-2613	301	5	antibiotic	antibiotic	ADJ
dti-2613	301	6	resistance	resistance	NOUN
dti-2613	301	7	and	and	CCONJ
dti-2613	301	8	identification	identification	NOUN
dti-2613	301	9	of	of	ADP
dti-2613	301	10	the	the	DET
dti-2613	301	11	aerobic	aerobic	ADJ
dti-2613	301	12	bacteria	bacteria	NOUN
dti-2613	301	13	isolated	isolate	VERB
dti-2613	301	14	from	from	ADP
dti-2613	301	15	pleural	pleural	ADJ
dti-2613	301	16	fluids	fluid	NOUN
dti-2613	301	17	obtained	obtain	VERB
dti-2613	301	18	from	from	ADP
dti-2613	301	19	patients	patient	NOUN
dti-2613	301	20	.	.	PUNCT
dti-2613	302	1	eur	eur	PROPN
dti-2613	302	2	rev	rev	PROPN
dti-2613	302	3	med	med	PROPN
dti-2613	302	4	pharmacol	pharmacol	PROPN
dti-2613	302	5	sci	sci	PROPN
dti-2613	302	6	.	.	PUNCT
dti-2613	303	1	2022;26(19):7236	2022;26(19):7236	NUM
dti-2613	303	2	-	-	SYM
dti-2613	303	3	7244	7244	NUM
dti-2613	303	4	.	.	PUNCT
dti-2613	304	1	pubmed	pubmed	PROPN
dti-2613	304	2	27	27	NUM
dti-2613	304	3	.	.	PUNCT
dti-2613	305	1	ouedraogo	ouedraogo	PROPN
dti-2613	305	2	as	as	ADP
dti-2613	305	3	,	,	PUNCT
dti-2613	305	4	sanou	sanou	NOUN
dti-2613	305	5	m	m	PROPN
dti-2613	305	6	,	,	PUNCT
dti-2613	305	7	kissou	kissou	PROPN
dti-2613	305	8	a	a	PROPN
dti-2613	305	9	,	,	PUNCT
dti-2613	305	10	et	et	PROPN
dti-2613	305	11	al	al	PROPN
dti-2613	305	12	.	.	PROPN
dti-2613	305	13	high	high	ADJ
dti-2613	305	14	prevalence	prevalence	NOUN
dti-2613	305	15	of	of	ADP
dti-2613	305	16	extended	extend	VERB
dti-2613	305	17	-	-	PUNCT
dti-2613	305	18	spectrum	spectrum	NOUN
dti-2613	305	19	β	β	NOUN
dti-2613	305	20	-	-	PUNCT
dti-2613	305	21	lactamase	lactamase	ADJ
dti-2613	305	22	producing	produce	VERB
dti-2613	305	23	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	305	24	among	among	ADP
dti-2613	305	25	clinical	clinical	ADJ
dti-2613	305	26	isolates	isolate	NOUN
dti-2613	305	27	in	in	ADP
dti-2613	305	28	burkina	burkina	PROPN
dti-2613	305	29	faso	faso	PROPN
dti-2613	305	30	.	.	PUNCT
dti-2613	306	1	bmc	bmc	PROPN
dti-2613	306	2	infect	infect	PROPN
dti-2613	306	3	dis	dis	PROPN
dti-2613	306	4	.	.	PUNCT
dti-2613	307	1	2016;16(1):326	2016;16(1):326	NOUN
dti-2613	307	2	.	.	PUNCT
dti-2613	308	1	crossref	crossref	PROPN
dti-2613	308	2	pubmed	pubmed	PROPN
dti-2613	308	3	28	28	PROPN
dti-2613	308	4	.	.	PUNCT
dti-2613	309	1	sonda	sonda	PROPN
dti-2613	309	2	t	t	PROPN
dti-2613	309	3	,	,	PUNCT
dti-2613	309	4	van	van	PROPN
dti-2613	309	5	zwetselaar	zwetselaar	NOUN
dti-2613	309	6	m	m	PROPN
dti-2613	309	7	,	,	PUNCT
dti-2613	309	8	alifrangis	alifrangis	VERB
dti-2613	309	9	m	m	PROPN
dti-2613	309	10	,	,	PUNCT
dti-2613	309	11	lund	lund	PROPN
dti-2613	309	12	o	o	PROPN
dti-2613	309	13	,	,	PUNCT
dti-2613	309	14	kibiki	kibiki	PROPN
dti-2613	309	15	g	g	PROPN
dti-2613	309	16	,	,	PUNCT
dti-2613	309	17	aarestrup	aarestrup	PROPN
dti-2613	309	18	fm	fm	PROPN
dti-2613	309	19	.	.	PROPN
dti-2613	310	1	meta	meta	VERB
dti-2613	310	2	-	-	PUNCT
dti-2613	310	3	analysis	analysis	NOUN
dti-2613	310	4	of	of	ADP
dti-2613	310	5	proportion	proportion	NOUN
dti-2613	310	6	estimates	estimate	NOUN
dti-2613	310	7	of	of	ADP
dti-2613	310	8	extended	extend	VERB
dti-2613	310	9	-	-	PUNCT
dti-2613	310	10	spectrum	spectrum	NOUN
dti-2613	310	11	-	-	PUNCT
dti-2613	310	12	beta	beta	NOUN
dti-2613	310	13	-	-	PUNCT
dti-2613	310	14	lactamase	lactamase	NOUN
dti-2613	310	15	-	-	PUNCT
dti-2613	310	16	producing	produce	VERB
dti-2613	310	17	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	310	18	in	in	ADP
dti-2613	310	19	east	east	PROPN
dti-2613	310	20	africa	africa	PROPN
dti-2613	310	21	hospitals	hospital	NOUN
dti-2613	310	22	.	.	PUNCT
dti-2613	311	1	antimicrob	antimicrob	PROPN
dti-2613	311	2	resist	resist	VERB
dti-2613	311	3	infect	infect	NOUN
dti-2613	311	4	control	control	NOUN
dti-2613	311	5	.	.	PUNCT
dti-2613	312	1	2016;5:18	2016;5:18	NOUN
dti-2613	312	2	.	.	PUNCT
dti-2613	313	1	crossref	crossref	PROPN
dti-2613	313	2	29	29	NUM
dti-2613	313	3	.	.	PUNCT
dti-2613	314	1	garoy	garoy	PROPN
dti-2613	314	2	ey	ey	NOUN
dti-2613	314	3	,	,	PUNCT
dti-2613	314	4	gebreab	gebreab	NOUN
dti-2613	314	5	yb	yb	PROPN
dti-2613	314	6	,	,	PUNCT
dti-2613	314	7	achila	achila	NOUN
dti-2613	314	8	oo	oo	INTJ
dti-2613	314	9	,	,	PUNCT
dti-2613	314	10	et	et	PROPN
dti-2613	314	11	al	al	PROPN
dti-2613	314	12	.	.	PUNCT
dti-2613	315	1	methicillin	methicillin	NOUN
dti-2613	315	2	-	-	PUNCT
dti-2613	315	3	resistant	resistant	ADJ
dti-2613	315	4	staphylococcus	staphylococcus	NOUN
dti-2613	315	5	aureus	aureus	NOUN
dti-2613	315	6	(	(	PUNCT
dti-2613	315	7	mrsa	mrsa	NOUN
dti-2613	315	8	):	):	PUNCT
dti-2613	315	9	prevalence	prevalence	NOUN
dti-2613	315	10	and	and	CCONJ
dti-2613	315	11	antimicrobial	antimicrobial	ADJ
dti-2613	315	12	sensitivity	sensitivity	NOUN
dti-2613	315	13	pattern	pattern	NOUN
dti-2613	315	14	among	among	ADP
dti-2613	315	15	patients	patient	NOUN
dti-2613	315	16	—	—	PUNCT
dti-2613	315	17	a	a	DET
dti-2613	315	18	multicenter	multicenter	ADJ
dti-2613	315	19	study	study	NOUN
dti-2613	315	20	in	in	ADP
dti-2613	315	21	asmara	asmara	PROPN
dti-2613	315	22	,	,	PUNCT
dti-2613	315	23	eritrea	eritrea	PROPN
dti-2613	315	24	.	.	PUNCT
dti-2613	316	1	can	can	AUX
dti-2613	316	2	j	j	PROPN
dti-2613	316	3	infect	infect	VERB
dti-2613	316	4	dis	dis	PROPN
dti-2613	316	5	med	med	PROPN
dti-2613	316	6	microbiol	microbiol	PROPN
dti-2613	316	7	.	.	PUNCT
dti-2613	317	1	2019:8321834	2019:8321834	NUM
dti-2613	317	2	,	,	PUNCT
dti-2613	317	3	9	9	NUM
dti-2613	317	4	pg	pg	NOUN
dti-2613	317	5	.	.	PUNCT
dti-2613	318	1	crossref	crossref	PROPN
dti-2613	318	2	30	30	NUM
dti-2613	318	3	.	.	PUNCT
dti-2613	319	1	bedawi	bedawi	PROPN
dti-2613	319	2	eo	eo	PROPN
dti-2613	319	3	,	,	PUNCT
dti-2613	319	4	ricciardi	ricciardi	PROPN
dti-2613	319	5	s	s	PROPN
dti-2613	319	6	,	,	PUNCT
dti-2613	319	7	hassan	hassan	PROPN
dti-2613	319	8	m	m	PROPN
dti-2613	319	9	,	,	PUNCT
dti-2613	319	10	et	et	PROPN
dti-2613	319	11	al	al	PROPN
dti-2613	319	12	.	.	PROPN
dti-2613	320	1	ers	er	NOUN
dti-2613	320	2	/	/	SYM
dti-2613	320	3	ests	est	NOUN
dti-2613	320	4	statement	statement	NOUN
dti-2613	320	5	on	on	ADP
dti-2613	320	6	the	the	DET
dti-2613	320	7	management	management	NOUN
dti-2613	320	8	of	of	ADP
dti-2613	320	9	pleural	pleural	ADJ
dti-2613	320	10	infection	infection	NOUN
dti-2613	320	11	in	in	ADP
dti-2613	320	12	adults	adult	NOUN
dti-2613	320	13	.	.	PUNCT
dti-2613	321	1	eur	eur	PROPN
dti-2613	321	2	respir	respir	PROPN
dti-2613	321	3	j.	j.	PROPN
dti-2613	321	4	2023;61(2):61	2023;61(2):61	PROPN
dti-2613	321	5	.	.	PUNCT
dti-2613	322	1	crossref	crossref	PROPN
dti-2613	322	2	pubmed	pubmed	PROPN
dti-2613	322	3	31	31	NUM
dti-2613	322	4	.	.	PUNCT
dti-2613	323	1	shen	shen	PROPN
dti-2613	323	2	kr	kr	PROPN
dti-2613	323	3	,	,	PUNCT
dti-2613	323	4	bribriesco	bribriesco	PROPN
dti-2613	323	5	a	a	X
dti-2613	323	6	,	,	PUNCT
dti-2613	323	7	crabtree	crabtree	PROPN
dti-2613	323	8	t	t	PROPN
dti-2613	323	9	,	,	PUNCT
dti-2613	323	10	et	et	PROPN
dti-2613	323	11	al	al	PROPN
dti-2613	323	12	.	.	PUNCT
dti-2613	324	1	the	the	DET
dti-2613	324	2	american	american	PROPN
dti-2613	324	3	association	association	PROPN
dti-2613	324	4	for	for	ADP
dti-2613	324	5	thoracic	thoracic	NOUN
dti-2613	324	6	surgery	surgery	NOUN
dti-2613	324	7	consensus	consensus	NOUN
dti-2613	324	8	guidelines	guideline	NOUN
dti-2613	324	9	for	for	ADP
dti-2613	324	10	the	the	DET
dti-2613	324	11	management	management	NOUN
dti-2613	324	12	of	of	ADP
dti-2613	324	13	empyema	empyema	NOUN
dti-2613	324	14	.	.	PUNCT
dti-2613	325	1	j	j	PROPN
dti-2613	325	2	thorac	thorac	PROPN
dti-2613	325	3	cardiovasc	cardiovasc	PROPN
dti-2613	325	4	surg	surg	PROPN
dti-2613	325	5	.	.	PUNCT
dti-2613	326	1	2017;153(6	2017;153(6	NUM
dti-2613	326	2	):	):	PUNCT
dti-2613	326	3	e129	e129	PROPN
dti-2613	326	4	-	-	PUNCT
dti-2613	326	5	e146	e146	PROPN
dti-2613	326	6	.	.	PUNCT
dti-2613	327	1	crossref	crossref	PROPN
dti-2613	327	2	pubmed	pubmed	PROPN
dti-2613	327	3	32	32	NUM
dti-2613	327	4	.	.	PUNCT
dti-2613	328	1	dwomoh	dwomoh	PROPN
dti-2613	328	2	fp	fp	NOUN
dti-2613	328	3	,	,	PUNCT
dti-2613	328	4	kotey	kotey	PROPN
dti-2613	328	5	fcn	fcn	PROPN
dti-2613	328	6	,	,	PUNCT
dti-2613	328	7	dayie	dayie	ADJ
dti-2613	328	8	ntkd	ntkd	NOUN
dti-2613	328	9	,	,	PUNCT
dti-2613	328	10	et	et	PROPN
dti-2613	328	11	al	al	PROPN
dti-2613	328	12	.	.	PROPN
dti-2613	328	13	phenotypic	phenotypic	ADJ
dti-2613	328	14	and	and	CCONJ
dti-2613	328	15	genotypic	genotypic	NOUN
dti-2613	328	16	detection	detection	NOUN
dti-2613	328	17	of	of	ADP
dti-2613	328	18	carbapenemase	carbapenemase	NOUN
dti-2613	328	19	-	-	PUNCT
dti-2613	328	20	producing	produce	VERB
dti-2613	328	21	escherichia	escherichia	NOUN
dti-2613	328	22	coli	coli	NOUN
dti-2613	328	23	and	and	CCONJ
dti-2613	328	24	klebsiella	klebsiella	NOUN
dti-2613	328	25	pneumoniae	pneumoniae	ADJ
dti-2613	328	26	in	in	ADP
dti-2613	328	27	accra	accra	NOUN
dti-2613	328	28	,	,	PUNCT
dti-2613	328	29	ghana	ghana	PROPN
dti-2613	328	30	.	.	PUNCT
dti-2613	329	1	plos	plos	PROPN
dti-2613	329	2	one	one	NUM
dti-2613	329	3	.	.	PUNCT
dti-2613	330	1	2022;17(12):e0279715	2022;17(12):e0279715	NOUN
dti-2613	330	2	.	.	PUNCT
dti-2613	331	1	crossref	crossref	PROPN
dti-2613	331	2	pubmed	pubmed	PROPN
dti-2613	331	3	33	33	NUM
dti-2613	331	4	.	.	PUNCT
dti-2613	332	1	hackman	hackman	PROPN
dti-2613	332	2	h	h	PROPN
dti-2613	332	3	,	,	PUNCT
dti-2613	332	4	arhin	arhin	ADJ
dti-2613	332	5	r	r	PROPN
dti-2613	332	6	,	,	PUNCT
dti-2613	332	7	gordon	gordon	PROPN
dti-2613	332	8	a	a	PROPN
dti-2613	332	9	,	,	PUNCT
dti-2613	332	10	mensah	mensah	PROPN
dti-2613	332	11	snb	snb	PROPN
dti-2613	332	12	.	.	PUNCT
dti-2613	333	1	emergence	emergence	NOUN
dti-2613	333	2	of	of	ADP
dti-2613	333	3	carbapenem	carbapenem	NOUN
dti-2613	333	4	-	-	PUNCT
dti-2613	333	5	resistant	resistant	ADJ
dti-2613	333	6	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	333	7	among	among	ADP
dti-2613	333	8	extendedspectrum	extendedspectrum	ADP
dti-2613	333	9	beta	beta	NOUN
dti-2613	333	10	-	-	PUNCT
dti-2613	333	11	lactamase	lactamase	ADJ
dti-2613	333	12	producers	producer	NOUN
dti-2613	333	13	in	in	ADP
dti-2613	333	14	accra	accra	NOUN
dti-2613	333	15	,	,	PUNCT
dti-2613	333	16	ghana	ghana	PROPN
dti-2613	333	17	.	.	PUNCT
dti-2613	333	18	2017;7(24	2017;7(24	NUM
dti-2613	333	19	)	)	PUNCT
dti-2613	333	20	.	.	PUNCT
dti-2613	334	1	online	online	ADV
dti-2613	334	2	34	34	NUM
dti-2613	334	3	.	.	PUNCT
dti-2613	335	1	abubakar	abubakar	PROPN
dti-2613	335	2	u	u	PROPN
dti-2613	335	3	,	,	PUNCT
dti-2613	335	4	tangiisuran	tangiisuran	NOUN
dti-2613	335	5	b	b	NOUN
dti-2613	335	6	,	,	PUNCT
dti-2613	335	7	elnaem	elnaem	PROPN
dti-2613	335	8	mh	mh	PROPN
dti-2613	335	9	,	,	PUNCT
dti-2613	335	10	sulaiman	sulaiman	PROPN
dti-2613	335	11	sas	sas	PROPN
dti-2613	335	12	,	,	PUNCT
dti-2613	335	13	khan	khan	PROPN
dti-2613	335	14	fu	fu	PROPN
dti-2613	335	15	.	.	PUNCT
dti-2613	336	1	mortality	mortality	NOUN
dti-2613	336	2	and	and	CCONJ
dti-2613	336	3	its	its	PRON
dti-2613	336	4	predictors	predictor	NOUN
dti-2613	336	5	among	among	ADP
dti-2613	336	6	hospitalized	hospitalize	VERB
dti-2613	336	7	patients	patient	NOUN
dti-2613	336	8	with	with	ADP
dti-2613	336	9	infections	infection	NOUN
dti-2613	336	10	due	due	ADP
dti-2613	336	11	to	to	ADP
dti-2613	336	12	extended	extend	VERB
dti-2613	336	13	spectrum	spectrum	NOUN
dti-2613	336	14	beta	beta	NOUN
dti-2613	336	15	-	-	PUNCT
dti-2613	336	16	lactamase	lactamase	NOUN
dti-2613	336	17	(	(	PUNCT
dti-2613	336	18	esbl	esbl	NOUN
dti-2613	336	19	)	)	PUNCT
dti-2613	336	20	enterobacteriaceae	enterobacteriaceae	PROPN
dti-2613	336	21	in	in	ADP
dti-2613	336	22	malaysia	malaysia	PROPN
dti-2613	336	23	:	:	PUNCT
dti-2613	336	24	a	a	DET
dti-2613	336	25	retrospective	retrospective	ADJ
dti-2613	336	26	observational	observational	ADJ
dti-2613	336	27	study	study	NOUN
dti-2613	336	28	.	.	PUNCT
dti-2613	337	1	futur	futur	PROPN
dti-2613	337	2	j	j	PROPN
dti-2613	337	3	pharm	pharm	PROPN
dti-2613	337	4	sci	sci	PROPN
dti-2613	337	5	2022;8:17:1	2022;8:17:1	NUM
dti-2613	337	6	-	-	SYM
dti-2613	337	7	8	8	NUM
dti-2613	337	8	.	.	PUNCT
dti-2613	338	1	crossref	crossref	PROPN
dti-2613	338	2	35	35	NUM
dti-2613	338	3	.	.	PUNCT
dti-2613	339	1	olowo	olowo	PROPN
dti-2613	339	2	-	-	PUNCT
dti-2613	339	3	okere	okere	VERB
dti-2613	339	4	a	a	PRON
dti-2613	339	5	,	,	PUNCT
dti-2613	339	6	ibrahim	ibrahim	PROPN
dti-2613	339	7	yke	yke	PROPN
dti-2613	339	8	,	,	PUNCT
dti-2613	339	9	olayinka	olayinka	PROPN
dti-2613	339	10	bo	bo	PROPN
dti-2613	339	11	,	,	PUNCT
dti-2613	339	12	et	et	PROPN
dti-2613	339	13	al	al	PROPN
dti-2613	339	14	.	.	PROPN
dti-2613	339	15	phenotypic	phenotypic	ADJ
dti-2613	339	16	and	and	CCONJ
dti-2613	339	17	genotypic	genotypic	ADJ
dti-2613	339	18	characterization	characterization	NOUN
dti-2613	339	19	of	of	ADP
dti-2613	339	20	clinical	clinical	ADJ
dti-2613	339	21	carbapenem	carbapenem	NOUN
dti-2613	339	22	-	-	PUNCT
dti-2613	339	23	resistant	resistant	ADJ
dti-2613	339	24	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	339	25	isolates	isolate	NOUN
dti-2613	339	26	from	from	ADP
dti-2613	339	27	sokoto	sokoto	PROPN
dti-2613	339	28	,	,	PUNCT
dti-2613	339	29	northwest	northwest	PROPN
dti-2613	339	30	nigeria	nigeria	PROPN
dti-2613	339	31	.	.	PUNCT
dti-2613	340	1	new	new	ADJ
dti-2613	340	2	microbes	microbe	NOUN
dti-2613	340	3	new	new	ADJ
dti-2613	340	4	infect	infect	NOUN
dti-2613	340	5	.	.	PUNCT
dti-2613	341	1	2020;37:100727	2020;37:100727	NUM
dti-2613	341	2	.	.	PUNCT
dti-2613	342	1	crossref	crossref	PROPN
dti-2613	342	2	pubmed	pubmed	PROPN
dti-2613	342	3	36	36	NUM
dti-2613	342	4	.	.	PUNCT
dti-2613	343	1	ballot	ballot	PROPN
dti-2613	343	2	de	de	PROPN
dti-2613	343	3	,	,	PUNCT
dti-2613	343	4	bandini	bandini	PROPN
dti-2613	343	5	r	r	PROPN
dti-2613	343	6	,	,	PUNCT
dti-2613	343	7	nana	nana	PROPN
dti-2613	343	8	t	t	PROPN
dti-2613	343	9	,	,	PUNCT
dti-2613	343	10	et	et	PROPN
dti-2613	343	11	al	al	PROPN
dti-2613	343	12	.	.	PUNCT
dti-2613	344	1	a	a	DET
dti-2613	344	2	review	review	NOUN
dti-2613	344	3	of	of	ADP
dti-2613	344	4	multidrug	multidrug	NOUN
dti-2613	344	5	-	-	PUNCT
dti-2613	344	6	resistant	resistant	ADJ
dti-2613	344	7	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	344	8	in	in	ADP
dti-2613	344	9	a	a	DET
dti-2613	344	10	neonatal	neonatal	ADJ
dti-2613	344	11	unit	unit	NOUN
dti-2613	344	12	in	in	ADP
dti-2613	344	13	johannesburg	johannesburg	PROPN
dti-2613	344	14	,	,	PUNCT
dti-2613	344	15	south	south	PROPN
dti-2613	344	16	africa	africa	PROPN
dti-2613	344	17	.	.	PUNCT
dti-2613	345	1	bmc	bmc	PROPN
dti-2613	345	2	pediatr	pediatr	NOUN
dti-2613	345	3	.	.	PUNCT
dti-2613	346	1	2019;19(1):320	2019;19(1):320	NOUN
dti-2613	346	2	.	.	PUNCT
dti-2613	347	1	crossref	crossref	PROPN
dti-2613	347	2	pubmed	pubmed	PROPN
dti-2613	347	3	37	37	NUM
dti-2613	347	4	.	.	PUNCT
dti-2613	348	1	kotb	kotb	PROPN
dti-2613	348	2	s	s	PART
dti-2613	348	3	,	,	PUNCT
dti-2613	348	4	lyman	lyman	PROPN
dti-2613	348	5	m	m	PROPN
dti-2613	348	6	,	,	PUNCT
dti-2613	348	7	ismail	ismail	PROPN
dti-2613	348	8	g	g	PROPN
dti-2613	348	9	,	,	PUNCT
dti-2613	348	10	et	et	PROPN
dti-2613	348	11	al	al	PROPN
dti-2613	348	12	.	.	PUNCT
dti-2613	349	1	epidemiology	epidemiology	NOUN
dti-2613	349	2	of	of	ADP
dti-2613	349	3	carbapenemresistant	carbapenemresistant	PROPN
dti-2613	349	4	enterobacteriaceae	enterobacteriaceae	PROPN
dti-2613	349	5	in	in	ADP
dti-2613	349	6	egyptian	egyptian	ADJ
dti-2613	349	7	intensive	intensive	ADJ
dti-2613	349	8	care	care	NOUN
dti-2613	349	9	units	unit	NOUN
dti-2613	349	10	using	use	VERB
dti-2613	349	11	national	national	ADJ
dti-2613	349	12	healthcare	healthcare	PROPN
dti-2613	349	13	-	-	PUNCT
dti-2613	349	14	associated	associate	VERB
dti-2613	349	15	infections	infection	NOUN
dti-2613	349	16	surveillance	surveillance	NOUN
dti-2613	349	17	data	datum	NOUN
dti-2613	349	18	,	,	PUNCT
dti-2613	349	19	2011	2011	NUM
dti-2613	349	20	-	-	SYM
dti-2613	349	21	2017	2017	NUM
dti-2613	349	22	.	.	PUNCT
dti-2613	350	1	antimicrob	antimicrob	ADJ
dti-2613	350	2	resist	resist	VERB
dti-2613	350	3	infect	infect	ADJ
dti-2613	350	4	control	control	NOUN
dti-2613	350	5	.	.	PUNCT
dti-2613	351	1	2020;9(1):2	2020;9(1):2	PROPN
dti-2613	351	2	.	.	PUNCT
dti-2613	352	1	crossref	crossref	PROPN
dti-2613	352	2	pubmed	pubmed	PROPN
dti-2613	352	3	38	38	NUM
dti-2613	352	4	.	.	PUNCT
dti-2613	353	1	boyd	boyd	PROPN
dti-2613	353	2	se	se	PROPN
dti-2613	353	3	,	,	PUNCT
dti-2613	353	4	holmes	holmes	PROPN
dti-2613	353	5	a	a	PRON
dti-2613	353	6	,	,	PUNCT
dti-2613	353	7	peck	peck	ADJ
dti-2613	353	8	r	r	NOUN
dti-2613	353	9	,	,	PUNCT
dti-2613	353	10	livermore	livermore	PROPN
dti-2613	353	11	dm	dm	PROPN
dti-2613	353	12	,	,	PUNCT
dti-2613	353	13	hope	hope	VERB
dti-2613	353	14	w.	w.	PROPN
dti-2613	353	15	oxa-48like	oxa-48like	PROPN
dti-2613	353	16	β	β	NOUN
dti-2613	353	17	-	-	NOUN
dti-2613	353	18	lactamases	lactamase	NOUN
dti-2613	353	19	:	:	PUNCT
dti-2613	353	20	global	global	ADJ
dti-2613	353	21	epidemiology	epidemiology	NOUN
dti-2613	353	22	,	,	PUNCT
dti-2613	353	23	treatment	treatment	NOUN
dti-2613	353	24	options	option	NOUN
dti-2613	353	25	,	,	PUNCT
dti-2613	353	26	and	and	CCONJ
dti-2613	353	27	development	development	NOUN
dti-2613	353	28	pipeline	pipeline	NOUN
dti-2613	353	29	.	.	PUNCT
dti-2613	354	1	antimicrob	antimicrob	PROPN
dti-2613	354	2	agents	agents	PROPN
dti-2613	354	3	chemother	chemother	PROPN
dti-2613	354	4	.	.	PUNCT
dti-2613	355	1	2022;66(8):e0021622	2022;66(8):e0021622	X
dti-2613	355	2	.	.	PUNCT
dti-2613	356	1	crossref	crossref	PROPN
dti-2613	356	2	pubmed	pubmed	PROPN
dti-2613	356	3	39	39	NUM
dti-2613	356	4	.	.	PUNCT
dti-2613	357	1	jomehzadeh	jomehzadeh	NOUN
dti-2613	357	2	n	n	CCONJ
dti-2613	357	3	,	,	PUNCT
dti-2613	357	4	jahangirimehr	jahangirimehr	NOUN
dti-2613	357	5	f	f	PROPN
dti-2613	357	6	,	,	PUNCT
dti-2613	357	7	chegeni	chegeni	PROPN
dti-2613	357	8	sa	sa	PROPN
dti-2613	357	9	.	.	PUNCT
dti-2613	357	10	virulenceassociated	virulenceassociate	VERB
dti-2613	357	11	genes	gene	NOUN
dti-2613	357	12	analysis	analysis	NOUN
dti-2613	357	13	of	of	ADP
dti-2613	357	14	carbapenemase	carbapenemase	NOUN
dti-2613	357	15	-	-	PUNCT
dti-2613	357	16	producing	produce	VERB
dti-2613	357	17	escherichia	escherichia	NOUN
dti-2613	357	18	coli	coli	NOUN
dti-2613	357	19	isolates	isolate	NOUN
dti-2613	357	20	.	.	PUNCT
dti-2613	358	1	plos	plos	PROPN
dti-2613	358	2	one	one	NUM
dti-2613	358	3	.	.	PUNCT
dti-2613	359	1	2022;17(5):e0266787	2022;17(5):e0266787	NUM
dti-2613	359	2	.	.	PUNCT
dti-2613	359	3	crossref	crossref	PROPN
dti-2613	359	4	pubmed	pubmed	PROPN
dti-2613	359	5	https://doi.org/10.1186/s40560-020-0429-6	https://doi.org/10.1186/s40560-020-0429-6	PROPN
dti-2613	359	6	https://doi.org/10.1093/jacamr/dlab092	https://doi.org/10.1093/jacamr/dlab092	NOUN
dti-2613	359	7	https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed	https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-neede	VERB
dti-2613	359	8	https://doi.org/10.33393/dti.2022.2422	https://doi.org/10.33393/dti.2022.2422	PROPN
dti-2613	359	9	https://www.ncbi.nlm.nih.gov/pubmed/36304435	https://www.ncbi.nlm.nih.gov/pubmed/36304435	PUNCT
dti-2613	360	1	https://doi.org/10.1136/bmjopen-2019-030266	https://doi.org/10.1136/bmjopen-2019-030266	ADV
dti-2613	360	2	https://www.ncbi.nlm.nih.gov/pubmed/31964661	https://www.ncbi.nlm.nih.gov/pubmed/31964661	ADV
dti-2613	360	3	https://doi.org/10.1016/j.jgar.2022.04.005	https://doi.org/10.1016/j.jgar.2022.04.005	VERB
dti-2613	360	4	https://www.ncbi.nlm.nih.gov/pubmed/35429666	https://www.ncbi.nlm.nih.gov/pubmed/35429666	NUM
dti-2613	360	5	https://doi.org/10.3390/pharmacy11020074	https://doi.org/10.3390/pharmacy11020074	PROPN
dti-2613	360	6	https://www.ncbi.nlm.nih.gov/pubmed/37104080	https://www.ncbi.nlm.nih.gov/pubmed/37104080	NUM
dti-2613	360	7	https://doi.org/10.1016/j.ijantimicag.2020.106203	https://doi.org/10.1016/j.ijantimicag.2020.106203	PROPN
dti-2613	360	8	https://www.ncbi.nlm.nih.gov/pubmed/33075511	https://www.ncbi.nlm.nih.gov/pubmed/33075511	PROPN
dti-2613	360	9	https://doi.org/10.53597/remim.v14i2.1363	https://doi.org/10.53597/remim.v14i2.1363	NUM
dti-2613	360	10	https://doi.org/10.1099/jmm.0.001182	https://doi.org/10.1099/jmm.0.001182	PROPN
dti-2613	360	11	https://www.ncbi.nlm.nih.gov/pubmed/32375948	https://www.ncbi.nlm.nih.gov/pubmed/32375948	NUM
dti-2613	360	12	https://doi.org/10.1371/journal.pone.0172652	https://doi.org/10.1371/journal.pone.0172652	PROPN
dti-2613	360	13	https://www.ncbi.nlm.nih.gov/pubmed/28245252	https://www.ncbi.nlm.nih.gov/pubmed/28245252	NUM
dti-2613	360	14	https://doi.org/10.1136/thx.2010.137000	https://doi.org/10.1136/thx.2010.137000	PROPN
dti-2613	360	15	https://www.ncbi.nlm.nih.gov/pubmed/20696693	https://www.ncbi.nlm.nih.gov/pubmed/20696693	NUM
dti-2613	360	16	https://www.sfm-microbiologie.org/2020/10/02/casfm-eucast-v1-2-octobre-2020/	https://www.sfm-microbiologie.org/2020/10/02/casfm-eucast-v1-2-octobre-2020/	NOUN
dti-2613	360	17	https://doi.org/10.1101/810622	https://doi.org/10.1101/810622	X
dti-2613	360	18	https://doi.org/10.1111/j.1469-0691.2011.03570.x	https://doi.org/10.1111/j.1469-0691.2011.03570.x	NOUN
dti-2613	360	19	https://www.ncbi.nlm.nih.gov/pubmed/21793988	https://www.ncbi.nlm.nih.gov/pubmed/21793988	PRON
dti-2613	360	20	https://doi.org/10.5897/ajmr2017.8598	https://doi.org/10.5897/ajmr2017.8598	NOUN
dti-2613	360	21	https://www.ncbi.nlm.nih.gov/pubmed/36263534	https://www.ncbi.nlm.nih.gov/pubmed/36263534	NUM
dti-2613	360	22	https://doi.org/10.1186/s12879-016-1655-3	https://doi.org/10.1186/s12879-016-1655-3	PROPN
dti-2613	360	23	https://www.ncbi.nlm.nih.gov/pubmed/27400864	https://www.ncbi.nlm.nih.gov/pubmed/27400864	PRON
dti-2613	360	24	https://doi.org/10.1186/s13756-016-0117-4	https://doi.org/10.1186/s13756-016-0117-4	VERB
dti-2613	360	25	https://doi.org/10.1155/2019/8321834	https://doi.org/10.1155/2019/8321834	PROPN
dti-2613	360	26	https://doi.org/10.1183/13993003.01062-2022	https://doi.org/10.1183/13993003.01062-2022	PART
dti-2613	361	1	https://www.ncbi.nlm.nih.gov/pubmed/36229045	https://www.ncbi.nlm.nih.gov/pubmed/36229045	NUM
dti-2613	361	2	https://doi.org/10.1016/j.jtcvs.2017.01.030	https://doi.org/10.1016/j.jtcvs.2017.01.030	NOUN
dti-2613	361	3	https://www.ncbi.nlm.nih.gov/pubmed/28274565	https://www.ncbi.nlm.nih.gov/pubmed/28274565	NUM
dti-2613	361	4	https://doi.org/10.1371/journal.pone.0279715	https://doi.org/10.1371/journal.pone.0279715	NOUN
dti-2613	361	5	https://www.ncbi.nlm.nih.gov/pubmed/36584159	https://www.ncbi.nlm.nih.gov/pubmed/36584159	ADP
dti-2613	361	6	https://core.ac.uk/download/pdf/234657611.pdf	https://core.ac.uk/download/pdf/234657611.pdf	PROPN
dti-2613	361	7	https://core.ac.uk/download/pdf/234657611.pdf	https://core.ac.uk/download/pdf/234657611.pdf	PROPN
dti-2613	361	8	https://doi.org/10.1186/s43094-022-00406-8	https://doi.org/10.1186/s43094-022-00406-8	NUM
dti-2613	361	9	https://doi.org/10.1016/j.nmni.2020.100727	https://doi.org/10.1016/j.nmni.2020.100727	PROPN
dti-2613	361	10	https://www.ncbi.nlm.nih.gov/pubmed/32939286	https://www.ncbi.nlm.nih.gov/pubmed/32939286	ADJ
dti-2613	361	11	https://doi.org/10.1186/s12887-019-1709-y	https://doi.org/10.1186/s12887-019-1709-y	PROPN
dti-2613	361	12	https://www.ncbi.nlm.nih.gov/pubmed/31493789	https://www.ncbi.nlm.nih.gov/pubmed/31493789	NUM
dti-2613	361	13	https://doi.org/10.1186/s13756-019-0639-7	https://doi.org/10.1186/s13756-019-0639-7	NUM
dti-2613	361	14	https://www.ncbi.nlm.nih.gov/pubmed/31911830	https://www.ncbi.nlm.nih.gov/pubmed/31911830	NUM
dti-2613	361	15	https://doi.org/10.1128/aac.00216-22	https://doi.org/10.1128/aac.00216-22	PROPN
dti-2613	361	16	https://www.ncbi.nlm.nih.gov/pubmed/35856662	https://www.ncbi.nlm.nih.gov/pubmed/35856662	PRON
dti-2613	361	17	https://doi.org/10.1371/journal.pone.0266787	https://doi.org/10.1371/journal.pone.0266787	NOUN
dti-2613	361	18	https://www.ncbi.nlm.nih.gov/pubmed/35536848	https://www.ncbi.nlm.nih.gov/pubmed/35536848	PROPN
dti-2613	361	19	hôpital	hôpital	PROPN
dti-2613	361	20	du	du	PROPN
dti-2613	361	21	mali	mali	PROPN
dti-2613	361	22	:	:	PUNCT
dti-2613	361	23	antibiotic	antibiotic	ADJ
dti-2613	361	24	resistance	resistance	NOUN
dti-2613	361	25	in	in	ADP
dti-2613	361	26	ipes100	ipes100	PROPN
dti-2613	361	27	©	©	PROPN
dti-2613	361	28	2023	2023	NUM
dti-2613	361	29	the	the	DET
dti-2613	361	30	authors	author	NOUN
dti-2613	361	31	.	.	PUNCT
dti-2613	362	1	drug	drug	NOUN
dti-2613	362	2	target	target	NOUN
dti-2613	362	3	insights	insight	NOUN
dti-2613	362	4	issn	issn	VERB
dti-2613	362	5	1177	1177	NUM
dti-2613	362	6	-	-	SYM
dti-2613	362	7	3928	3928	NUM
dti-2613	362	8	www.aboutscience.eu/dti	www.aboutscience.eu/dti	VERB
dti-2613	362	9	40	40	NUM
dti-2613	362	10	.	.	PUNCT
dti-2613	363	1	pilmis	pilmis	PROPN
dti-2613	363	2	b	b	PROPN
dti-2613	363	3	,	,	PUNCT
dti-2613	363	4	jullien	jullien	PROPN
dti-2613	363	5	v	v	NOUN
dti-2613	363	6	,	,	PUNCT
dti-2613	363	7	tabah	tabah	PROPN
dti-2613	363	8	a	a	PROPN
dti-2613	363	9	,	,	PUNCT
dti-2613	363	10	zahar	zahar	PROPN
dti-2613	363	11	jr	jr	PROPN
dti-2613	363	12	,	,	PUNCT
dti-2613	363	13	brun	brun	NOUN
dti-2613	363	14	-	-	PUNCT
dti-2613	363	15	buisson	buisson	PROPN
dti-2613	363	16	c.	c.	PROPN
dti-2613	363	17	piperacillin	piperacillin	PROPN
dti-2613	363	18	-	-	PUNCT
dti-2613	363	19	tazobactam	tazobactam	NOUN
dti-2613	363	20	as	as	ADP
dti-2613	363	21	alternative	alternative	ADJ
dti-2613	363	22	to	to	ADP
dti-2613	363	23	carbapenems	carbapenem	NOUN
dti-2613	363	24	for	for	ADP
dti-2613	363	25	icu	icu	PROPN
dti-2613	363	26	patients	patient	NOUN
dti-2613	363	27	.	.	PUNCT
dti-2613	364	1	ann	ann	PROPN
dti-2613	364	2	intensive	intensive	ADJ
dti-2613	364	3	care	care	NOUN
dti-2613	364	4	.	.	PUNCT
dti-2613	365	1	2017;7(1):113	2017;7(1):113	X
dti-2613	365	2	.	.	PUNCT
dti-2613	366	1	crossref	crossref	PROPN
dti-2613	366	2	pubmed	pubmed	PROPN
dti-2613	366	3	41	41	NUM
dti-2613	366	4	.	.	PUNCT
dti-2613	367	1	gutiérrez	gutiérrez	NOUN
dti-2613	367	2	-	-	PUNCT
dti-2613	367	3	gutiérrez	gutiérrez	PROPN
dti-2613	367	4	b	b	PROPN
dti-2613	367	5	,	,	PUNCT
dti-2613	367	6	rodríguez	rodríguez	NOUN
dti-2613	367	7	-	-	PUNCT
dti-2613	367	8	baño	baño	PROPN
dti-2613	367	9	j.	j.	PROPN
dti-2613	367	10	current	current	ADJ
dti-2613	367	11	options	option	NOUN
dti-2613	367	12	for	for	ADP
dti-2613	367	13	the	the	DET
dti-2613	367	14	treatment	treatment	NOUN
dti-2613	367	15	of	of	ADP
dti-2613	367	16	infections	infection	NOUN
dti-2613	367	17	due	due	ADJ
dti-2613	367	18	to	to	ADP
dti-2613	367	19	extended	extend	VERB
dti-2613	367	20	-	-	PUNCT
dti-2613	367	21	spectrum	spectrum	NOUN
dti-2613	367	22	betalactamase	betalactamase	NOUN
dti-2613	367	23	-	-	PUNCT
dti-2613	367	24	producing	produce	VERB
dti-2613	367	25	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	367	26	in	in	ADP
dti-2613	367	27	different	different	ADJ
dti-2613	367	28	groups	group	NOUN
dti-2613	367	29	of	of	ADP
dti-2613	367	30	patients	patient	NOUN
dti-2613	367	31	.	.	PUNCT
dti-2613	368	1	clin	clin	PROPN
dti-2613	368	2	microbiol	microbiol	PROPN
dti-2613	368	3	infect	infect	PROPN
dti-2613	368	4	.	.	PUNCT
dti-2613	369	1	2019;25(8):932	2019;25(8):932	NUM
dti-2613	369	2	-	-	SYM
dti-2613	369	3	942	942	NUM
dti-2613	369	4	.	.	PUNCT
dti-2613	370	1	crossref	crossref	PROPN
dti-2613	370	2	pubmed	pubmed	PROPN
dti-2613	370	3	42	42	NUM
dti-2613	370	4	.	.	PUNCT
dti-2613	371	1	grabein	grabein	PROPN
dti-2613	371	2	b	b	PROPN
dti-2613	371	3	,	,	PUNCT
dti-2613	371	4	ebenhoch	ebenhoch	PROPN
dti-2613	371	5	m	m	PROPN
dti-2613	371	6	,	,	PUNCT
dti-2613	371	7	kühnen	kühnen	PROPN
dti-2613	371	8	e	e	PROPN
dti-2613	371	9	,	,	PUNCT
dti-2613	371	10	thalhammer	thalhammer	PROPN
dti-2613	371	11	f.	f.	PROPN
dti-2613	371	12	calculated	calculate	VERB
dti-2613	371	13	parenteral	parenteral	ADJ
dti-2613	371	14	initial	initial	ADJ
dti-2613	371	15	treatment	treatment	NOUN
dti-2613	371	16	of	of	ADP
dti-2613	371	17	bacterial	bacterial	ADJ
dti-2613	371	18	infections	infection	NOUN
dti-2613	371	19	:	:	PUNCT
dti-2613	371	20	infections	infection	NOUN
dti-2613	371	21	with	with	ADP
dti-2613	371	22	multi	multi	ADJ
dti-2613	371	23	-	-	ADJ
dti-2613	371	24	resistant	resistant	ADJ
dti-2613	371	25	gram	gram	NOUN
dti-2613	371	26	-	-	PUNCT
dti-2613	371	27	negative	negative	ADJ
dti-2613	371	28	rods	rod	NOUN
dti-2613	371	29	—	—	PUNCT
dti-2613	371	30	esbl	esbl	NOUN
dti-2613	371	31	producers	producer	NOUN
dti-2613	371	32	,	,	PUNCT
dti-2613	371	33	carbapenemase	carbapenemase	NOUN
dti-2613	371	34	-	-	PUNCT
dti-2613	371	35	producing	produce	VERB
dti-2613	371	36	enterobacteriaceae	enterobacteriaceae	NOUN
dti-2613	371	37	,	,	PUNCT
dti-2613	371	38	carbapenemresistant	carbapenemresistant	NOUN
dti-2613	371	39	acinetobacter	acinetobacter	ADV
dti-2613	371	40	baumannii	baumannii	PROPN
dti-2613	371	41	.	.	PUNCT
dti-2613	372	1	gms	gms	NOUN
dti-2613	372	2	infect	infect	PROPN
dti-2613	372	3	dis	dis	PROPN
dti-2613	372	4	.	.	PUNCT
dti-2613	373	1	2020;8	2020;8	PROPN
dti-2613	373	2	:	:	PUNCT
dti-2613	374	1	doc04	doc04	PROPN
dti-2613	374	2	.	.	PUNCT
dti-2613	375	1	pubmed	pubmed	PROPN
dti-2613	375	2	43	43	NUM
dti-2613	375	3	.	.	PUNCT
dti-2613	376	1	dranenko	dranenko	PROPN
dti-2613	376	2	no	no	INTJ
dti-2613	376	3	,	,	PUNCT
dti-2613	376	4	tutukina	tutukina	PROPN
dti-2613	376	5	mn	mn	PROPN
dti-2613	376	6	,	,	PUNCT
dti-2613	376	7	gelfand	gelfand	PROPN
dti-2613	376	8	ms	ms	PROPN
dti-2613	376	9	,	,	PUNCT
dti-2613	376	10	kondrashov	kondrashov	PROPN
dti-2613	376	11	fa	fa	PROPN
dti-2613	376	12	,	,	PUNCT
dti-2613	376	13	bochkareva	bochkareva	PROPN
dti-2613	376	14	oo	oo	INTJ
dti-2613	376	15	.	.	PUNCT
dti-2613	377	1	chromosome	chromosome	NOUN
dti-2613	377	2	-	-	PUNCT
dti-2613	377	3	encoded	encode	VERB
dti-2613	377	4	ipah	ipah	NOUN
dti-2613	377	5	ubiquitin	ubiquitin	NOUN
dti-2613	377	6	ligases	ligase	NOUN
dti-2613	377	7	indicate	indicate	VERB
dti-2613	377	8	non	non	ADJ
dti-2613	377	9	-	-	ADJ
dti-2613	377	10	human	human	ADJ
dti-2613	377	11	enteroinvasive	enteroinvasive	ADJ
dti-2613	377	12	escherichia	escherichia	NOUN
dti-2613	377	13	.	.	PUNCT
dti-2613	378	1	sci	sci	PROPN
dti-2613	378	2	rep	rep	PROPN
dti-2613	378	3	.	.	PROPN
dti-2613	378	4	2022;12:1	2022;12:1	NUM
dti-2613	378	5	-	-	SYM
dti-2613	378	6	10	10	NUM
dti-2613	378	7	.	.	PUNCT
dti-2613	379	1	crossref	crossref	PROPN
dti-2613	379	2	https://doi.org/10.1186/s13613-017-0334-x	https://doi.org/10.1186/s13613-017-0334-x	PROPN
dti-2613	379	3	https://www.ncbi.nlm.nih.gov/pubmed/29127502	https://www.ncbi.nlm.nih.gov/pubmed/29127502	NUM
dti-2613	379	4	https://doi.org/10.1016/j.cmi.2019.03.030	https://doi.org/10.1016/j.cmi.2019.03.030	NOUN
dti-2613	379	5	https://www.ncbi.nlm.nih.gov/pubmed/30986558	https://www.ncbi.nlm.nih.gov/pubmed/30986558	X
dti-2613	379	6	https://www.ncbi.nlm.nih.gov/pubmed/32373429	https://www.ncbi.nlm.nih.gov/pubmed/32373429	PROPN
dti-2613	379	7	https://doi.org/10.1038/s41598-022-10827-3	https://doi.org/10.1038/s41598-022-10827-3	NUM